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CHAPTER 1 
GENERAL INTRODUCTION 
1.1. INTRODUCTORY REMARKS 
Muscle tissue is responsible for locomotion and is important for the 
posture of man and animals. The cells of this highly specialized tissue are 
elongated in the direction of contraction, and therefore called muscle fi-
bers. There are two general categories of muscle tissue in the body, cross-
striated and smooth (nonstriated) muscle (Fig. 1.1). The latter forms, 
among others, the visceral and blood vessel musculature and is innervated 
by the autonomic nervous system, so that its contraction is not subject to 
voluntary control. Smooth muscle will not be considered in this study. 
Upon microscopic examination, striated muscle exhibits regularly 
k-20*im-^ nuclei 
part of skeletal muscle cell 
heart muscle cell 
Fig. 1.1. Schematic presentation of the various kinds of muscle cells. Myo-
fibrils are shown on the left side of the skeletal muscle cell. 
The sculptured surfaces on both ends of the ramified heart muscle 
cell represent the interdigitated junctions (intercalated discs) 
with neighbouring muscle cells, bearing junctional complexes 
that provide for mutual attachment and electrical conduction. 
(Reproduced, with permission, from Alberts et ai., 1983). 
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spaced transverse bands along the length of the fiber, and is subdivided in-
to two distinct types, cardiac and skeletal muscle. Cardiac muscle makes up 
the wall of the heart and its rhythmical contraction is involuntary. On the 
contrary, contraction of skeletal muscle is voluntary. In most mammals, in-
cluding man, the proportion of the total body weight represented by skeletal 
muscle varies with the age of the individual, being about 25% at birth and 
over 40% at maturity. In man it may decline to 30% or less in old age. 
Large differences exist in the energy metabolism of different organs, 
e.g. liver, muscle, brain and kidney, but also among the various types of 
muscle. Skeletal muscle shows a lower metabolic capacity per kg tissue than 
liver and kidney, but its relatively large mass (18 and 11 times that of 
liver for man and rat, respectively) makes that this tissue plays a signi-
ficant role in the overall metabolism of the body. Our knowledge about the 
regulation of energy metabolism of muscle, especially that of man, is limi-
ted. Extension of this knowledge will provide a better insight in the func-
tioning of normal and pathological muscle and may form a basis for diagnosis 
and possibly therapy of metabolic disorders. 
Previously, studies were performed at this laboratory focussed on 
fatty acid oxidation by skeletal and cardiac muscle of man and rat (see 
Thesis Van Hinsbergh, 1979). In those studies isolated mitochondria and a 
postnuclear fraction were applied to limit the complexity of the system. On 
this basis we further investigated the utilization of fatty acids for mus-
cular energy production, using various cell-free and cellular systems. In 
the following sections the general properties of striated muscle tissue 
will be described and a survey will be given of the present knowledge on 
energy production and utilization in skeletal and cardiac muscle. A de-
tailed description is given of the pathway of fatty acid oxidation. Since 
we also investigated the role of fatty acid-binding protein in the intra-
cellular fatty acid metabolism, the current knowledge about this protein is 
reviewed. The chapter will be concluded with the aim and scope of this 
study. 
1.2. MORPHOLOGY AND GENERAL PROPERTIES OF SKELETAL AND CARDIAC MUSCLE 
Both skeletal and cardiac myscle are built up of large numbers of 
parallel orientated muscle fibers, enclosed in a thin envelope of connec-
tive tissue. For skeletal muscle, this connective tissue thickens towards 
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Fig. 1.2. Typical appearance of individual isolated rat myocardial cells 
under the light microscope. As in the intact tissue, the isolated 
cells branch freely and are irregular in cross section. Separa-
tion of the cells from its neighbours has occurred by cleavage at 
the intercalated disc.(Reproduced, with permission, from Dow et 
ai., 1981a) . 
the end of the muscle, thus forming the tendons by which the muscle is ge-
nerally attached to the skeleton. Each individual muscle fiber is surroun-
ded by a rich bed of capillaries, supplying substrates and oxygen and remo-
ving products and carbon dioxide. 
Skeletal muscle fibers are multinucleated cells, formed by fusion of 
arrays of myoblasts during embryogenesis. The nuclei usually lie subsarco-
lemmally (Fig. 1.1). The cells are very long (up to 10-20 cm in man), in 
some muscles (e.g. m.soleus) they may run from the origin of the muscle to 
its insertion. The diameter of the adult mammalian muscle fibers ranges 
from 10 to 100 \m or more. Cardiac muscle cells are much shorter, have an 
irregular shape and are often branched (Figs. 1.1 and 1.2). The points of 
adhesion between adjacent cells can be recognized as transverse dark lines 
called intercalated discs. There are only a few nuclei in each cardiac cell, 
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Fig. 1.3. Schematic presentation of part of a mammalian skeletal muscle fi­
ber. The sarcoplasmic reticulum, which consists of longitudinal 
sarcotubules and transverse terminal cisternae, is in contact 
with the transverse tubuli at the so-called triad. The myofibrils 
are orientated in the direction of the fiber. Magnification, 
24,000 x. (Reproduced, with permission, from Krstic, 1978). 
usually situated deep in the interior of the fiber. 
The striated muscle cell is supplied with an excitable membrane, the 
sarcolemma, which contains many tubular invaginations known as the T-system 
(Figs. 1.3 and 1.4), and which is involved in the onset of contraction. Car­
diac muscle contains more and much larger transverse tubuli (Τ tubuli) than 
skeletal muscle. Apparently, no point in a cardiac muscle fiber is at more 
than 2-3 ym distance from the extracellular space. In skeletal muscle this 
distance is 4-25 pm (Bloom & Fawcett, 1975). These channels provide impor-
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Mitochondrion 
T-tubule 
Sorcolemma 
Sarcoplasmic 
reticulum 
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T-tubule 
(sarcolemmal 
invagination) 
Contact of reticulum 
with T-tubule 
Fig. 1.4. Schematic presentation of part of a mammalian cardiac muscle cell. 
The mitochondria and Τ tubuli are more numerous and much larger 
than in skeletal muscle fibers. The relatively simple sarcoplas­
mic reticulum has few terminal cisternae and there are no triads. 
Instead, small terminal extensions of the reticulum are in con­
tact with the cell membrane, either at the cell surface or at the 
Τ tubuli. (Reproduced, with permission, from Bloom & Fawcett, 
1975). 
tant additional surface for the exchange of metabolites between the muscle 
fiber and the extracellular space, especially in heart. 
The sarcoplasm is nearly completely filled with contractile material, 
which in skeletal muscle is visible in the light microscope as discrete 
myofibrils but in cardiac muscle shows a more continuous nature (Figs. 1.3 
and 1.4). The contractile proteins in skeletal and cardiac muscle are orga­
nized in functional units (sarcomeres), that will, however, not be consi-
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dered in détail here. The sarcoplasmic reticulum surrounding the myofibrils 
comprises of a continuous system of membranes. It forms a separate compart-
ment in the muscle fiber in which Ca2+ ions are stored during rest. The 
sarcoplasmic reticulum corresponds to the endoplasmic reticulum of other 
cell types, but in mature muscle fibers it contains only few associated ri-
bosomes. Its spatial orientation in the fiber is strictly related to the 
repeating order of the sarcomeres (Fig. 1.3). At regular intervals the sar-
coplasmic .reticulum forms an elaborate system of transversely orientated 
channels called terminal cisternae, which are in close contact with the Τ 
tubuli. In cardiac muscle the sarcoplasmic reticulum and terminal cisternae 
are less developed (Fig. 1.4). Small terminal expansions of the reticular 
network are closely applied to the membrane of the Τ tubuli. 
Mitochondria may be located in longitudinal rows between the contrac­
tile material "but also subsarcolemmally. Mitochondrial accumulations are 
often present at the nuclear poles and at sites where capillaries are situ­
ated just' outside the muscle fiber. The number, size and distribution of 
mitochondria vary considerably in different types of skeletal muscle and in 
heart. Mitochondria of mammalian skeletal muscle usually are 1-2 \m long, 
but those, in cardiac muscle are about 2.5 urn and may occasionally reach 7 
or 8 pm (Bloçm & Fawcett, 1975). Spherical lipid droplets and glycogen gra-
nules are often located near mitochondria. 
Upon transmittance of a nerve pulse to the muscle, a wave of depola-
rization spreads over the sarcolemma and is conducted through the T-system 
to the sarcoplasmic reticulum. This causes a rapid efflux of Ca2+ ions and 
eventually results in muscular contraction. The energy needed for this con-
traction and for the subsequent pumping back of the Ca2+ ions into the sar-
coplasmic reticulum is delivered by the hydrolysis of ATP. 
In adult striated muscle three types of muscle fibers can be discer-
ned, which show differences in contractile and metabolic properties, con-
sistent with the functional demands of the muscle (Peter et al., 1972). The 
classification commonly used for animal skeletal muscles is given in Table 
1.1. It should be stressed that each muscle is composed of a mixture of the 
various fiber types. Oxidative (red) muscle fibers are usually found in the 
deep part of a muscle group, whereas glycolytic (white) fibers are super-
ficially located, like in rat m.quadriceps femoralis (Baldwin et al., 1972). 
Rat diaphragm contains about 60% slow-twitch oxidative fibers (Close, 1972). 
Adult rat m.soleus is almost exclusively (80-96%) built up of fast-twitch 
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Table 1.1. Characteristics of animal skeletal muscle fiber types. 
Color 
Mitochondrial content 
Distribution of mito-
chondria 
Myoglobin content 
Capillary supply 
Fiber diameter 
Slow-twitch 
oxidative 
(SO) 
red 
moderate/high 
mainly inter-
myofibrillar 
high 
high 
small 
Fast-twitch 
oxidative 
glycolytic 
(FOG) 
intermediate 
high 
intermyofibril-
lar/subsarco-
lemmal 
high 
high 
moderate 
Fast-twitch 
glycolytic 
(FG) 
white 
low 
intermyofibril-
lar 
low 
low 
large 
Data were obtained from Baldwin et ait 1972), Close (1972) and Peter et ai. 
(1972). 
oxidative glycolytic fibers (Baldwin et al., 1972; Close, 1972). In the rat 
the characteristic differences between the fibers are not yet apparent at 
birth, as all skeletal muscles then are slowly contracting. During subse-
quent postnatal development they increase their speed of contraction along 
different courses, which is the result of a process of differentiation of 
the fibers. The muscles acquire distinct patterns of fiber types in order 
to meet work demands (Close, 1972; Kelly & Rubinstein, 1980; Stockdale et 
ai., 1981). 
1.3. MUSCLE METABOLISM 
In muscle energy is needed for the performance of mechanical work, 
that is contraction and relaxation (reuptake of Ca 2 + ions into the sarco-
plasmic reticulum), and restoration of the membrane potential after a nerve 
pulse, but also for other vital processes, including the maintenance of 
cellular organization, heat production during rest and anabolic activities. 
The energy for most of these processes is obtained from the hydrolysis of 
ATP. In resting mammalian muscle the ATP pool is only about 6 praol/g and 
during contraction would be depleted in a few seconds, unless it is reple-
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MYOFIBRIL MITOCHONDRION CAPILLARY 
& 
SARCOPLASM 
Fig. 1.5. Schematic presentation of energy metabolism in muscle. ATP can be 
regenerated by a one-step reaction from creatine phosphate or 
from ADP, and by multistep mechanisms from intracellularly stored 
substrates (glycogen and triacylglycerols) or from blood-borne 
substrates (glucose and fatty acids). 
nished. Regeneration of ATP from ADP can occur in various ways: instantane-
ously from creatine phosphate, by anaerobic glycolysis (production of lac-
tate), and by oxidative phosphorylation in mitochondria (aerobic pathway). 
When increasing amounts of ATP are utilized, these three processes contri-
bute to its replenishment in this order. 
Creatine phosphate 
In muscle, the reserve of high energy phosphate is mainly stored in 
creatine phosphate (about 20-30 vtmol/g in resting mammalian skeletal muscle). 
Creatine phosphate serves as a small, but instantaneously available source 
of energy. Rephosphorylation of ADP occurs by a single enzymatic step, cata-
lyzed by creatine (phospho)kinase (Fig. 1.5). The formed creatine is rephos-
phorylated during rest or prolonged or intermittent exercise. Creatine ki-
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пазе exists in different iso-enzymes and with variable localization (Schol-
te, 1973a). In rat heart 33% of the total cellular creatine kinase activity 
resides in the myofibrils, 19% in the mitochondria, and 48% in the cytosol. 
For rat skeletal muscle these values are A, 3 and 93%, respectively (Schölte, 
1973a). 
The role of creatine and creatine phosphate in muscle is not yet fully 
understood. The creatine kinase reaction has been considered to function in 
buffering the cellular ATP supply, thereby smoothing the metabolic response 
to changes in work load and providing a reservoir of ATP for brief periods 
of anoxia. Studies of Saks et a.Z. (1978, 1980) and Kupriyanov et ai. (1981) 
have shown that in rat heart the mitochondrial iso-enzyme, which is bound 
to the outer surface of the inner membrane, efficiently couples creatine 
phosphate synthesis to ATP production by its specific localization and cou-
pling to adenine nucleotide translocase. On the basis of these observations 
it was proposed that the primary function of the system is to provide for 
energy shuttle from the mitochondria to the site of energy utilization 
(Wilson et ai., 1981; Seraydarian, 1982). 
Another mechanism, by which the muscle ATP pool can be instantaneous-
ly replenished, involves transphosphorylation of two molecules of ADP by 
myokinase, but this reaction only occurs under extreme or pathological con-
ditions . 
АлаегоЪіс glycolysis and oxidative phosphorylation 
Ultimately, all energy required for ATP synthesis is obtained from 
the degradation of carbon-hydrogen bonds of various intramuscularly stored 
or blood-borne substrates: carbohydrates, fatty acids and amino acids. In 
the absence of oxygen ADP can be phosphorylated during glycogenolysis and 
glycolysis, in combination with lactate production (Fig. 1.5). Anaerobic 
glyco(geno)lysis generates, however, only a limited amount of ATP. There­
fore, this pathway appears to be important only during a short period of 
muscle work and at a maximal load (Table 1.2). Oxidative degradation of 
substrates, occurring inside the mitochondria, delivers much more energy. 
Electrons are transferred from the substrates via NAD and/or flavoproteins 
to molecular oxygen. The proton gradient generated over the mitochondrial 
inner membrane during the flux of the electrons through the respiratory 
chain, drives the synthesis of ATP and other processes, such as transloca­
tion of cations (Mitchell, 1977). The function of muscle mitochondria has 
recently been reviewed (Veerkamp, 1981). 
11 
Contribution of substrates to muscu2ar energy production 
The relative contribution of the various aubstrates to the muscular 
energy production is influenced by nutritional and hormonal conditions, the 
duration, intensity and kind of exercise (Table 1.2), training, muscle fi­
ber composition, pathology, and also by the developmental stage of the in­
dividual. The main fuels for oxidative catabolism in muscle mitochondria 
are pyruvate (originating from glycogen, glucose, alanine or lactate) and 
fatty acids. The interaction of carbohydrate and fatty acid metabolism in 
skeletal and cardiac muscle in man was recently reviewed by Kajjser (1982). 
Since the intramuscular pools of triacylglycerols and glycogen are rather 
limited, skeletal and, especially, cardiac muscle mainly rely upon exoge­
nous substrates for energy production. The contribution of glucose is in­
creased after feeding and decreased during fasting in man (Wahren, 1979). 
In the post-absorptive state the net contribution of glucose is low, since 
a marked portion of the small amount of glucose taken up is returned to 
venous blood in the form of lactate, pyruvate and alanine (Wahren, 1979). 
In this condition fatty acids are the main fuel for the resting muscle. In 
conditions of sustained exercise or long-term fasting, branched-chain amino 
ГаМе 1.2. Contribution of substrates to muscular energy production in man 
in the post-absorptive state. 
Substrate Recovery 
or rest 
Exercise 
Short Intermittent 
intense intense 
1 min 1 h 
Continuous 
moderate 
Ih 4 h 
Creatine phosphate 
Glycogen 
Glucose 
Fatty acids 
Branched-chain amino acids 
Acetoacetate 
Lactate 
(+) 
( + ) + 
+ ++ 
++ ++ 
(+) 
- no or little; + important; ++ marked; (+) alternatively utilization and 
production. 
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acids (Davies et al., 1980; Rennie et al., 1981) and acetoacetate (Berger et 
al., 1978) are also used (Table 1.2). 
Insufficient oxygen supply during the first minutes of exercise may 
cause a delay in energy production from oxidative phosphorylation and a 
high rate of anaerobic glycolysis (Hermaneen, 1979). The supply of fatty 
acids tç the muscle rises during sustained exercise by an increased blood 
flow and an increased lipolysis of triacylglycerols in the adipose tissue 
(Gollnick, 1977; Jones et al., 1980). The increased supply to muscle leads 
to a higher rate of fatty acid oxidation and accumulation of citrate and/or 
acetyl-CoA in the muscle fiber (Rennie it Holloszy, 1977; Kaijser, 1982). 
These metabolites may inhibit phosphofructokinase or pyruvate dehydrogenase 
(Newsholme et al., 1977; Kaijser, 1982) and in this way decrease glucose and 
glycogen utilization. In skeletal muscle fatty acids may contribute from 20 
to 80% of the energy production (Fritz et al., 1958; Bylund et al., 1975; Ha-
genfeldt, 1979). The continuously working cardiac muscle is adapted to ae-
robic metabolism and preferentially oxidizes fatty acids, but may also use 
ketone bodies during fasting (Neely & Morgan, 1974). In the heart the rela-
tive contributions of carbohydrates and fatty acids to the substrate utili-
zation are hardly altered by the work intensity of the heart, but more di-
rectly determined by the availability (i.e. plasma concentration) of the 
substrates (Kaijser, 1982). 
1.4 FATTY ACID OXIDATION 
Sources of fatty acids 
In blood plasma fatty acids are present non-covalently bound to albu-
min (free fatty acids) and esterified in triacylglycerols, forming part of 
lipoproteins. The free fatty acid (FFA) is the principal form utilized by 
muscle tissue. They arise mainly from lipolysis of triacylglycerols in adi-
pose tissue. The half life of the plasma FFA is only 1-2 min (Spector & 
Fletcher, 1978). The plasma concentration of FFA usually varies from 0.2 to 
0.6 mM, but may rise up to 1.5 mM during prolonged fasting or exercise, 
during recovery after exercise, and during disease (Gollnick, 1979; Spector 
4 Fletcher, 1978; Hagenfeldt, 1979; Jones et al., 1980). The albumin concen-
tration is about 0.6 mM in both man and rat, so that the FFA:albumin molar 
ratio ranges from 0.3 : 1 to 2.5 : 1. The albumin-bound fatty acids comprise 
the long-chain fatty acids found in adipose tissue, i.e. (both man and rat) 
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mainly palmitate (25-30 mol%) and oleate (30-40%), and also palmitoleate 
(4-6%), stéarate (6-10%), linoleate (13-17%) and arachidonate (3-5%) (Grim-
mer et al., 1963; Hagenfeldt, 1968; Rogiers, 1981). The various fatty acids 
are bound by albumin with different affinity (Spector, 1975; Kragh-Hansen, 
1981). Albumin has a few high-affinity binding sites for fatty acids and a 
greater number of weaker sites. The many other compounds that are bound by 
albumin, such as bilirubin, steroids and drugs (e.g. clofibric acid), may 
influence the fatty acid binding by the protein. 
Fatty acids taken up in muscle also originate from chylomicron and 
VLD-lipoprotein triacylglycerols, which are hydrolyzed by lipoprotein li-
pase localized at the endothelium in the muscle capillaries (Fig. 1.6). In 
skeletal muscle the lipoprotein lipase activity is highest in muscles with 
a high content of oxidative muscle fibers (Borensztajn et al., 1975; Linder 
et al., 1976; Mackie et al., 1980). In human and rat skeletal muscle and in 
rat heart the activity of this enzyme increases during starvation (Linder 
et al., 1976; Lithell et al., 1978; Mackie et al., 1980) and prolonged exer-
cise (Borensztajn et al., 1975; Lithell et al., 1979; Mackie et al., 1980; 
Oscai et al., 1982). Exercise increases also the utilization of intramuscu-
larly stored triacylglycerols, mainly during the initial phase of moderate 
exercise, when the blood supply of FFA is not yet elevated (Essen, 1978), 
and during prolonged vigorous exercise (Reitman et al., 1973; Essén, 1977; 
Stankiewicz-Choroszucha & Górski, 1978; Oscai et al., 1982). 
The reported triacylglycerol contents of rat heart and skeletal 
muscle vary from 1 to 25 pmol/g wet weight tissue (Masoro, 1967; Reitman et 
al., 1973; Abumrad et al., 1978; Stankiewicz-Choroszucha Sc Górski, 1978; 
Stearns et al., 1979; Okano et al., 1980; Stam & Hülsmann, 1981; Oscai et al., 
1982). This large variation is due to differences of age and strain of the 
animals and of the diet, but also of the conditions for sampling and mea-
surement, since breakdown of triacylglycerols is rapid after decapitation 
(Frayn & Maycock, 1980). Generally, the triacylglycerol content is in red 
muscle fibers > intermediate muscle fibers s cardiac muscle > white muscle fi-
bers (Reitman et al., 1973; Okano et al., 1980). Training of rats decreases 
the muscle triacylglycerol stores, but increases the capacity to use them 
(Oscai et al., 1982). Lipoprotein lipase may play a role in regulating the 
concentration of endogenous triacylglycerols in rat heart and skeletal 
muscle (Palmer et al., 1981; Oscai et al., 1982). 
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Uptake and cellular transport of fatty acids 
The rate of fatty acid uptake and utilization by peripheral tissues 
depends to a large extent on the concentration of fatty acids in the blood, 
but also on the metabolic activity of the tissue in question. The initial 
rate of uptake of FFA by human and rat skeletal and cardiac muscle is line­
arly related to their plasma concentration, both at rest and during exer­
cise (Spector et al., 1965; Hagenfeldt, 1979; Kaijser, 1982). Uptake of FFA 
appears to be an energy-independent process (Spector, 1971). An increase of 
the FFA¡albumin molar ratio increases the unbound fatty acid concentration 
(Spector, 1975), and also the myocardial uptake of FFA (Oram et al., 1973; 
Miller et al., 1976; Hagenfeldt, 1979). When the rate of removal of intra-
cellular FFA is increased by increasing the rate of oxidative metabolism, 
the rate of FFA uptake by isolated rat hearts also increased (Neely et al., 
1976). Thus, the net rate of FFA uptake by cardiac muscle depends on the 
concentration gradient across the muscle cell membrane (Idell-Wenger & 
Neely, 1978; Van der Vusse et ai., 19Ö3). Under normal conditions the con-
centration of unbound FFA in plasma will vary from 1 to 10 μΜ (Spector, 
1975; Idell-Wenger & Neely, 1978). With the exception of arachidonate, no 
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differences in the fractional extraction of individual FFA by human muscle 
were observed (Hagenfeldt, 1975), so that palmitate and oleate appear the 
main FFA taken up into muscular tissue. Whether such factors as pH, lactate 
and binding properties of circulating and cellular proteins influence the 
uptake of the various individual FFA differently is not known. 
On their way from the blood plasma to the interior of the cell, the 
fatty acids have to pass several barriers, i.e. the capillary endothelium, 
the interstitial space, and the muscle cell membrane. The present knowledge 
about the mechanisms underlying the transport across these barriers is 
still rather limited. In contrast to liver and kidney, the muscle capillary 
wall does not contain pores through which substances could diffuse freely. 
Electron microscopic studies, however, revealed the presence of vesicles in 
the cytosol of the capillary endothelial cell (Bloom 4 Fawcett, 1975). 
These vesicles may be the main route for the transcapillary movement of 
molecules. Transport of fatty acids and other lipophilic compounds was also 
suggested to occur by lateral movement in a continuous interface composed 
of the plasma and vesicle membranes of the endothelial cell, and possibly 
also the plasma membrane of the muscle cell (Scow et al., 1980). 
Transport of fatty acids in the interstitial space may also be media-
ted by albumin. Its presence in the interstitial space, and also in the 
transverse tubular system, has been demonstrated with immunocytochemical 
methods (Yokota, 1982). The concentration of albumin in interfiber fluid 
from guinea pig skeletal muscle is about 42% of that in the vascular com-
partment (i.e. about 0.24 mM) (Creese et al., 1962). The concentration in 
human suction blister fluid, which might be regarded as representative of 
muscle interstitial fluid, was 29% of that of plasma (Vermeer et al., 1979). 
The mechanism by which the fatty acid gains entry to the tissue cell 
interior once separated from albumin is still a point of discussion. It 
was long assumed that the uptake of fatty acids occurs by simple diffusion 
through the plasma membrane. During the last years, however, several inves-
tigators have proposed the existence of a specific membrane carrier system 
for the transport of fatty acids. Stremmel et al.(1983a(b) presented evi-
dence for the existence of an oleate binding protein in the rat liver cell 
plasma membrane. A bilirubin binding protein of M 55,000 was earlier iden-
tified in this membrane (Reichen & Berk, 1979; Wolkoff & Chung, 1980). 
Fatty acid uptake by rat adipocytes is facilitated by a saturable, phlore-
tin-inhibitable mechanism that is presumably protein in nature (Abumrad et 
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al., 1981). Samuel et ai. (1976) and Paris et al. (1978) also observed a sa­
turable fatty acid uptake process in embryonic chick cardiac cells. On the 
other hand, De Creila & Light (1980a,b) concluded that fatty acids pene­
trate adult rat heart myocytes by simple diffusion and that the saturable 
uptake component observed in previous studies reflected predominantly meta­
bolism. Several of these workers reported that at a high concentration of 
unbound fatty acids permeation occurs, however, by a non-saturable process, 
resembling passive diffusion (Samuel et al., 1976; De Creila & Light, 1980a; 
Abumrad et al., 1981). Therefore, the putative function of a membrane pro­
tein in the uptake and/or transfer of long-chain fatty acids remains to be 
established. 
Weisiger et al. (1981, 1982) argued that in liver the single-pass ex­
traction ratios of many albumin-bound ligands (e.g. long-chain fatty acids, 
bile acids, bilirubin, dyes and drugs) appear rather high compared to the 
іл vitro observed rate of dissociation of these ligands from albumin. On 
the basis of kinetic studies of oleate and bilirubin uptake in relation to 
albumin concentration in the perfused rat liver and isolated rat hepato-
cytes, they proposed that the hepatic uptake of these compounds is not 
determined by the fraction of the free ligand, but involves saturable inter­
action of the albumin-ligand complex with a specific receptor site on the 
liver cell surface (Weisiger et al., 1980, 1981, 1982; Ockner et al., 1983). 
Evidence for a specific albumin receptor on the rat adipocyte surface was 
also reported (Brandes et al., 1982). Several other investigators could, how­
ever, not confirm the existence of the postulated receptor in liver (Strem-
mel et al., 1983a; Stollman et al., 1983), adipose tissue (Abumrad et al., 
1981) and cultured human leukemic myeloid cells (Morand et al., 1982).Strem-
mel et al. (1983a) suggested that the above-mentioned apparent discrepancy 
is explained by the fact that albumin-ligand complexes dissociate more ra­
pidly in vivo than predicted from studies in vitro. 
The intracellular transport of the FFA is assumed to be mediated by 
low -M fatty acid-binding proteins (FABP), which are found in the cytosol 
of many tissues, including skeletal and cardiac muscle (Ockner et al., 1972; 
Mishkin et al., 1972). It is not yet known whether FABPs are also involved 
in or influence the uptake of FFA by the muscle, e.g. by promoting FFA de-
sorption from the plasma membrane. These proteins will be discussed in sec­
tion 1.5. 
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Fatty acid oxidation pathway 
Long-chain fatty acids are mostly degraded by B-oxidation, although 
other pathways also are known. α-Oxidation, the removal of one carbon atom 
at a time from the carboxyl end of the molecule, has been detected in brain 
tissue (Fulco, 1967). Cytoplasmic ω-oxidation was found in liver and may 
contribute to total fatty acid oxidation in states of excessive fat catabo­
lismi starvation, diabetes) (Bjorkhem, 1978; Kam et ai., 1978; Gregersen & 
Ingerslev, 1979)· The presence of a- and ω-oxidation has not been esta­
blished in skeletal muscle and heart. 
The g-oxidation of long-chain fatty acids was traditionally envisaged 
to occur solely in mitochondria. It is now well established, however, that 
peroxisomes also contain enzymes for fatty acid degradation (Lazarow & De 
Duve, 1976; Masters & Holmes, 1977, 1979; De Duve, 1983). Peroxisomes (or 
microbodies) are spherical, single-membrane organelles of about 0.5-1 μπι, 
which were named after their involvement in the production (oxidases) and 
degradation (catalase) of hydrogen peroxide. Although cytochemical methods 
demonstrated the presence of peroxisomes in liver, striated muscles and 
other tissues (Hand, 197A;Christie & Steward, 1979; Tolbert, 1981), peroxi­
somal fatty acid oxidation has mainly been studied in liver. There are only 
a few recent reports on peroxisomal fatty acid oxidation in heart (Small et 
ai., 1980; Norseth et al., 1982, 1983) and skeletal muscle (Small et al., 
1980; Shumate & Chokski, 1981). 
The first step in the cellular metabolism of fatty acids is the con­
version of the relatively unreactive carboxylic group into the more reac­
tive coenzyme A thioester. This process, referred to as activation, is ca­
talyzed by long-chain acyl-CoA synthetases (Fig. 1.7), which in the liver 
are located on the outer mitochondrial membrane, the peroxisomal membrane 
and the endoplasmic reticulum. The energy for this reaction is obtained 
from hydrolysis of ATP, by which AMP is formed. In liver the К for palmi-
tate is similar (about 5 uM) for the mitochondrial and the peroxisomal syn­
thetases (Knsans, 1980), indicating that at this level there is no prefe­
rence for fatty acids to enter the mitochondrial or peroxisomal ß-oxidation 
pathway. In heart the long-chain acyl-CoA synthetase activity appears, how-
ever, to be exclusively localized on the mitochondrial membrane (Normann et 
al., 1983). The activation reaction is controlled by the acyl-CoA:coenzyme A 
ratio and the total concentration of coenzyme A (Idell-Wenger & Neely, 
1978). The formed long-chain acyl-CoA is relatively insoluble in water and 
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Fig. 1.7. Schematica! presentation of the pathway of long-chain fatty acid 
oxidation in mitochondria. (Modified after Aprille, 1976). 
like fatty acids is probably bound to FABP (Mishkin & Turcotte, 1974) and 
lipid membranes. Short-chain and medium-chain acyl-CoA synthetases are also 
present in heart and liver, but the former shows a very low activity in rat 
skeletal muscle (Schölte & Groot, 1975). 
The acyl-CoA ester can be used either for the synthesis of phospho-
lipids and triacylglycerols in the cytosol or for the oxidation within mi-
tochondria or peroxisomes. In order to undergo mitochondrial oxidation, the 
acyl residues have to be transported into the mitochondrial matrix via a 
carnitine-dependent shuttle mechanism, which is composed of two carnitine 
acyltransferases, localized on the outer and inner surface of the mitochon-
drial inner membrane, respectively, and acylcarnitine translocase (Fig. 1.7) 
(Bremer, 1977; Hoppel, 1982). By this mechanism the cytosolic and mitochon-
drial pools of coenzyme A are strictly separated. The transport of acyl-
carnitine across the inner membrane involves a 1:1 exchange with L-carniti-
ne, which means that the content of carnitine on both sites of the membrane 
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remains constant under physiological conditions. Exchange transport appears 
to be driven by concentration gradients and is independent of metabolic 
energy. The transfer of the acyl group from coenzyme A to L-carnitine is 
promoted by the high cytosolic carnitine¡coenzyme A ratio, which is even 
higher in muscle than in liver (Oram et al., 1975; Idell-Wenger & Neely, 
1978). The physiological function of this ratio may be to direct fatty 
acids toward either lipid synthesis or oxidation. The relatively low rates 
of lipid synthesis in heart compared to liver are in agreement with this 
conception (Idell-Wenger & Neely, 1978). Based on substrate specificity mi-
tochondria may contain four distinct carnitine acyltransferases, that are 
reactive towards short-chain acyl esters (chain length of 2-10 carbon 
atoms), medium-chain acyl esters (6-10 carbon atoms), long-chain acyl es-
ters (8 carbon atoms or higher), and branched-chain acyl esters. The car-
nitine long-chain acyltransferase (carnitine palmitoyltransferase) is ex-
clusively a mitochondrial enzyme in liver, heart and skeletal muscle (Hop-
pel, 1982), but the carnitine short-chain and carnitine medium-chain acyl-
transferases are also present in peroxisomal and microsomal fractions of 
о 
II 
C H | - C — SCoA CoASH 
т л и Curale 
NADH* 0 — \ " Ό " synthtlair 
+ H* Y ^ - T H i C - C O O H 
Yf OiJoiceti lc 
NAD·,. Z'Mehlr 
'—ydrhydroeenasf 
CHj-COOH 
H O - C - C O O H 
Сигам \ ~ ^ н^-СООН 
Ac<min,ir\l rb-Aionilite 
^Иі-сооя 
с—соон 
çHi-œoe 
unie НС—СООН 
но-с—СООН 
H \ - NAD* 
/jo* urate 
àehyiìrogeiiase 
0 0 , * 
Ж 
NADH 
H* 
(jHi-cooe 
cu, 
COASH ί"0 0 0" 
a-Kelrigtularule \ . О 
äehydwtenase I / « - K t l o j l u u t i l c 
O O M С ^ _ ^ NA 
I ' NADH + H* 
( -SCoA 
II 
о 
NAD* 
«DP Suiunyl (ΌΑ 
Fig. 1.8. Citric acid cyc le . 
20 
rat liver (Markwell et ai., 1973, 1976; Bieber et al., 1982). Beef heart mi-
tochondria, however, do not contain a specific carnitine medium-chain acyl-
transferase (Clarke & Bieber, 1981). 
Intramitochondrial degradation of the fatty acyl-CoA ester occurs via 
ß-oxidation, whereby acetyl-CoA residues are split off from the carboxylic 
end of the fatty acid by a repeated sequence of processes: oxidation, hy-
dration, oxidation and thiolytic cleavage (Fig. 1.7). The four tightly 
linked enzymes, which catalyze the reactions, are: fatty acyl-CoA dehydro-
genase, enoyl-CoA hydratase, L-3-hydroxyacyl-CoA dehydrogenase and 3-oxo-
acyl-CoA thiolase (Engel, 1978; Middleton, 1978). Some of these enzymes are 
known to exist in various forms with different chain-length specificity. 
During ß-oxidation one molecule of flavoprotein and one of NAD are re-
duced and one molecule acetyl-CoA is formed per cycle. The major part of 
the energy present in the fatty acid molecule is released during the oxida-
tion of the acetyl-CoA in the citric acid cycle (Fig. 1.8). The reducing 
equivalents (NADH and FADH2) produced during ß-oxidation and citric acid 
cycle are oxidized in the respiratory chain, located in the inner mitochon-
drial membrane, to lead to the generation of ATP via oxidative phosphoryla-
tion (Fig. 1.7). Proper functioning of the mitochondrial energy supply is 
dependent on the presence and adequate order of all the constituents of 
this chain and the ATP-synthesizing system. 
Peroxisomes do not contain a carnitine-dependent transport system for 
long-chain acyl-CoA esters, since carnitine palmitoyltransferase activity 
is not found in these organelles and peroxisomal acyl-CoA oxidation is not 
stimulated by carnitine (Markwell et al., 1977; Mannaerts et ai., 1979). Per-
oxisomal 0-oxidation occurs similar to that of mitochondria, except that in 
the first reaction, which is catalyzed by a flavin-linked oxidase, two 
electrons are transferred from acyl-CoA to molecular oxygen, with the for-
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mation of enoyl-CoA and H2O2 (Fig. 1.9). The latter product is decomposed 
by catalase. The subsequent three reactions are the same as those in mito-
chondrial ß-oxidation, but the enzymes all are different from their mito-
chondrial counterparts (Inestrosa et al., 1980; Osumi et al., 1980; Lazarow, 
1981a). It is unknown at present, whether the NADH generated at the third 
0-oxidation reaction is reoxidized within the peroxisome or in the cytosol 
(Lazarow, 1982). 
The peroxisomal ß-oxidation system has a maximal activity towards 
acyl-CoA esters of 12-18 carbon atoms and little towards Ce and d, acyl-CoA 
esters (Lazarow, 1978; Osumi & Hashimoto, 1978; Hryb & Hogg, 1979), so that 
the oxidation is not complete. At the most five ß-oxidation cycles were ob-
served with palmitoyl-CoA oxidation by isolated rat liver peroxisomes (La-
zarow, 1978; Osmundsen et ai., 1979). Therefore, the acetyl-CoA and short-
chain acyl-CoA esters that accumulate as the end products of peroxisomal 
6-oxidation may be transported to the mitochondrion for entry into the ci-
tric acid cycle or mitochondrial B-oxidation pathway, respectively (Fig. 
1.10), or may be used for biosynthetic purposes elsewhere. Carnitine and/or 
FABP may play a role in the removal of these peroxisomal products. The per-
oxisomal ß-oxidation reactions are insensitive to KCN when assayed in vitro, 
because they are not linked directly to the mitochondrial respiratory chain 
(Lazarow & De Duve, 1976; Mannaerts et al., 1979). 
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In liver, the relative contribution of peroxisomes to the overall 
oxidation of palmitate and oleate appears to be only 5-10% under normal 
conditions (Mannaerts et ai., 1979; Thomas et al., 1980). Peroxisomes may, 
however, play a significant role in the oxidation of very long chain fatty 
acids (22 carbon atoms or higher) (Neat et al., 1981). 
Control of fatty acid oxidation 
In heart muscle, the mam factors controlling the rate of fatty acid 
oxidation appear to be: d ) fatty acid supply by the blood, which is deter­
mined by the diet and hormonal control of fatty acid mobilization from 
liver and adipose tissue, (n) the level of high-energy phosphates and the 
redox state of the mitochondria, and (in) the availability of coenzyme A 
both in the mitochondrial compartment and in the cytosolic space (Oram et 
ai., 1973; Idell-Wenger & Neely, 1978). The transport system for acyl units 
across the inner mitochondrial membrane may function as an important regu­
latory site for fatty acid oxidation (Idell-Wenger, 1981; Idell-Wenger et 
ai., 1982). Malonyl-CoA, which inhibits the outer carnitine palmitoyltrans­
ferase in liver and heart (McGarry et ai., 1978a,b, 1983; Saggerson & Car­
penter, 1981), and short-chain acyl-CoA esters may thereby play a regula­
tory role. 
1.5. FATTY ACID-BINDING PROTEIN 
Introduction 
In 1972, Ockner et ai. and Mishkin et ai. reported that the cytosol 
of rat liver, intestinal mucosa, adipose tissue, kidney and of cardiac and 
skeletal muscle contains a protein of molecular weight of about 12,000, 
that m vitro exhibits a high affinity for the non-covalent binding of 
oleate. The protein appeared to be identical with the smaller of two pre­
viously described hepatic cytosolic amon-binding proteins, called proteins 
В and A by Ketterer et ai. (1967) and Y (or ligandin) and Ζ by Levi et ai. 
(1969). Therefore, three different designations of the protein are used: 
fatty acid-bindmg protein (FABP), Z-protein and protein A. Throughout this 
study we will, however, use the former term. 
The presence of this binding protein in the cytosol was originally 
suggested in order to explain the observed differences in intestinal ab­
sorption among long-chain fatty acids and to account for the apparent faci-
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lity with which these fatty acids traverse the cytosol, thus ascribing a 
role to the protein intracellularly much like that of albumin extracellu-
larly (Ockner et ai., 1972; Mishkin et al., 1972). Subsequent research esta-
blished that FABP does not only act to 'solubilize' long-chain fatty acids 
but also influences the activities of various enzymes of lipid metabolism. 
Since many other lipidie compounds are also bound by FABP, including long-
chain acyl-CoA esters, bilirubin, bile acids and salts, aminoazo dyes, 
hexachlorophene, sulfobromophtalein, cholesterol and sex steroid hormones 
and their sulphates, it is clear that the protein may potentially play an 
important role in cellular lipid metabolism. In the following text we pre-
sent a brief review of the current knowledge of FABP. 
Physicochemical characterization of FABP 
Initially FABP was identified by measuring the association of radio-
actively labeled fatty acids with specific protein fractions by gel-filtra-
tion (Ockner et al., 1972; Mishkin et al., 1972). Comigration with labeled 
fatty acid or with colored organic anions, like bilirubin or sulfobromo-
phtalein, is still commonly applied for the purification and assay of FABP. 
However, this technique appears not adequate, since fatty acids and organic 
anions also bind with a high affinity to most types of gel material (Mish-
kin et al., 1975; Stein et al., 1976) and therefore may dissociate from the 
proteins as filtration proceeds. Furthermore, due to this interaction and 
to competition of FABP with other proteins (e.g. albumin) for available li-
gand, the method appears not suitable for the quantitation of FABP in pro-
tein samples. The presence of labeled ligands on FABP also impairs charac-
terization and further studies of the protein. 
FABP has been purified and characterized from rat, rabbit and bovine 
liver, human and rat adipose tissue, rat and pig heart and rat intestinal 
mucosa. Purification is usually performed by gel-filtration on Sephadex G-
75, anion- or cation-exchange chromatography, and sometimes preparative 
isoelectric focusing (e.g. Ketterer et al., 1976; Fournier et al., 1978; Bar-
bour & Chan, 1979; Ul-Haq et ai., 1982). Other applied purification steps 
include ammonium sulphate precipitation (Matsushita et ai., 1977; Trulzsch 4 
Arias, 1981; Takahashi et ai., 1982), heat treatment (Billheimer & Gaylor, 
1980) and affinity chromatography (Ockner et ai., 1982). The molecular 
weight, isoelectric point and amino acid composition of the various puri-
fied preparations are summarized in Tables 1.3 and I.A. Recently, Ul-Haq et 
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Table 1.3. Properties of FABP and of some related proteins. 
Origin Designation 
г 
value 
Isoelectric Reference 
point(s) 
Rat liver 
Rabbit liver 
FABP 12,080 
FABP 10,000е 
Ζ 12,500C 
ΙΑ,300 
14,000С 
^2,ooot 
11,000С 
n.d. 
14,000 
Band С 11,450 
12,000C 
SCPi 15,000 
1в,000Ъ 
16,200С 
Ζ 12,000b 
11,000С 
Bovine liver FABP 
Rat adipose tissue FABP 
Human adipose tissue FABP 
Rat intestinal mucosa FABP 
Rat heart 
Pig heart 
FABP 
FABP 
12,000 
12,000е 
12,000C 
12,100Ь 
12,400C 
12,000С 
12,000С 
6.9 
5.9 
5.2 
6.0 
7.3 
n.d. 
7.0 
Оскпег et al., 1982 
Suzue & Marcel, 1975 
Trulzsch 4 Arias, 1981 
Takahashi et ai., 1982 
Matsushita et ai., 1977 
1.6-2.6 Rüstow et ai., 1982 
8.8-9.3 
5.0 Ketterer et ai., 1976 
5.9 
7.6 
5.5 Billheimer & Gaylor, 1980 
6.0 
7.0 
7.0 Dempsey et ai., 1981 
7.0 Matsushita et al., 1977 
5-9 Haunerland & Spener, 1980 
n.d. Ul-Haq et ai., 1982 
n.d. Ul-Haq et al., 1982 
5.6 Ockner & Manning, 1974 
5.0 Fournier et al., 1978 
4.8 Fournier et al., 1983a 
a
 Amino acid analysis 
bGel filtration 
c
 SDS-gel electrophoresis 
d In the presence of oleate pi =5.0 
n.d., not determined 
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al. (1983) reported the purification of FABP from rat and monkey lung tissue 
but these authors did not yet give physicochemical data of the proteins. 
All FABPs studied so far have a molecular weight of 11,000-14,000, 
but show large differences in isoelectric point (Table 1.3). Three groups 
reported that upon isoelectric focusing, homogeneous rat liver FABP preci­
pitates at pH 5.0-5.5, 5.9-6.0 and 7.0-7.6 (Ketterer et ai., 1976; Billhei-
mer & Gaylor, 1980; Trulzsch & Arias, 1981). The three forms of FABP had a 
closely similar amino acid composition and ultraviolet spectrum, were immu-
chemically identical, but exhibited different affinities for long-chain 
fatty acids and sulfobromophtalein, the form with the highest pJ value ha­
ving the highest affinity. Heterogeneity in FABP may, however, result from 
interaction of the protein with ampholytes or exogenous ligands (Trulzsch & 
Arias, 1981), or may be caused by denaturation (Dempsey et ai., 198I). Bin­
ding of long-chain fatty acids to bovine liver FABP (Haunerland & Spener, 
I98O) and human serum albumin (Basu et ai., 1978) was reported to be accom­
panied by a lower pi value. Therefore, it is likely that FABP from all tis­
sues and species examined is a neutral protein with pJ 7.0-7.5 (Table 1.3). 
The amino acid composition has yet only been determined for rat liver 
FABP (Table 1.4). The data reported by the various investigators are in 
close agreement. The primary structure of rat liver FABP was recently re­
ported (Takahashi et ai., 1982). 
Tables 1.3 and 1.4 also give the physicochemical properties of Band С 
protein and of sterol carrier proteini (SC?!) from rat liver. These pro­
teins stimulate a number of microsomal enzyme activities involved in cho­
lesterol biosynthesis from squalene (Billheimer & Gaylor, 1980; Dempsey et 
ai., 1981). These data, and the findings that SCPi shows a high affinity for 
long-chain fatty acids and organic anions (Ritter & Dempsey, 1973; Grabow-
ski et ai., 1976; Dempsey et ai., 1981) and stimulates hepatic fatty acid 
activation and esterification by membrane-bound enzymes (Daum & Dempsey, 
1979, 1980), indicate that Band С protein and SCPj are mutually identical 
and very similar or identical to FABP (cf. chapter 10). 
Immunochemical assays for the detection and quantitation of FABP were 
developed for rat liver, adipose tissue and jejunal FABP (Ockner & Manning, 
1974; Stein et ai., 1976; Ketterer et ai., 1976; Trulzsch & Arias, 1981; Rüs-
tow et ai., 1982; Ockner et ai., 1982; Ul-Haq et ai., 1983). With the assays 
immunochemical cross-reactivity was observed for FABPs from various rat 
tissues (Ockner & Manning, 1974; Rüstow et ai., 1982 ) but not for human and 
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Table 1.4. Amino acid composition of FABP and related proteins of rat liver 
(in residues/1000 amino acid residues). 
Amino 
acid 
Asp 
Thr 
Ser 
Glu 
Pro 
Gly 
Ala 
Cysa 
Val 
Met 
lie 
Leu 
Туг 
Phe 
His 
Lys 
Arg 
Trp 
FABP 
Ockner 
et al., 
1982 
87 
94 
48 
131 
16 
96 
17 
17 
91 
53 
66 
48 
25 
47 
15 
130 
18 
0 
z
b 
Trulzsch 
& Arias, 
1981 
78 
81 
33 
142 
12 
102 
17 
13 
107 
21 
70 
53 
14 
49 
17 
156 
35 
n.d. 
z
c 
Takahashi 
et al., 
1982 
86 
91 
47 
139 
12 
93 
18 
6 
93 
54 
70 
49 
23 
47 
17 
139 
17 
n.d. 
Ad 
Ketterer 
et al., 
1976 
97 
101 
52 
152 
n.d.e 
94 
19 
n.d. 
79 
50 
60 
51 
19 
51 
16 
141 
18 
0 
Band С 
Billheimer 
& Gaylor, 
1980 
99 
112 
53 
139 
21 
100 
20 
7 
71 
25 
66 
57 
25 
49 
18 
129 
19 
n.d. 
SCP! 
Dempsey 
et al., 
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16 
10 
95 
54 
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a
 Determined as carboxymethyl cysteine 
b
 Given for the protein of pi" 7.2 
c
 The second peak after DEAE-cellulose purification 
dThe protein of pJ 7.6 (form III) 
e
n.d., not determined 
rat FABP (Rüstow et ai., 1982; Ul-Haq et ai., 1983). The presence of immuno-
chemically distinct FABPs in the rat tissues is, however, not excluded. 
Analysis of the binding of long-chain fatty acids to protein is ham-
pered by their low aqueous solubility and their low rate of diffusion 
through dialysis membranes, so that a complete Scatchard plot can usually 
not be obtained. With equilibrium-dialysis studies, Ketterer et ai. (1976) 
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found that rat liver FABP shows а К. for palmitate of 1 uNl and for palmi-
d 
toyl-CoA of 0.14 μΜ. For sulfobromophtalein and several steroids they ob­
served a class of strong binding sites (K, 0.1-3 μΜ) and several weaker 
sites (Ketterer et al., 1976). On the basis of coelution of different 
amounts of radioactively labeled ligands with cytosolic proteins from a 
gel-filtration column, Mishkin et al. (1972) estimated the К for oleate to 
be 2.8 μΜ and Mishkin & Turcotte (1974) found the К for palmitoyl-CoA to 
be 0.24 μΜ. With this technique it was also found that the relative binding 
was greater for unsaturated than for saturated fatty acids (Ockner et ai., 
1972; Mishkin et ai., 1972). With the use of a charcoal binding assay, War­
ner & Neims (1975) observed an apparent К for hexachlorophene and biliru­
bin of 20 and 50 μΜ, respectively. 
Ockner et al. (1982) demonstrated that in rat liver 60% of the cyto­
solic long-chain fatty acids are associated with the FABP-containing frac­
tion. 50-60% of these endogenous fatty acids are unsaturated (mainly oleate, 
linoleate and erucate). This is a substantial enrichment in these acids 
compared to plasma and indicates that FABP preferentially binds unsaturated 
fatty acids (Burnett et ai., 1979; Rüstow et ai., 1982; Ockner et ai., 1982). 
The saturated fatty acids are mainly palmitate (20-30%) and stéarate (8-
14%). The amount of endogenous fatty acids associated with rat liver FABP 
was reported to be 0.46 (Burnett et ai., 1979), 0.70 (Rüstow et ai., 1982) 
and 0.26 mol/mol FABP (Ockner et ai., 1982). Rüstow et ai. (1982) also found 
that phospholipids (0.41 mol/mol FABP) and small amounts of mono-, di- and 
triacylglycerols and of cholesterol were endogenously bound by FABP. How-
ever, Burnett et ai. (1979) and Ockner et ai. (1982) found virtually no de-
tectable phospholipid. 
Delipidation of FABP obviously is important for the proper study of 
its binding characteristics and effects on metabolic events. However, only 
few investigators delipidated their preparations, mostly with 20% (v/v) 
n-butanol, by the method of Morton (1955), or with diisopropyl ether, by 
the method of Cham & Knowles (1976). Trulzsch & Arias (1981) reported that 
the delipidation procedure employing n-butanol was highly denaturing for 
hepatic FABP, but Fournier et ai. (1978) and Barbour & Chan (1979) did not 
mention difficulties using this method. Using a Sephadex G-25 binding assay, 
Ockner et ai. (1982) found that the fatty acid-binding affinity of liver 
FABP hardly changed or decreased after delipidation with diisopropyl ether. 
Hence, a suitable non-denaturing delipidation procedure is greatly needed 
(cf. chapter 8). 
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Rat liver cytosol was also found to contain a fatty acid-binding pep-
tide of M^ 1500-2000 and pi 5.7 (Suzue & Marcel, 1975; Rustow et al., 1978). 
The peptide does not appear to be an artifactual product of FABP, but to be 
present within mitochondria and microsomes, and physiologically not in the 
cytosol (Rüstow et al., 1979). 
Functional properties of FABP 
Although much information about the role of FABP in cellular long-
chain fatty acid metabolism has come forth by indirect evidence, it has 
also been possible to directly attribute physiological properties to the 
protein. Purified rat heart FABP was demonstrated to be able to transfer 
its bound fatty acid to the mitochondrial 6-oxidative system (Fourmer et 
al., 1978). Appelkvist & Dallner (1980) provided evidence for the involve-
ment of FABP in peroxisomal fatty acid oxidation. By binding long-chain 
fatty acids and their acyl-CoA esters, rat liver FABP exercises indirect 
control on the activity of acetyl-CoA carboxylase (Lunzer et al., 1977) and 
of several membrane-bound enzymes, such as mitochondrial ATP/ADP-transloca-
se (Barbour & Chan, 1979), mitochondrial and microsomal acyl-CoA synthetase 
(Wu-Rideout et ai., 1976; Ockner 4 Manning, 1976; Burnett et al., 1979), 
microsomal glycerol 3-phosphate acyltransferase and diacylglycerol acyl-
transferase (Mishkin ί Turcotte, 1974; Burnett et al., 1979), and microsomal 
methyl sterol oxidase, hydroxymethylglutaryl-CoA reductase and acyl-CoA: 
cholesterol acyltransferase (Grinstead et al., 1983). Purified FABP also 
stimulates hepatic tnacylglycerol synthesis in cell-free systems (O'Doher-
ty & Kuksis, 1975; Burnett et al., 1979; Intani et ai., 1980). 
In several studies significant correlations were observed between the 
tissue content of FABP and the rate of fatty acid uptake or utilization in 
several conditions involving dietary, hormonal and pharmacological manipu­
lations. By means of a quantitative radial immunodiffusion assay for puri­
fied intestinal FABP, Ockner & Manning (1974) found that the FABP concen­
tration in mucosa from the proximal and middle part of the rat jejuno-ileum 
exceeded that in the distal third, and furthermore that FABP concentrations 
were responsive to changes in the fat content of the diet. With immunoche­
mical techniques, Rustow et ai. (1982) demonstrated that increasing the fat 
content of the diet from 1 to 25% also significantly rises the cytosolic 
concentration of FABP in rat liver, adipose tissue and heart. The liver 
cytosol of obese Zucker rats shows a 1.7-fold higher fatty acid-binding ac-
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tivity per mg protein when compared to that of lean rata (Morrow et al., 
1979). 
The utilization of oleate and its incorporation into triacylglycerols 
were greater in hepatocyte suspensions from adult female rats than from 
males, and correspond to a higher FABP concentration in liver cytosol of 
female rats (Ockner et al., 1979). Furthermore, these sex differences in 
both fatty acid utilization and FABP content could be reproduced by hormone 
administration to castrated rats (Ockner et al., 1980). Clofibrate feeding 
to rats increases the hepatic content of FABP as well as the uptake rate of 
free fatty acids (Fleischner et al., 1975; Renaud et al., 1978; Kawashima et 
al., 1982), and the tissue content of long-chain acyl-CoA, acetyl-CoA and 
total coenzyme A (Bail et al., 1979). The decreased tissue concentration of 
long-chain acyl-CoA in several Morris hepatomas with respect to control and 
host liver is accompanied by a markedly lower cytosolic FABP concentration 
(Mishkin & Halperin, 1977; Mishkin et al., 1977). 
Concluding remarks 
FABP may play an important role in cellular lipid metabolism, as can 
be concluded from the observations that FABP binds a wide variety of li-
gands, influences the activity of several membrane-bound enzymes involved 
in lipid metabolism, and that its cytosolic concentration is relatively 
high (4-5% of cytosolic protein in rat liver, Ockner et al., 1982) and cor-
relates with changes in fatty acid uptake or utilization. The precise 
nature of its involvement has, however, not been fully defined. FABP may 
also serve to control the compartmentalization of fatty acids and its deri-
ved acyl-CoA esters. In this respect, it is interesting that Capron et al. 
(1979) observed by immunocytochemical techniques that the protein has not a 
uniform distribution in liver cells, but instead shows a preferential loca-
lization around the mitochondria and the membranes of the smooth endoplas-
mic reticulum. Subcellular distribution studies revealed that in rat intes-
tinal mucosa (Ockner 4 Manning, 1974) about 15% and in rat liver (Conneely 
et al., 1983) about 40% of the cellular FABP is membrane-associated. 
1.6. OUTLINE OF THE PRESENT STUDY 
The aim of our investigation was to obtain further insight into 
various aspects of fatty acid oxidation in muscle. First, we compared the 
30 
use of cell-free and cellular systems for the study of fatty acid oxidation 
in rat skeletal muscle as well as in human and rat heart, and examined the 
postnatal development of the capacity of fatty acid oxidation in several 
types of rat muscle. The second part of the thesis deals with studies on 
the assay and purification of fatty acid-binding protein and its role in 
cellular fatty acid metabolism. 
In a previous study from this laboratory (Thesis Van Hinsbergh, 1979) 
a sensitive and accurate assay was developed for the determination of long-
chain fatty acid oxidation rates with isolated muscle mitochondria. We exa-
mined the application of this assay for muscle whole homogenates, intact 
muscular preparations and isolated rat heart cells,and subsequently com-
pared various aspects of fatty acid oxidation in these systems (chapters 3 
and 7). In particular, with the more complex cellular systems, we deter-
mined the influence of fatty acids of endogenous origin on the oxidation of 
exogenous palmitate. Cell-free and cellular systems were applied for the 
study of the postnatal development of fatty acid oxidation in rat skeletal 
and cardiac muscle (chapter 4). We elucidated the nature and origin of ¡3-
oxidation intermediates that were previously observed to accumulate during 
palmitate oxidation in cell-free systems (chapter 5). Because of contra-
dictory reports on the effect of Clofibrate administration on muscle fatty 
acid oxidation, we reevaluated and compared the effect of this drug on the 
palmitate oxidation capacity of rat skeletal muscle and liver (chapter 6). 
For the study of the fatty acid-binding protein it was necessary to 
develop a more adequate procedure for the detection and assay of this pro-
tein (chapter 8). The material applied for the latter procedure appeared 
also suitable for the delipidation of serum albumin (chapter 9)· In chapter 
10 we estimated the content of the fatty acid-binding protein in rat heart 
and liver cytosol and investigated its diurnal rhythm. Subsequently, the 
fatty acid-binding protein was purified and partially characterized from 
rat heart and liver (chapter 11). 
In chapter 12 a general survey and summary of the results will be 
given. 
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CHAPTER 2 
GENERAL EXPERIMENTAL PROCEDURES 
2.1. SOURCE OF TISSUES 
Animals 
Random-bred albino rats of the Wistar strain were used. The animals 
were males, weighing either 90-120 or 180-240 g, except when their pen-
and postnatal development was studied (chapter A). Animals were fed with a 
pelleted diet, containing 22% protein, A.8% fat and 67% carbohydrates. For 
Clofibrate treatment (chapter 6), rats were orally given 50 mg Clofibrate/ 
day in 1 ml 60% (v/v) glycerol solution for 7-10 days. For cholestyramine 
treatment (chapter 10), rats were fed with a pelleted diet, containing 1% 
(w/w) cholestyramine, for 5-7 days, as described by Kempen et al. (1982). 
Rats were maintained on a cycle of alternating 12-h periods of light and 
darkness (light on 7.00 a.m., light off 7.00 p.m.) and were sacrificed by 
cervical dislocation, routinely between 8.30 and 10.00 a.m., unless the 
effect of the diurnal rhythm was being investigated (chapter 10). 
Human muscle biopsies 
Biopsies of human m.pectoralis were obtained from breast carcinoma 
patients. Within 15 m m after breast amputation the biopsies were trans-
ferred to ice-cold SET-buffer (0.25 M sucrose, 2 mM EDTA and 10 mM Tns-HCl, 
pH 7.A). Subsequent transport of the material to the laboratory usually 
took 1-2 h. 
Biopsies (200-500 mg) of the right auricle of adult human heart were 
obtained during open-heart surgery before cannulation. Immediately after 
dissection the biopsies were transported to the laboratory (within 5 m m , 
on ice) and washed in calcium-free Krebs-Ringer bicarbonate buffer (pH 7.2), 
gassed with 02/C02 (95:5). Residual fat and connective tissue were removed. 
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2.2. BIOLOGICAL PREPARATIONS 
Intact muscular preparations 
Several types of striated muscular tissue from both rat and man were 
used. Rat diaphragms were rapidly excised and washed in calcium-free Krebs-
Ringer bicarbonate buffer (pH 7.2), gassed with Ог/СОг (95:5). After remo­
val of residual fat and connective and nerve tissue, the diaphragm was 
hemisected. Rat m.soleus and m.flexor digitorum brevis were exposed and 
dissected free by cutting the tendons at their points of insertion. The 
biopsies of human m.pectoralis were transferred to calcium-free Krebs-Rin­
ger bicarbonate buffer and portions of about 100 mg of teased fibers were 
prepared. 
Rat hearts were rapidly excised, cut into halves and blotted. Heart 
slices were prepared by dividing the human heart biopsies or the halves of 
isolated rat hearts into oblong pieces of about 50 mg. The isolation of 
rat cardiac myocytes is described in chapter 7. 
Preparation of whole homogenates and mitochondria 
After excision the tissues were immediately cooled in SET-buffer. All 
subsequent procedures were performed at 0 С The tissues were minced with a 
pair of scissors and whole homogenates (10%, w/v, for human m.pectoralis 
and rat m.quadriceps and m.flexor; 5%, w/v, for all other tissues) were 
prepared in the same buffer by hand homogenization using a teflon-glass 
Potter-Elvejhem tissue homogenizer and two pestles with different diameter 
(the intervening space was 0.12 and 0.05 mm, respectively). In case of m. 
flexor homogenization was performed with a Polytron tissue homogenizer. 
For preparation of mitochondria, the homogenates were centrifuged for 
5 min at 600 χ g and the resulting supernatants (termed postnuclear frac­
tion) for 10 min at 7000 χ д. The mitochondria were washed with a solution 
of 100 mM KCl, 50 mM Tris-HCl (pH 7.A), 1 mM MgCl2, 0.2 mM ATP and 0.5% 
(w/v) fatty acid-free albumin, and finally suspended in the same solution 
without albumin. The yield of mitochondria, isolated by this procedure, was 
10-20% for heart and skeletal muscle. The preparations will predominantly 
contain mitochondria from subsarcolemmal origin, since no proteolytic en­
zyme was used. 
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Preparation of rat liver and heart cytosol 
Rats were killed by cervical dislocation or anesthesized with di-
ethylether. After severing the vena cava inferior, the liver was perfused 
in situ through a catheter in the vena portae for 2 m m with ice-cold buf­
fer, consisting of 100 mM sucrose, 50 mM KCl, 30 mM EDTA and 50 mM K-phos-
phate (pH 7.2), or with 10 mM K-phosphate buffer (pH 7.4) containing 154 
mM NaCl. During perfusion the liver was gently massaged. Rat hearts were 
similarly perfused through a catheter inserted directly into the right 
ventricle with the perfusate emerging through the cut cerebral arteries. 
After excision the tissues were immediately cooled in ice-cold per­
fusion buffer. A 25% (w/v) homogenate was prepared in the same buffer by 
hand hoinogemzation at 0 С using a teflon-glass Potter-Elvejhem tissue 
homogemzer. The homogenate was centnfuged for 10 m m at 600 χ g and 4 С, 
and the resulting supernatant was centnfuged for 90 m m at 105,000 χ g 
and 4 С in a Beekman L2-65 В ultracentrifuge, using rotor 50 Τι. The clear 
105,000 χ g supernatant fraction (cytosol)was aspirated in order to mini­
mize contamination by floating fat and stored at -20 С 
2.3. BIOCHEMICAL METHODS 
Cytochrome с oxidase assay 
Cytochrome с oxidase (EC 1.9.3.1) activity was assayed by the method 
of Smith (1955) as modified by Van Hmsbergh et ai. (1978a). Before the 
assay mitochondrial membranes were broken by 4 cycles of freezing and tha­
wing. Preparations of freshly isolated mitochondria and rat cardiac myo­
cytes were diluted with 9 volumes of SET-buffer and then frozen and stored 
at -20 C. Assays were always carried out within two weeks after preparation. 
Activity of cytochrome с oxidase was determined spectrophotometncally at 
25 С in 50 mM K-phosphate buffer (pH 7.4) by measuring the decrease of re­
duced cytochrome с at 550 nm. The concentration of cytochrome с was 90 μΜ. 
All results are expressed in units of enzyme (ymol cytochrome с oxidized 
per m m at 25 C). 
Citrate synthase assay 
Citrate synthase (EC 4.1.3.7) activity was measured in supernatants 
of sonicated preparations according to the method of Shepherd & Garland 
(1969). The reaction involved is: 
35 
Acetyl-CoA + oxaloacetate » citrate + CoA-SH 
All preparations were stored аз described for the assay of cytochrome с 
oxidase. After sonication (Branson sonifier, set at 45 W, 4 χ 15 s at О С), 
the preparations were centrifuged for 5 min at 10,000 χ g and А С in a 
Burkard Koolspin microcentrifuge. Aliquots of the supernatant were used for 
the assay. The method is based on the chemical coupling of the released 
CoA-SH to S^'-dithiobis-^-nitrobenzoic acid), which can be traced by the 
formation of the absorbing mercaptide ion at 412 run. All results are given 
in units of enzyme (μιηοΐ coenzyme A liberated per min at 25 C). 
Creatine kinase assay 
Creatine kinase (EC 2.7.3.2) activity was measured at 37 С with the 
CK W-acetyl-L-cystein-activated monotest (Boehringer, Mannheim, F.R.G.), in 
which by a coupled assay procedure the formation of NADPH is traced at 340 
nm. Whole homogenates (1%, w/v) of fresh or incubated muscular preparations 
were prepared in SET-buffer, as described above. The homogenates were cen­
trifuged for 5 min at 10,000 χ g and aliquots of the supernatant were used 
for the assay. Creatine kinase activity was also measured in lO-ul samples 
withdrawn from the incubation media after certain time intervals. All re­
sults are given as relative activities or in units of enzyme (ymol/min at 
37 0C). 
Glycerol determination 
Glycerol was determined with the ultraviolet method, using a Boehrin­
ger Test Combination (Boehringer, Mannheim, F.R.G.). With this method the 
amount of glycerol is, by a coupled assay procedure, reflected in the 
amount of NADH consumed. NADH is determined by means of its absorption at 
340 nm. Before the glycerol determination, protein was precipitated by 
addition of 0.5 M perchloric acid at 0 С and centrifugation for 5 min at 
10,000 χ g. Subsequently, the supernatants were neutralized with КОН/КгНРО!,. 
Free fatty acid determination 
The total amount of long-chain free fatty acids (FFA) and phospholi­
pids were extracted from the protein sample with Dole's extraction mixture 
(isopropanol/heptane/0.5 M sulfuric acid, 40:10:1, by vol) (Dole & Meinertz, 
1960). Phospholipids were then separated from the long-chain fatty acids by 
binding to silicic acid (1 g per 40 ml of the heptane/isopropanol phase). 
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Fig. 2.1. Standard curve of palmitic acid determination with e 3Ni as tracer. 
The results are shown of a representative experiment out of four. 
Thereafter, the long-chain FFA were assayed radiochemically with the use of 
6 3Ni as tracer, as described by Ho (1970). With standard solutions of pal­
mitic acid in heptane we found a fatty acid to Ni ratio of 1.95 ±0.07 (mean 
+S.D. of four determinations) (Fig. 2.1), which corresponds to the forma­
tion of a Ni(fatty acid)2 complex (Ho, 1970; De Brabander & Verbeke, 1981). 
The recovery of fatty acids from the extraction procedure was determined 
by adding a known amount of palmitic acid in heptane solution to the ex­
traction mixture containing the protein sample, and was found to be 85-95%. 
Protein determination 
Protein was determined by the method of Lowry et ai. (1951), using 
bovine serum albumin as standard. 
2.1*. MATERIALS 
The specific reagents and materials used in this study are listed 
below together with their suppliers. 
[1- 1 ЦС]- and. [U-1 "С] palmitic acid, [l-^Cjoleic acid, [l-^C] succinate, 
L-fl-'^C]malate, "NiClj, W-f'C]methylated bovine serum albumin and 
ovalbumin: Amersham International, U.K. 
[l-^CjMyristic acid, [l-'^Cjlauric acid and [3-1 "Ό]palmitic acid: Applied 
37 
Science Europe, Oud-Beyerland, The Netherlands. 
[i6-'''С]Palmitic acid and Omnifluor: New England Nuclear, Dreieichenhain, 
F.R.G. 
Human, bovine and rat serum albumin (fraction V), horse heart and skeletal 
muscle myoglobin, Phosphorylase a, leucine aminopeptidase, ovalbumin, 
a-chymotrypsinogen and malonyl-CoA: Sigma Chemical Company, St. Louis, MO, 
U.S.A. 
Horse heart cytochrome c, coenzyme A, acetyl-CoA, ADP, ATP, NAD and 
antimycin A: Boehringer, Mannheim, F.R.G. 
L-Carnitine: Sigma Tau Ltd., Rome, Italy. 
D,L-Carnitine: Fluka, Buchs, Switzerland. 
Silicic acid: Mallinckrodt Chemical Works, St. Louis, MO, U.S.A. 
Active charcoal, Coomassie brilliant blue R-250 and silica gel 60 Η plates: 
Merck, Darmstadt, F.R.G. 
Clofibrate (Atromid S): ICI, Rotterdam, The Netherlands. 
Cholestyramine (Questran;: Bristol Myers, Weesp, The Netherlands. 
Collagenase (type II): Worthington Biochemical Corporation, Freehold, NJ, 
U.S.A. 
Aqualuma: J.T. Baker, Deventer, The Netherlands. 
Lipidex 1000 and Opti-Fluor: Packard Instrument Company, Inc., Downers 
Grove, IL, U.S.A. 
Sephadex G-75, DEAE-Sephacel, Protein A-Sepharose CL-4B, Percoli and 
Dextran T-70: Pharmacia Fine Chemicals, Uppsala, Sweden. 
Rabbit anti-rat albumin antiserum: Nordic Immunology, Tilburg, The Nether­
lands . 
Albumin was freed of fatty acids by acid-charcoal treatment according 
to the method of Chen (1967) or by Lipidex chromatography at 37 С (chapter 
9), dialyzed and lyophilized at neutral pH. 
Silicic acid was washed successively with petroleum benzine (boiling-
range 40-60 C), chloroform, methanol and acetone, and was activated by 
heating for 16 h at 120OC. 
All other chemicals were of the purest grade commercially available. 
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CHAPTER 3 
РАШГГАТЕ OXIDATION BY INTACT PREPARATIONS AND WHOLE 
HOMOGENATES OF SKELETAL MUSCLE' 
3.1. INTRODUCTION 
The important role of fatty acids аз fuel for the energy production 
in skeletal muscles is well established, although it is still not known to 
what extent fatty acids are preferred over other substrates under given 
conditions. It has been suggested that fatty acid oxidation may contribute 
from 20 to 80% of the energy production (Fritz et ai., 1958; Bylund et ai., 
1975; Hagenfeldt, 1979). The supply of fatty acids to muscle can vary large­
ly depending on the nutritional state (Wang et ai., 1979; Brass & Hoppel, 
1981), exercise (Carlson et ai., 1971; Hagenfeldt, 1979) and pathological 
conditions. Fatty acids can be supplied by serum albumin to which they are 
non-covalently bound, or else by the action of lipoprotein lipase on serum 
lipoproteins (Mackie et ai., 1980). Uptake of free fatty acids by muscle is 
linearly related to their arterial concentration (Hagenfeldt, 1979). Fatty 
acid binding to albumin is less tight at higher fatty acid¡albumin molar 
ratios (Spector & Fletcher, 1978). Reduction of the fatty acid:albumin 
ratio is accompanied by a proportional reduction in myocardial uptake of 
fatty acids (Miller et ai., 1976). 
Many studies dealing with fatty acid oxidation have employed cell-
free systems of muscle, while less information is available on oxidation in 
muscle preparations that contain intact cells (Fritz et ai., 1958; Neptune 
et ai., 1959; Fritz St Kaplan, I960; Schwartzman & Brown, I960; Eaton & 
Steinberg, 1961; Bodel et ai., 1962; Schonfeld & Kipnis, 1968; Bylund et ai., 
1975; Tutwiler, 1978; Stearns et ai., 1979; Pearce & Connett, 1980; Okano & 
Shimojo, 1982). In addition, with these preparations fatty acid oxidation 
was always calculated from the liberation of ^ СОг from '""C-labeled fatty 
•Adapted and extended from Glatz & Veerkamp (1982b). 
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acids alone, although measurement of the sum of '""COz and '"'C-labeled acid-
soluble products is a much more sensitive and accurate method (Van Hins-
bergh et al., 1978a,b). Therefore, we have first reevaluated the conditions 
for the in vitro determination of the palmitate oxidation rates by prepara­
tions of intact muscle. In addition, we have paid special attention to the 
effects of the palmitate concentration and the palmitate:albumin molar 
ratio. For comparison, palmitate oxidation rates were also determined in 
whole homogenates of muscle. The results indicate that the oxidation rate 
of exogenous palmitate in intact muscle greatly depends on the medium con­
centration of the unbound substrate and on the amount of free fatty acids 
derived from lipolysis of endogenous triacylglycerols. 
3.2. MATERIALS AND METHODS 
Male random-bred albino Wistar rats weighing 90-120 g were used. Un­
less the effect of starvation were being studied the animals were starved 
for 18 h. Intact muscular preparations were obtained and handled and whole 
homogenates were prepared as described in section 2.2. 
Assay of palmitate oxidation 
The intact muscular preparations were gently blotted on filter paper, 
weighed and immediately transferred to 20-ml incubation vials containing 
calcium-free Krebs-Ringer bicarbonate buffer (pH 7.2) gassed with O2/CO2 
(95:5), supplemented with 4 mM D,L-carnitine and 0.1 mM coenzyme A. The fi­
nal incubation volume was 2.5 ml (hemidiaphragm and m.pectoralis fibers), 
1 ml (m.soleus) or 0.5 ml (m.flexor), giving 40-50 mg muscle/ml in all 
cases. The vials were sealed with rubber caps and equipped with a disposa­
ble center well. After 5 min preincubation at 37 С the reaction was started 
by the addition of f1 "Ό] palmitate bound to dialyzed, fatty acid-free albu­
min in various molar ratios. The incubation proceeded at 37 С for 60 min 
(m.pectoralis) or 90 min (all other tissues) and was terminated by the 
addition of 0.5 ml 3 M perchloric acid to the medium, followed by a second 
incubation for 18 h at 4 С. ^ СОг produced was trapped in 0.3 ml ethanol-
amine/ethyleneglycol (1:2, v/v) injected into the center well. Thereafter 
the acid incubation mixture was centrifuged in a Burkard Koolspin micro­
centrifuge and an aliquot of the supernatant was assayed for radioactivity 
by liquid scintillation counting in Aqualuma. Radioactivity of ^ COj was 
A0 
measured in 10 ml toluene/methanol (2:1, v/v) containing 0.4% Omnifluor. 
Palmitate oxidation rates were calculated from the production of 1ЦС02 and 
'"•C-labeled acid-soluble products and are expressed as nmol/min per g 
muscle (wet weight). To exclude biological variations the effect of certain 
metabolites was always tested with one hemidiaphragm or leg muscle, while 
contralateral muscles from the same rat were used as paired controls. In 
all experiments the two similar muscular preparations from one rat were 
never used for testing the same experimental condition. 
With homogenates the palmitate oxidation rate was measured in a me­
dium containing 0.25 M sucrose, 30 mM KCl, 10 mM K-phosphate, 5 mM MgCl2, 
1 mM EDTA, 75 mM Tris-HCl (pH 7-A) supplemented with 5 mM ATP, 1 mM NAD+, 
25 μΜ cytochrome c, 0.1 mM coenzyme A, 0.5 mM L-malate and 0.5 mM L-carni-
tine. The final incubation volume was 0.5 ml containing 50-100 μΐ homoge-
nate (2.5-5 mg muscle). Incubations were carried out with 120 μΜ [1- 1 цс]-
palmitate bound to albumin (molar ratio 5:1) essentially as described 
above except that the incubation time was 30 min. 
Lipolysis studies 
Hemidiaphragms were incubated for 30 min under the same conditions as 
described for the assay of palmitate oxidation. The glycerol and free fatty 
acids released into the medium were measured in separate aliquots taken at 
the end of each incubation and kept frozen at -20 С until analyzed. Glyce­
rol was determined as described in section 2.3. Free fatty acids were ex­
tracted according to the method of Dole & Meinertz (I960) and assayed 
radiochemically with the use of 6 3Ni as tracer (Ho, 1970) as described in 
section 2.3. For identification, the fatty acids were, after extraction, 
methylated with borium trifluoride in methanol (Morrison & Smith, 1964) and 
determined by gas-liquid chromatography (Veerkamp, 1970). 
Other assays 
Creatine kinase and citrate synthase activities were measured as 
described in section 2.3. 
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Fig. 3.1. Leakage of soluble creatine kinase into the medium during incu­
bation of rat hemidiaphragm in the presence of 4 mM D-glucose. 
Values represent means±S.D. of 6 preparations. 
3.3. RESULTS 
Jntactness of the muscular preparations 
To estimate the intactness of the muscular preparations we measured 
the leakage of soluble (cytosolic) creatine kinase during incubation in the 
presence of A mM D-glucose as the only substrate. Upon incubation of hemi­
diaphragm the activity appearing in the medium increased linearly with time 
(Fig. 3.1). After 90 min creatine kinase leakage amounted to 9.5 ±1.0% 
(mean±S.D. of 6 preparations). The sum of the activities present in the 
incubation medium and recovered in the hemidiaphragm after incubation was 
always equal to the activity of the non-incubated preparation of the coun­
ter hemidiaphragm. This indicates that the creatine kinase activity of the 
incubation medium was not underestimated due to proteolytic activity or 
some inhibitor. The total cellular creatine kinase activity, measured in 
10,000 χ g supernatants of sonicated whole homogenates of diaphragm was 
4260 ± 400 mol/min per g, of which 91 ±1% resides in the cytosol (means ± 
S.D. of 6 preparations). The latter value corresponds to data of Schölte 
(1973a) on rat masseter muscle. Upon incubation of m.soleus and m.flexor 
for 90 min and m.pectoralis for 60 min leakage of creatine kinase was 
2.1 ±0.4, 1.7 ±0.8 and 13.9±1.0%, respectively (means ±S.D. of 4 prepara-
tions). From these observations it is concluded that all muscular prepara-
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Fig. 3.2. Time dependence of the oxidation of 120 μΜ [l-11,C]palmitate bound 
to albumin (molar ratio 5:1) by rat hemidiaphragm. Values repre­
sent means ±S.D. of 10-12 preparations. 
tions can be regarded as remaining reasonably intact during incubation. 
Palfflitate oxidation by intact preparations and the effect of various factors 
With hemidiaphragm palmitate oxidation appeared to be linear with time 
for at least 90 min with a lag period of about 5 min (Fig. 3.2.). This lag 
period probably reflects the time required for steady-state isotopie labe­
ling of the intracellular space and metabolic pathways. A similar time de­
pendency was observed with m.soleus and m.flexor (data not shown). With 
teased fibers of human m.pectoralis linearity was observed for 60 min. Some 
authors preincubate hemidiaphragms at 37 С in buffer containing 4 mM D-glu-
cose to allow the preparation to recover from the hypoxic stress of the dis­
section (Goldberg et al., 1975; Pearce & Connett, 1980). After 30 min prein­
cubation the preparations showed the same oxidation rates and linearity with 
time when compared to those that were not preincubated. Therefore, preincu­
bation was omitted in all further experiments. 
Palmitate oxidation was linear with the amount of tissue material (up 
to 150 mg). No differences were observed between the oxidation rates of left 
and right hemidiaphragms, when incubated under the same conditions (data not 
shown). Like with cell-free preparations (Van Hinsbergh et ai., 1978a,b), 
palmitate oxidation rates can also be more accurately and sensitively be 
measured in intact muscular preparations from the sum of 1',С0
г
 and ^C-la-
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beled acid-soluble products than from l'tC02 production alone. During incu­
bation with [l-^Cjpalmitate 1',С0
г
 represented 50-60% of the total acid-
soluble products formed (cf. Table 5.2 and Fig. 5.1). 
Various metabolites were tested for their effect on palmitate oxida­
tion by hemidiaphragm (Table 3-1). Omission of L-carmtine, with or without 
coenzyme A, decreased the oxidation rate slightly (by 19%). For economical 
reasons we used in most experiments 4 mM D^-carmtine, which has the same 
effect as 2 mM L-carmtine. Coenzyme A itself had no effect. The oxidation 
rate was not influenced by the addition of L-malate, pyruvate or D-glucose, 
but was slightly decreased by Ca 2 +. The absence of an effect of D-glucose 
on palmitate oxidation is consistent with results of other studies (Fritz & 
Kaplan, 1960; Schwartzman & Brown, I960; Eaton & Steinberg, 1961). Glucose 
Table 3.1. Effect of various factors on palmitate oxidation by rat hemi­
diaphragm. 
Addition ( + ) or omission ( - ) Relative activity 
None 100 
- 0.1 mM CoASH 
- 4 mM D,L-carnitine 
- 0.1 mM CoASH - 4 mM D,L-carnitine 
- 4 mM D,L-carnitine + 2 mM L-carmtine 
+ 5 mM ATP 
+ 5 mM adenosine 
+ 1 mM L-malate 
+ 1 mM pyruvate 
+ 4 mM D-glucose 
+ 0.25 mM Ca 2 + 
+ 2.5 mM Ca 2 + 
100 ± 9 
81 ± 4 
8 2 + 7 
101 + 8 
124 1 2 2 
79 ± 2 
104 ± 3 
100 ± 1 
92 ± 3 
94 ± 10 
8 0 + 16 
(7) 
(4) 
(6) 
(4) 
(7) 
(3) 
(3) 
(3) 
(4) 
(5) 
(5) 
- 0.1 mM CoASH - 4 mM D.L-carmtine + 5 mM ATP 8 5 + 4 (3) 
- 0.1 mM CoASH - 4 mM D,L-carnitine + 1 mM L-malate 85 ± 3 (3) 
Standard medium contained 4 mM D,L-carnitine, 0.1 mM CoASH and 120 μΜ 
[l-11,C]palmitate bound to albumin (molar ratio 5:1). Values (in % of the 
control) are means +S.D. of the number of paired experiments given within 
parentheses. 
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markedly stimulates, however, the rate of incorporation of palmitate into 
muscle triacylglycerol (Eaton & Steinberg, 1961). ATP has a small and va­
riable stimulatory effect on palmitate oxidation, but only in the presence 
of carnitine and coenzyme A. This effect may relate to palmitate activation 
in some cells that are damaged during preparation of the muscles. The sti­
mulation is not due to adenosine supply, since this substance has an oppo­
site effect. 
The stimulation of the oxidation rate by carnitine relates to the 
degree of injury of the muscular preparation, since this stimulation was 
markedly enlarged when the hemidiaphragm preparation was plurally incised 
(Fig. 3.3). It is noteworthy that the oxidation rate itself is not depen­
dent on the degree of injury, if carnitine is present. Furthermore, a sti­
mulation of the same order of magnitude was also observed with plurally 
incised m.soleus, while carnitine did not affect the palmitate oxidation by 
intact m.soleus (Fig. 3.3). Also, the oxidation rate of carnitine-stimulated 
incised m.soleus is comparable to that of intact m.soleus. Thus, carnitine 
appears to be the main coenzyme of palmitate oxidation that is lost upon 
injury of the muscular preparation. Efflux of carnitine was observed with 
rat extensor digitorum longus (Rebouche, 1977). When measured in the absence 
of carnitine, the ratio between the production of '"'COa and l',C-labeled 
HEMIDIAPHRAGM M SOLEUS 
-Ucarn -L-carn - L e a r n -Learn 
intact incised intact incised 
Ш CO, D «ad-solubl· products 
Fig. 3.3. Effect of 2 mM L-carnitine on the oxidation of 120 yM [і- 1 цС]-
palmitate bound to albumin (molar ratio 5:1) by intact or incised 
rat hemidiaphragm and m.soleus. Values are means ±S.D. of 4 pre­
parations . 
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Table 3.2. Palmitate oxidation rates of intact muscles and whole homogenates 
of young rats and the effect of starvation. 
Muscle and 
condition 
Muscle 
weight 
mg 
Palmitate oxidation rate 
nmol/min 
Intact muscle 
/g muscle 
Whole homogenate 
/g muscle /unit citrate 
synthase 
Citrate 
synthase 
activity 
unit/g 
muscle 
Human m.pectoralis 4.38 + 1.51 2 9 . 8 ± 6 . 7 5.3 ± 1 . 4 
Rat diaphragm 
Fed 
Starved 18 h 
42 h 
66 h 
214 ± 17 
215 ± 6 
185 ± 14 
172 ± IS1 
2.47 ± 0 . 1 4 
2.83 + 0.38 
2.92 ± 0 . 5 1 
390 ±42 
371 ±42 
331 ±35 
4.01 ± 0 . 7 5 305 ± 6 6 
11.59 ± 1 . 4 6 
1 1 . 2 8 ± 1.13 
11.02 ± 0 . 9 2 
10.57 ± 2 . 2 9 
33.9 ± 3 . 2 
32.9 ± 1.0 
30.0 ± 2 . 6 
29.1 + 4 . 2 
Rat m.soleus 
Fed 74.7 ± 3 . 5 2.38 ± 0 . 6 8 288 + 30 
Starved 18 h 71.1 ± 2 . 9 2.13 ±0.26 301 ± 43 
42 h 68.2 ± 5 . 8 1.93 ± 0 . 2 8 248 ±14 
66h 6 7 . 5 ± 2 . 8 b 3 . 2 1 ± 0 . 7 2 b 2 2 3 ± 3 1 l 
9.04 + 0 . 2 8 
8.93 ±0.89 
9.12± 1.05 
9 . 3 4 ± 0 . 5 7 
32.8+4.0 
33.6 + 2.4 
26.7±3.0 
23.9 + 3.51 
Rat m.flexor digitorum brevis 
Fed 43.6±4.2 2.16±0.20 
Starved 18 h 47.2 ± 4 . 0 1.72 ±0.20 
42h 46.8±8.4 1.78±0.11 
66h 40.0±5.1 1.95 + 0.24 
25.9±6.0 5.12 + 0.96 3.7±0.5 
Oxidation rates were determined with 120 μΜ [і-1цС]palmitate bound to albu­
min (molar ratio 5:1). In case of intact muscles one hemidiaphragm or leg 
muscle was incubated per vial. The oxidation rate of each m.pectoralis was 
the mean of three separate fiber preparations. Muscle weights given are 
those of the entire diaphragm or of both leg muscles. In separate experi­
ments palmitate oxidation rates and citrate synthase activities were mea­
sured in whole homogenates which were prepared from entire diaphragm or 
from both leg muscles. At the beginning of starvation all rats used weighed 
110-120 g. After 18, 42 and 66 h of starvation, rat weights amounted to 
101 ±4, 91 ±6 and 83 ± 4 g, respectively (means ± S.D. of 4 animals). All 
values represent means±S.D. of 4-14 experiments. Values obtained with pre­
parations from fed rats are compared with those from rats starved for 66 h 
by the unpaired t-test. 
a P < 0.01 
Ρ < 0.05 
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acid-soluble products appears to correlate with the degree of injury of the 
muscular preparation, since with intact hemidiaphragm and m.soleus this 
ratio amounted to 1.50 ±0.15 and 1.11 ±0.1 A and with incised hemidiaphragm 
and m.soleus to 2.01 ±0.18 and 1.62 + 0.20, respectively (means ± S.D., 3-6 
experiments). Therefore, intactness may also be judged from the relative 
contributions of '"'COj and 1цС-1аЬе1еа acid-soluble products to the total 
palmitate oxidation rate in these muscular preparations. 
Comparison of oxidation rates of intact preparations and whole homogenates 
and the effect of starvation 
With intact muscular preparations from fed animals the palmitate oxi­
dation rates did not differ among the muscles examined (Table 3.2). After 
starvation of the animals for 66 h the oxidation rates were 40-60% higher 
with hemidiaphragm and m.soleus but remained unaltered with m.flexor. With 
whole homogenates we measured palmitate oxidation at cofactor and substrate 
concentrations that gave maximal oxidation rates. The oxidation rates of 
homogenates of diaphragm and m.soleus, expressed per g muscle, are compara­
ble and more than 10-fold higher than those of m.flexor or human m.pectora-
lis. Upon starvation for 66 h they decrease by about 20% (Table 3.2). How­
ever, when the oxidation rates are expressed relative to the citrate syn­
thase activity, there is no significant decrease with starvation (Table 
3.2). 
Because m.flexor contains comparatively large amounts of connective 
tissue it is difficult to homogenize this muscle by the Potter-Elvejhem 
method. Therefore, we used a Polytron tissue homogenizer. To check if this 
treatment injures muscle mitochondria, we measured palmitate oxidation 
rates and the activities of cytochrome с oxidase and citrate synthase of 
homogenates of diaphragm, prepared by either the Potter-Elvejhem or the 
Polytron method. The ratios of activities (Polytron relative to the Potter-
Elvejhem method) were 0.98±0.03, 0.63 ±0.08 and 1.10±0.18 for palmitate 
oxidation, cytochrome с oxidase and citrate synthase, respectively (means ± 
S.D., h hemidiaphragms, tested in paired experiments). It appears that in 
the mitochondria from the Polytron treatment the membrane-associated enzyme 
cytochrome с oxidase loses part of its activity. However, this activity 
still seems high enough to enable palmitate oxidation to proceed unaltered. 
The palmitate oxidation rates measured in Polytron homogenates of m.flexor 
can, therefore, be compared with those of the other muscles. 
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Fig. 3.4. Concentration dependence of palmitate oxidation by rat hemidia-
phragm for several albumin concentrations (A) and for several 
palmitate¡albumin molar ratios (B; facing page). Values are means 
±S.D. of 6-14 hemidiaphragms. In (A) the inset figure shows the 
reciprocal of the palmitate oxidation rate versus the reciprocal 
of the palmitate concentration. The inset figure in (B) shows the 
S.D. for 0-0.5 mM palmitate. All concentrations were corrected 
for substrate utilization according to the method of Lee & Wilson 
(1971). 
Concentration dependence of palmitate oxidation by hemidiaphragm 
With hemidiaphragm we studied the dependence of the palmitate oxida-
tion rate on external substrate concentration (0-3 mM) at several albumin 
concentrations (0.1-0.6 mM) and palmitate¡albumin molar ratios (0.5-5.0). 
Throughout this range of physiologically relevant concentrations the oxi-
dation rate appeared to increase with both the palmitate concentration and 
the palmitate¡albumin molar ratio (Fig. 3.4). For all albumin concentra-
tions examined we calculated the maximal oxidation rates and apparent К 
values (Table 3.3) from the corresponding Lineweaver-Burk plots (inset of 
Fig 3.4 A). Linear-regression analysis revealed high correlation coeffi­
cients and maximal oxidation rates that did not show much dependence on the 
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Table 3.3. Kinetic parameters of the concentration dependence of palmitate 
oxidation by rat hemidiaphragm. 
Condition Albumin 
concentration 
(mM) 
0.10 
0.20 
0.40 
0.60 
Apparent 
К 
m 
(mM) 
1.64 
1.43 
2.76 
2.70 
max 
Correlation 
coefficient 
(nmol/min per g) 
Starved 18 h 29.6 
22.6 
31.9 
27.9 
0.98 
0.99 
0.98 
0.97 
Starved 66 h 0.40 0.98 24.8 0.95 
Parameters of each linear regression line were calculated with the aid of 
the individual oxidation rates of all hemidiaphragms corresponding to the 
specific concentration curve (visualized in the inset of Fig. 3.4 A and in 
Fig. 3.5). For each curve 30-36 hemidiaphragms, distributed over 4 diffe­
rent palmitate concentrations, were used. 
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Fig. 3.5. Lineweaver-Burk plots of the concentration dependence of palmitate 
oxidation by whole homogenates of diaphragm (o) and m.quadriceps 
(Δ), measured at 0.4 tnM albumin. The results are shown of a typi­
cal experiment with homogenates of muscles obtained from the same 
rat. All concentrations were corrected for substrate utilization 
according to the method of Lee & Wilson (1971). 
albumin concentration (23-32 nmol/min per g ) . At 0.1 and 0.2 mM albumin the 
apparent К was, however, lower than at 0.4 and 0.6 mM albumin (Table 3.3). 
For comparison we also measured the concentration dependence of pal­
mitate oxidation in whole homogenates of diaphragm. At 0.A mM albumin the 
apparent К was 372 ±98 μΜ and the maximal oxidation rate 701 ± 140 nmol/min 
per g (means±S.D., 4 experiments with rats that had been starved for 18 h) 
(Fig. 3.5)· With whole homogenates of rat m.quadriceps we observed under 
these conditions a similar apparent к , but a much lower maximal oxidation 
rate (360 + 88 μΜ and 249 ± 30 nmol/min per g, respectively; means ± S.D., 4 
experiments). 
In order to determine the extent to which endogenous fatty acids may 
influence the oxidation of exogenous palmitate in diaphragm, we have mea­
sured the effect of the nutritional state on the kinetic parameters of pal­
mitate oxidation and also the rate of endogenous fatty acid consumption. 
After starvation the apparent К for palmitate oxidation by hemidiaphragm 
decreased considerably, while the maximal oxidation rate hardly changed 
(Fig. 3.6). Glycerol release increased linearly with time and was not mar-
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Fig. 3.6. Effect of prolonged starvation on the concentration dependence of 
palmitate oxidation by rat hemidiaphragm at 0.4 mM albumin. 
Values are means ±S.D. of 6-9 preparations. Rats weighing 110-120 
g at the beginning of starvation were starved for 18 h (·) or for 
66 h (о). All concentrations were corrected for substrate utili­
zation according to the method of Lee & Wilson (1971). 
kedly changed by the presence of 120 μΜ palmitate bound to albumin (molar 
ratio 5:1), or of 0.4 mM albumin. Hemidiaphragm and m.soleus from fed rats 
showed comparable rates of glycerol release (Table 3.4), which are slightly 
less than those observed with rat heart slices (section 7.3). The release 
of fatty acids to the medium appeared rather variable (Table 3.4) and was 
2-3-fold higher in the presence of the palmitate-albumin complex (results 
not shown). The latter observation may relate to withdrawal of fatty acids 
from the muscle by albumin. The released fatty acids were palmitic acid 
(49%), stearic acid (23%) and oleic acid (28%). The palmitate oxidation was 
also measured in the muscles which were first used for the release experi­
ments. After reincubation a similar oxidation rate was observed as in the 
non-preincubated muscles. The rate of endogenous fatty acid consumption, 
calculated from the release of glycerol into the medium and corrected for 
the release of free fatty acids, amounts to 25-30 nmol/min per g for both 
hemidiaphragm and m.soleus from fed rats (Table 3.4). This value is of the 
same order of magnitude as the calculated maximal oxidation rate for hemi­
diaphragm (Table 3.3). 
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Table 3.4. Endogenous free fatty acid consumption by rat hemidiaphragm and 
m.soleus. 
Muscle and 
condition 
Glycerol Free fatty acid Endogenous free fatty 
release release acid consumption 
Hemidiaphragm 
Fed 
Starved 66 h 
M.soleus 
Fed 
Starved 66 h 
15.8± 1.8 (12) 16.1 ±5.6 (6) 
12.7 ±2.8b (10) 15.3±5.8 (A) 
11.3±2.0 (8) 12.4±4.9 (A) 
6.2±2.1 (A) 6.8 + 3.4 (3) 
29.9±9.5 (6) 
17.6 + 8.Ia (A) 
24.6 + 7.6 (4) 
14.0±6.6 (3) 
The muscles were incubated for 30 min without added substrate. The glycerol 
and free fatty acids released into the medium were measured in separate ali-
quots taken at the end of the incubations. Endogenous free fatty acid con­
sumption was calculated from the release of glycerol and corrected for the 
release of free fatty acids. All values are given in nmol/min per g muscle 
(wet weight) and represent means + S.D. of the number of preparations indi­
cated within parentheses. Values obtained with preparations from fed rats 
are compared with those from rats starved for 66 h by the unpaired t-test. 
a . 
P< 0.05 
'P< 0.01 
:
 P< 0.001 
After prolonged starvation (66 h) the glycerol release was signifi­
cantly lower in both hemidiaphragm and m.soleus, when compared to fed ani­
mals (Table 3.4). The release of free fatty acids also tended to be lower 
in both muscles, so that the calculated rate of endogenous free fatty acid 
consumption was after starvation only about 60% of that of muscles from fed 
rats (Table 3.4). 
3.4. DISCUSSION 
The present findings demonstrate that intact human and rat skeletal 
muscle in vitro oxidizes palmitate at constant and high rates for at least 
60 and 90 min, respectively. The oxidation rate is highly dependent upon 
the fatty acid availability within the substrate concentration range stu­
died. The latter data confirm earlier observations that the production of 
'"•СОг from [I-1 "c]palmitate by rat diaphragm (Fritz et ai., 1958; Bodel et 
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ai., 1962) and m.extensor digitorum longus (Eaton & Steinberg, 1961) rises 
with increasing concentration of fatty acids in the medium. The observation 
that with hemidiaphragm the oxidation rate is hardly influenced by a 
variety of substances added to the Incubation medium (Table 3.1) shows that 
this muscle preparation retains its viability during incubation. Lundholm 
et ai. (1975) also observed that teased human muscle fibers maintain a nor­
mal ultrastructure during incubation and that several regulatory systems 
remain intact. These results indicate that provision of oxygen and sub­
strate by diffusion is sufficient to maintain a steady metabolic rate, 
which is necessary for the study of fatty acid metabolism. 
The palmitate oxidation rates measured by us for intact rat muscle 
are generally two to four times as high as those reported by others for 
rat hemidiaphragm (Fritz & Kaplan, I960; Bodel et ai., 1962; Tutwiler, 1978; 
Stearns et ai., 1979; Higgins et ai., 1981), m.soleus (Stearns et ai., 1979; 
Pearce & Connett, 1980) and m.extensor digitorum longus (Eaton & Steinberg,' 
1961). This is due to the fact that these investigators only measured '"СОг 
production, which merely accounts for about 50% of the oxidation rate (Fig. 
3.3). With teased fibers from human skeletal muscle Bylund et ai. (1975) 
measured the '''СОг production from [U-1'*C] palmitate and found a lower oxi­
dation rate than our value for human m.pectoralis. 
The concentration of free external palmitate is larger at a higher 
palmitate¡albumin molar ratio, since fatty acids are then less tightly 
bound to albumin (Spector & Fletcher, 1978). This explains our observation 
that at relatively low albumin concentrations (0.1 and 0.2 mM) the apparent 
К for palmitate oxidation is lower than at high (0.4 and 0.6 mM) albumin 
m 
concentrations (Table 3.3, Fig. 3.4). However, recent studies indicate that 
at low fatty acid concentrations the hepatic uptake of long-chain fatty 
acids is not determined by the concentrations of free or total fatty acid, 
but by the concentrations of albumin and of the albumin-fatty acid complex 
(Weisiger et ai., 1981). It could be argued that the apparent К is associa-
m 
ted with palmitate uptake by the muscle rather than with its oxidation. 
Transport of fatty acids across the muscle plasma membrane may be rate-li-
miting, since at the same substrate concentration the oxidation rate mea­
sured after prolonged starvation is nearly twice as high as for fed animals 
(Fig. 3.5)· There is, however, no evidence that the permeability of the 
sarcolemmar membrane for fatty acids changes during starvation. 
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Free fatty acids derived from endogenous lipid stores, mainly inter-
myofibrillar triacylglycerol pools, can also enter the fatty acid oxidation 
pathway, thereby causing label dilution of the exogenously added [ll,C]-pal-
mitate and hence underestimation of the fatty acid oxidation rate. The 
degree of label dilution is dependent upon the concentration of exogenous 
fatty acid and the rate of endogenous lipolysis. Owing to competitive inhi­
bition, the apparent К for the oxidation of exogenous as well as endoge­
nous fatty acids will be lower than the К for the oxidation of exogenous 
m 
palmitate. However, high concentrations of exogenous fatty acids inhibit 
endogenous lipolysis in rat heart (Crass, 1977) and m.soleus (Pearce & Con-
nett, 1980), probably by product inhibition of the tissue lipase. With 120 
μΜ palmitate we found no inhibition of glycerol release from hemidiaphragm. 
The inhibition may still complicate measurements of lipolysis and oxidation 
of external fatty acids. The linearity of the oxidation with time indicates 
a nearly immediate equilibration of the pools of external and endogenously 
formed fatty acids. 
During prolonged starvation the apparent К for palmitate oxidation, 
when measured in the presence of 0.4 mM albumin, markedly decreased, but 
the calculated maximal oxidation rate was not significantly changed (Table 
3.3). This suggests a more limited availability of endogenous fatty acids 
after prolonged starvation. The rate of endogenous free fatty acid consump­
tion was indeed lowered after starvation (Table 3.4). These observations 
may relate to the decrease of the triacylglycerol content of the diaphragm 
of these young rats upon starvation (Neptune et ai., 1959; Masoro, 1967; 
Abumrad et al., 1978). An increase in '''СОг production from external lRe­
labeled fatty acids was earlier observed in hemidiaphragm after starvation 
(Schwartzmann & Brown, I960; Fritz 4 Kaplan, I960; Bodel et al., 1962). The 
low apparent К for palmitate oxidation in homogenates of diaphragm can be 
explained from the negligible label dilution with endogenously derived sub­
strates due to the large medium volume. We conclude that the apparent К 
m 
for the oxidation of exogenous palmitate by intact hemidiaphragm in vitro 
is greatly affected by the degree of label dilution with endogenously 
derived free fatty acids. These endogenous lipid pools have a physiological 
importance, since intramuscular triacylglycerol is mobilized during exer­
cise, predominantly in the slow oxidative red fibers (Reitman et al., 1973; 
Stankiewicz-Choroszucha & Gôrski, 1978; Jones et al., 1980; Oscai et al., 
1982). 
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Although diaphragm and m.soleus are comprised almost entirely of slow 
oxidative red fibers (Baldwin et al., 1972; Gould, 1973), whereas m.flexor 
is a fast-twitch mixed type muscle, there is no great difference in the 
palmitate oxidation rates of these muscles, when they are obtained from fed 
animals (Table 3.2). This may be due to a difference in label dilution with 
endogenous substrates, since in red fibers the tnacylglycerol content is 
much higher (Reitman et al., 1973; Okano et al., 1980) and triacylglycerol-
derived fatty acids are relatively more available (Reitman et al., 1973; 
Stankiewicz-Choroszucha 4 Gôrski, 1978; Oscai et al-, 1982) than in white 
fibers. Recently, Okano & Shimojo (1982) have reported higher palmitate 
oxidation rates for slices of red than of white portions of m.quadriceps, 
but all of their values are much lower than ours. In diaphragm and m.soleus 
a decreased mobilizatjon of endogenous fatty acids may result in higher 
oxidation rates of external substrate after starvation for 66 h, while m 
m.flexor presumably hardly any change in label dilution occurs. 
The 20% decrease observed in the palmitate oxidation rate of whole 
homogenates of diaphragm and m.soleus from fasted animals (Table 3.?) may 
be related to a small decrease in mitochondrial content, since no change 
of palmitate oxidation rates is observed when these rates are expressed 
relative to the citrate synthase activity. For all muscles examined, the 
palmitate oxidation rates of intact muscle are much lower than those of 
whole homogenates. This difference is likely to be due to three factors: 
(i) an underestimation of the oxidation rate of the intact muscle due to 
label dilution, (n) the resting state of these in vitro muscular prepara-
tions in which they do not use much of their metabolic capacity (Fritz et 
al., 1958; Taegtmeyer et al., 1980; McLane et al., 1981), and (in) the use 
of entire muscles, which have 5-7 times lower [l-'^C]palmitate oxidation 
rates than muscle cells isolated from m.flexor by incubation with collage-
nase and gentle trituration (Zuurveld, J.G.E.M. and Veerkamp, J.Η., unpu­
blished data). 
In summary, we have described a method for the assay of palmitate 
oxidation in intact muscle preparations. Several metabolic characteristics 
of these preparations have been investigated, including the dependence on 
external substrate concentration, the role of endogenously derived fatty 
acids, the effect of various cofactors, and the comparison with oxidation 
measurements in whole homogenates. This study serves as a basis for further 
investigations of the postnatal development of palmitate oxidation (chap-
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ter 4) and of the fatty acid oxidation by cellular preparations of human 
and rat heart (chapter 7). 
3.5. SUMMARY 
The palmitate oxidation by intact preparations of rat hemidiaphragm, 
m.soleus and m.flexor digitorum brevis and by teased fibers of human m.pec-
toralis has been studied. 
The structural and metabolic viability of these preparations in vitro 
is shown by a low leakage of soluble creatine kinase, a constant rate of 
palmitate oxidation and a small stimulatory effect of L-carnitine. 
The palmitate oxidation rate of hemidiaphragm increases with the pal­
mitate concentration (0-3 mM) and with the palmitate:albumin molar ratio 
(0.5-5.0). The apparent К for palmitate oxidation is about 1.5 mM at 0.1 
m 
and 0.2 mM albumin and about 2.7 mM at 0.4 and 0.6 mM albumin, which cor­
relates with the higher affinity of albumin for palmitate at lower palmi­
tate ¡albumin molar ratios. After prolonged starvation the apparent К at 
0.4 mM albumin is markedly decreased. In whole homogenates of diaphragm and 
of m.quadriceps femoralis the apparent К is only about 370 μΜ at 0.4 mM 
albumin. 
The calculated maximal oxidation rate is not significantly different 
for all albumin concentrations examined (23-32 nmol/min per g), does not 
change after starvation, and is about equal to the rate of endogenous fatty 
acid consumption (25-30 nmol/min per g). 
Our results suggest that substrate availability is an important fac­
tor for the oxidation rate of exogenous palmitate by hemidiaphragm in vitro 
and that the apparent К largely depends upon the degree of label dilution 
by fatty acids of endogenous origin. 
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CHAPTER 4 
POSINATAL DEVELOPMENT OF РАШГГАТЕ OXIDATION AND 
MITOCHONDRIAL ENZYME АСП ГПЕЗ IN RAT CARDIAC AND 
SKELETAL MUSCLE' 
4.1. INTRODUCTION 
The development of fatty acid oxidation has been studied more exten­
sively in mammalian liver than in muscle. In rat liver the oxidation capa­
city is higher during the suckling period than prenatally or after weaning 
and appears to follow changes in dietary fat supply (Bailey & Lockwood, . 
1973, Foster & Bailey, 1976; Krahling et al., 1979; Chalk et al., 1983). In 
heart and skeletal muscle the development of anaerobic metabolism has re­
ceived more attention. Activities of glycogen metabolizing enzymes increase 
postnatally in rat heart (Novak et al., 1972; Baldwin et al-, 1977)and skele­
tal muscle (Novak et al., 1972; Baldwin et al., 1978; Villa-Moruzzi et ai., 
1979) and in rabbit skeletal muscle (Smith, 1980) with major changes being 
completed in 3-4 weeks. 
The fatty acid oxidation capacity of heart muscle appears to rise 
perinatally and during early postnatal development in rat (Wittels & Bress-
ler, 1965) and calf (Warshaw & Terry, 1970), but not in pig (Wolfe et ai., 
1978). In rat heart the postnatal rise is accompanied by an increase of the 
activities of several enzymes associated with oxidative metabolism (Lang, 
1965; Wittels 4 Bressler, 1965; Walpurger, 1967; Warshaw, 1972; McMillin-
Wood, 1975; Baldwin et al., 1977) and the concentration of cytochromes 
(Hallman et al., 1972; Kinnula & Hassmen, 1977; Baldwin et al., 1977), car­
nitine (Wittels 4 Bressler, 1965; Robles-Valdes et al., 1976; Borum, 1978) 
and mitochondrial protein (Hallman et al., 1972; Kinnula 4 Hassinen, 1977; 
David et al., 1979; Rakusan, 1980). On the basis of morphometnc studies it 
has been reported that the latter is due to an increase of both the number 
and size of mitochondria (David et al., 1979; Olivetti et al., 1980), and to 
»Adapted from Glatz 4 Veerkamp (1982a). 
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an increase of only their size (Vitorica et al., 1981). Little is known 
about changes of fatty acid oxidation in developing skeletal muscle. In 
porcine leg muscle homogenates the palmi tate oxidation rate, based on ''•СОг 
production, increases with the age of the animal (Wolfe et al., 1978). In 
rat skeletal muscle carnitine content (Borum, 1978) and citrate synthase 
activity (Baldwin et al., 1978; Kloosterboer et al., 1979) increase during 
the suckling period. The age dependence of fatty acid oxidation has never 
been studied in intact muscular preparations. 
In order to establish possible developmental differences between 
various types of muscle, we have measured the palmitate oxidation rate both 
in intact preparations of diaphragm and m.flexor digitorum brevis and in 
whole homogenates of heart, diaphragm and m.quadriceps femoralis of rats 
one day before birth and at different periods (0-65 days) after birth. The 
activities of the mitochondrial enzymes cytochrome с oxidase and citrate 
synthase have also been determined. The results indicate that during post­
natal development the oxidative capacity of all muscles increases consi­
derably, together with development. We have determined the palmitate oxi­
dation rate and cytochrome с oxidase and citrate synthase activities in 
mitochondrial preparations, in order to establish whether this increase is 
due to an increase in the number of mitochondria and/or to a higher speci­
fic activity of the oxidative system. 
4.2. MATERIALS AND METHODS 
Animals 
Albino Wistar rats were used in all experiments. At birth the nest 
size was, if necessary, decreased routinely to eight animals, since growth 
rate is affected markedly by litter size (Rakusan et al., 1978; Timson, 
1982). At regular intervals after birth one animal from each nest was kil­
led. Fetal age was determined by dated matings. Newborn animals (day 0) 
were killed within 12 h after birth. Animals were fed ad libitum until the 
start of the experiment. 
Tissue preparation 
Diaphragms and m.flexor digitorum brevis were obtained and handled 
as described in section 2.2, with the modification that the diaphragm was 
only cut into halves in the case of 37- and 60-72 -day-old rats. The weight 
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of ra.flexor from 0-6 - day-old animals was calculated from the protein con­
tent of the incubation mixture, measured after the experiment. As the pro­
tein content of diaphragm does not alter during the suckling period 
(168 ±15 (n = 36) and 165 ±11 (n = 20) mg/g muscle for 0-6 and 9-20-day-old 
rats, respectively), the value for m. flexor from 9-20-day-old rats 
(131 ±17 mg/g muscle, η = 19) was used for the calculation. Whole homoge-
nates (5 or 10%, w/v) and mitochondria were prepared from heart, diaphragm 
and m.quadriceps femoralis as described in section 2.2. In the case of new­
born animals the tissues from 4-6 rats of the same nest were taken together. 
Assay of palmitate oxidation and enzyme activities 
The intact muscular preparations were gently blotted on filter paper, 
weighed and immediately transferred to vials containing calcium-free Krebs-
Ringer bicarbonate buffer (pH 7.2) gassed with O2/CO2 (95:5). supplemented 
with A mM D,L-carnitine and 0.1 mM coenzyme A. The final incubation volume · 
was 1 ml per 50 mg muscle with a minimum of 0.5 ml. Oxidation rates were 
measured with 120 μΜ [l-^Cjpalmitate bound to dialyzed, fatty acid-free 
albumin in a 5:1 molar ratio. The incubations proceeded for 90 min at 37 C. 
Further details on the assay of '"'COj and '''C-labeled acid-soluble products 
are given in section 3.2. 
Palmitate oxidation in homogenates and isolated mitochondria was 
measured in a medium containing 0.25 M sucrose, 30 mM KCl, 10 mM K-phos-
phate, 5 mM MgCl2, 1 mM EDTA, 75 mM Tris-HCl (pH 7.4), supplemented with 
5 mM ATP, 1 mM NAD , 25 yM cytochrome c, 0.1 mM coenzyme A, 0.5 mM L-malate 
and 0.5 mM L-carnitine. The final incubation volume was 0.5 ml containing 
25-100 μΐ homogenate (1-5 mg muscle) or 25 μΐ mitochondrial suspension 
(100-200 \ig protein). Incubations were carried out with 120 μΜ palmitate 
essentially as described for the intact muscular preparations (section 
3.2), except that the incubation time was 15 min (mitochondria) or 30 min 
(homogenates). 
Assays of cytochrome с oxidase and citrate synthase activities and of 
protein are described in section 2.3. 
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Fig. 4.1. Age dependence of palmitate oxidation by intact diaphragm or 
hemidiaphragm (37 and 60-72-day-old rats) (·) and m.flexor digi-
torum brevis (FDB) (o). Routinely two m.flexor muscles from the 
same animal were incubated together. Hemidiaphragras were always 
taken from different animals. Values represent means ±S.D. for 
4-8 experiments. 
4.3. RESULTS 
Palmitate oxidation by intact muscular preparations 
The intactness of hemidiaphragm and m.flexor digitorura brevis was 
confirmed by a low leakage of soluble (cytosolic) creatine kinase during 
the incubation (section 3.3). Palmitate oxidation was measured routinely in 
the presence of carnitine and coenzyme A, as some leakage of these cofac­
tors takes place (section 3.3). 
The age dependence of the [і-ІЦС]palmitate oxidation rate by intact 
diaphragm and m.flexor is shown in Fig. 4.1. On the first day after birth 
the oxidation rate increases in both diaphragm and ra.flexor by 178 and 
173%, respectively, and falls gradually thereafter to a rate which for 
60-72 -day-old rats is about 35% of that at birth. No differences were 
found in the oxidation rate of intact muscles from 21-day-old foetal and 
newborn rats. In Fig. 4.1 each value represents the mean of the oxidation 
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Fig. 4.2. Age dependence of palmitate oxidation by intact diaphragm. Repre­
sentation of oxidation rates of individual diaphragm preparations. 
rates of intact muscles from rats of the same age. The variation coeffi­
cient is rather large and amounts to 8-20% of the mean value. However, the 
same is true for the weights of diaphragm and m.flexor. When palmitate oxi­
dation rates are related to muscle weight (Fig. 4.2), it appears that the 
individual values within one age group show a better fit to the curve. The 
magnitude of the standard deviation in Fig. 4.1 is thus caused partly by 
taking rat age as a parameter. 
Palmitate oxidation by whole homogenates 
Palmitate oxidation by whole homogenates and mitochondria proceeded 
at a constant rate during the incubation periods used and was proportional 
to the amount of tissue material. Oxidation rates did not vary much with 
the palmitate concentration in the range of 60-500 μΜ, but were maximal at 
120 μΜ palmitate. All cofactors were present at concentrations that as­
sured maximal oxidation rates. 
In whole homogenates of all three muscles examined, heart, diaphragm 
and m.quadriceps, the palmitate oxidation rate increases steadily from the 
prenatal level, reaching a maximum at 15-20 days postnatally (Fig. 4.3). 
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Fig. 4.3. Age dependence of palmitate oxidation by whole homogenates of 
heart (·), diaphragm (o) and m.quadrceps (Δ). Values represent 
means ±S.D. for 4-8 experiments. 
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Fig. 4.4. Age dependence of the activities of cytochrome с oxidase (left) 
and citrate synthase (right), measured in whole homogenates of 
heart (·), diaphragm (o) and m.quadriceps (Δ) . Values represent 
means ±S.D. for 4-14 experiments. 
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Fig. ^.5. Age dependence of palmitate oxidation relative to mitochondrial 
enzyme activities. Palmitate oxidation rates and the activities 
of cytochrome с oxidase and citrate synthase were measured in 
whole homogenates as described in section 4.2. Values represent 
means +S.D. for 4-10 preparations. 
This increase is especially large in heart, where the adult value is nearly 
three times as high as the value for newborn rats (780 vs. 293 nmol/min per 
g muscle). 
Activities of mitochondrial marker enzymes 
The activities of the mitochondrial marker enzymes cytochrome с oxi­
dase and citrate synthase were measured in the whole homogenates that also 
had been used for the palmitate oxidation experiments. Both enzyme activi-
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Table 4.1. Comparison of tissue capacity, mitochondrial activity and mitochondrial content of muscles from 
newborn and adult rats. 
Heart 
Newborn Adult 
Diaphragm 
Newborn Adult 
M.quadriceps 
Newborn Adult 
Tissue capacity 
(per g muscle) 
Palmitate oxidation 293 ± ЗА 733 ± 47 
Cytochrome с oxidase 181 ±60 341 ±46 
Citrate synthase 31.1± 7.8 71.6+ 4.9 
Mitochondrial activity 
(per mg protein) 
Palmi ta te o x i d a t i o n 8.79 ± 0 . 6 2 18.08 + 0.46 
Cytochrome с oxidase 5.41 + 1.18 7 . 8 0 + 1 . 1 2 
C i t r a t e synthase 0.99 ±0.06 1.45 ± 0 . 3 0 
Mitochondrial content 
(mg prote in/g muscle) 
Pa lmi ta te o x i d a t i o n 33.3 ± 4.5 4 0 . 5 + 4.5 
Cytochrome с oxidase 33.5 ± 1 3 . 2 43 .7± 8.5 
C i t r a t e synthase 3 1 . 5 ± 8.1 4 9 . 4 ± 1 0 . 7 
144 ± 2 6 213 ±15 
86 ± 1 4 181 ± 5 2 
1 9 . 7 ± 1.9 2 6 . 6 ± 2.0 
4 . 6 9 ± 0 . 3 3 1 0 . 1 7 ± 0 . 5 3 
2 . 1 9 ± 0 . 4 4 5.87 + 0.81 
0 . 5 5 ± 0 . 0 9 1 . 0 7 ± 0 . 0 7 
3 0 . 6 ± 5-9 2 1 . 0 ± 1.8 
3 9 . 3 ± 1 0 . 0 30.8 + 9.8 
3 5 . 8 ± 6.9 2 4 . 9 ± 2 . 5 
5 1 . 4 ± 8 . 2 116 ±15 
1 6 . 2 ± 5 . 8 84 ± 1 7 
5 . 7 ± 1 . 1 , 13.4 ± 3.6 
3 . 1 2 ± 0 . 1 9 6 . 9 3 ± 2 . 0 4 
1 . 1 9 ± 0 . 1 9 8 . 6 6 ± 2 . 7 7 
0 . 3 0 ± 0 . 0 6 1 . 2 2 ± 0 . 3 2 
1 6 . 5 ± 2 . 8 1 6 . 7 ± 5 . 3 
1 3 . 6 ± 6 . 3 9 . 7 ± 3 . 6 
1 8 . 9 ± 5 . 3 11.0 + 4.1 
Palmitate oxidation rates and the activities of cytochrome с oxidase and citrate synthase were determined in 
whole homogenates and isolated mitochondria as described in section 4.2. Oxidation rates and enzyme activities 
are expressed as nmol/min and ymol/min, respectively, per g muscle for whole homogenates and per mg protein 
for mitochondria. Mitochondrial protein content was calculated as tissue capacity divided by mitochondrial ac­
tivity. Values are means +S.D. for 5-10 experiments. 
ties show developmental changes similar to those in the palmitate oxidation 
rate (Fig. 4.4). From before birth, the marker enzyme activities increase 
steadily to reach a maximum at 20-37 days (cytochrome с oxidase) and 15-20 
days (citrate synthase). 
Palmitate oxidation rates based on these enzyme activities are pre­
sented in Fig. 4.5. The oxidation rates thus expressed are constant during 
development and, moreover, are of similar magnitude for the different 
muscles. When expressed relative to cytochrome с oxidase and citrate syn­
thase activity, the oxidation rates amount to 2-3 nmol/min per unit cyto­
chrome с oxidase (except for m.quadriceps during the suckling period) and 
8-12 nmol/min per unit citrate synthase. Thus, when palmitate oxidation 
rates are related to mitochondrial marker enzyme activities, no significant 
age dependence is observed, although the capacity of the mitochondrial sys­
tem increases considerably during postnatal development (Figs. 4.3 and 4.4). 
Mitochondrial activity and mitochondrial content 
The increased oxidative capacity can either be the result of an in­
creased mitochondrial activity or of an increased mitochondrial content, or 
a change of both. Therefore, we have compared mitochondrial activities and 
protein contents of heart, diaphragm and m.quadriceps from newborn (day 0) 
and adult rats. Mitochondrial protein content has been calculated by com­
paring mitochondrial parameters determined in whole homogenates and isola­
ted mitochondria. 
As parameters, we have measured palmitate oxidation rates and cyto­
chrome с oxidase and citrate synthase activities in both preparations. In 
the case of adult rats part of the whole homogenate has always been used 
for the isolation of the mitochondria, in order to permit a direct compari­
son. The mitochondrial contents calculated by means of either of the three 
parameters are in reasonable agreement (Table 4.1). In cardiac muscle the 
increase of the tissue capacity with age is the result of a simultaneous 
increase in mitochondrial activity and mitochondrial content. In both ske­
letal muscles, diaphragm and m.quadriceps, the mitochondrial content is 
lower in adult than in newborn rats. Therefore, a large increase in the 
mitochondrial activity, particularly in m.quadriceps, is responsible for 
the age-related increase in the oxidative capacity in these muscles. 
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Fig. 4.6. Age-related changes in the utilization of the fatty acid oxida-
tion capacity in diaphragm. Oxidation rates of intact diaphragm 
(Fig. 4.1) and of whole homogenates (Fig. 4.3) were used to cal-
culate the ratios. 
Comparison of palmitate oxidation rates of intact muscular preparations and 
whole homogenates 
Oxidation rates measured in whole homogenates, expressed per g 
muscle, represent the best approximation of the palmitate oxidation capaci-
ty. Oxidation rates measured at the same substrate concentration in intact 
muscular preparations can be compared with this capacity. For diaphragm 
this comparison can be made over the entire age range examined. The age 
dependence of the ratio of oxidation rates of intact diaphragm to those in 
whole homogenate is shown in Fig. 4.6. The ratio is maximal at 0-3 days, 
but only 0.032, and decreases with age. This could indicate that the uti-
lization of the fatty acid oxidation capacity decreases during develop-
ment, but may also be related to an increase of endogenous fatty acid pools 
in muscle of older animals (cf. chapter 3). 
4.4. DISCUSSION 
The present study clearly demonstrates that the palmitate oxidation 
capacities of rat heart, diaphragm and m.quadriceps increase considerably 
during postnatal development. As with heart, this observation is in agree-
ment with that of Warshaw (1972) and confirms the findings of Wittels & 
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Bressier (1965) that the 1 ЦС0 2 production from [l-^Cjpalmitate із higher 
in homogenates from the adult than from the newborn rat. However, we did 
not find a decrease of the oxidation capacity after weaning, as was repor­
ted by Lockwood 4 Bailey (1970) and Bailey & Lockwood (1973). Therefore, 
their suggestion that changes in the metabolism of fatty acids by the de­
veloping rat heart follow changes in the fat content of the diet, does not 
seem likely. Association of the increase of the palmitate oxidation capa­
city with the postnatal appearance of lipoprotein lipase activity in both 
heart and skeletal muscle (Cryer & Jones, 1978; Hamosh et al., 1978) is 
plausible. Recently, Carroll et al. (1983) have reported that the palmitate 
oxidation by homogenates of rat m.gastrocnemius increased only minimal 
from birth until 15 days of age and then increased more than five times 
until adulthood. Their oxidation rates were, however, based on only '"'COz 
production. 
Some authors suggested that in rat (Wittels & Bressler, 1965; War-
shaw, 1972) and bovine (Warshaw & Terry, 1970) heart the development of the 
fatty acid oxidation capacity would be determined by the peri- and post­
natal increase of the activity of the external carnitine palmitoyltransfe­
rase. However, this hypothesis has been questioned by others, who argued 
that the low enzyme activities found in fetal and newborn heart could have 
been underestimated due to the kind of mitochondrial preparation and assay 
(McMillin Wood, 1975; Tomec & Hoppel, 1975). 
The increase of the activities of cytochrome с oxidase and citrate 
synthase in all three muscles examined is consistent with the earlier re­
ported postnatal rise of both enzymes in rat heart (Lang, 1965; Warshaw, 
1972; Baldwin et al., 1977; Vitorica et al., 1981) and of citrate synthase 
in rat skeletal muscle (Baldwin et al., 1978; Kloosterboer et al., 1979) and 
guinea pig heart (Rolph et al., 1982). However, in rabbit skeletal muscle 
citrate synthase activity decreases with age (Smith, 1980). For diaphragm 
and heart the adult values of both enzyme activities are comparable to 
those recently reported by Hansford et al. (1982) for 6-month old rats. 
The origin of the age-related increase of the oxidative capacity is 
different for the three muscles examined. Mitochondrial activities of all 
muscles are elevated in the adult as compared to the newborn rat, but for 
m. quadriceps the difference is considerably larger than for heart or dia­
phragm (Table A.I). In heart the mitochondrial content also increases with 
age from 31-33 (newborn) to 41-49 mg/g muscle (adult). This parallel in-
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crease of both mitochondrial content and activity m heart agrees with ob­
servations of Hallman et al. (1972) and Kinnula & Hassinen (1977), who used 
cytochrome content as a mitochondrial marker. However, they reported 
higher values for the mitochondrial content of adult heart (80-88 mg/g 
muscle). On the other hand, our value is identical to those calculated by 
others (Abu-Erreish & Sanadi, 1978; Idell-Wenger et al., 1978; Feuvray & 
Plouet, 1981), who used cytochrome с oxidase and citrate synthase activity 
as mitochondrial markers. Also in guinea pig heart both the mitochondrial 
content and activity were found to increase during fetal and postnatal de­
velopment (Rolph et ai., 1982). 
The mitochondrial content of both diaphragm and m.quadriceps decrea­
ses with age (Table 4.1). M.gastrocnemius from 7 -day-old rats showed a 
mitochondrial content of 16 mg/g muscle (Kloosterboer et ai., 1979), which 
corresponds to our results with m.quadriceps. Recently, Davies et ai. 
(1981), using several enzyme activities and content of cytochromes as pa­
rameters, reported an average value of 19 mg/g muscle for adult skeletal 
muscle. The age-dependent decrease can be attributed m part to dispersion 
or dilution of mitochondria by myofibrillar protein (Burleigh, 1974). Our 
finding that the mitochondrial content and fatty acid oxidation capacity 
are higher in diaphragm than in m.quadriceps agrees with results of histo-
chemical studies. Adult diaphragm mainly consists of slowly contracting 
oxidative fibers (Close, 1972), while adult m.quadriceps is a rather mixed-
type muscle (Baldwin et ai., 1972). Although the functions of diaphragm and 
m.quadriceps differ substantially, the pattern of metabolic development is 
similar for the two muscles. 
In muscle a distinction has been made between subsarcolemmal and in-
termyofibrillar mitochondria. Several investigators reported that these 
two types of mitochondria differ metabolically in that the intermyofibnl-
lar mitochondria of both cardiac (Palmer et ai., 1977) and skeletal muscle 
(Krieger et ai., 1980; Brady & Tandler, 1981) show higher state 3 respira­
tion rates and enzyme activities. However, recently, Matlib et ai. (1981) 
have presented evidence that these differences can be created during iso­
lation and assay. They have not found differences in cytochrome content 
and enzyme activities between the two mitochondrial classes. In our stu­
dies the mitochondrial preparations isolated after hand homogemzation of 
adult rat muscle predominantly contain subsarcolemmal mitochondria. In 
newborn rat muscles the two mitochondrial classes cannot be distinguished. 
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Therefore, if there are metabolic differences between the two mitochon­
drial populations, this could affect our conclusions. 
The rapid increase of the palmitate oxidation rate in both intact 
diaphragm and m.flexor immediately after birth may be related to the en­
hancement of the functional capacity of the muscles during development. 
The subsequent decrease may be related to three factors: an impeded trans­
port of substrate in muscle of older animals, an increase of endogenous 
fatty acid pools, and changes in the regulation of fatty acid oxidation in 
the intact muscle cell during postnatal development. The pyruvate oxida­
tion rate of rat diaphragm shows a similar decrease with age (Zuurveld, 
J.G.E.M. and Veerkamp, J.H., unpublished observations). 
For all developmental stages examined, the palmitate oxidation rates 
are considerably lower in intact muscular preparations than in horaogenates. 
Possible explanations for this observation were already given in section 
3.4. 
4.5. SUMMARY 
The palmitate oxidation rate has been measured in intact diaphragm 
and m.flexor digitorum brevis and in whole homogenates of heart, diaphragm 
and m.quadriceps femoralis of developing rats between late fetal life and 
maturity. Activities of the mitochondrial enzymes cytochrome с oxidase and 
citrate synthase have also been determined. 
Immediately after birth the palmitate oxidation rate increases mar­
kedly in both intact diaphragm and m.flexor and falls gradually after day 
1 to adult values which are about 35% of those at birth. 
The oxidation capacities of diaphragm and m.quadriceps, but especial­
ly of heart, increase steadily during development, starting before birth 
and reaching adult values at 15-20 days postnatally. The activities of the 
mitochondrial enzymes show a similar developmental pattern. In heart the 
increase of oxidative capacity is the result of an increase of both mito­
chondrial content and mitochondrial activity. In diaphragm and m.quadri­
ceps the mitochondrial contents decrease with age, so the increase of 
their oxidative capacities is due to a large rise of the mitochondrial ac­
tivity. 
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CHAPTERS 
MITOCHONDRIAL AND PEROXISOMAL PALMTTATE OXIDATION* 
5.1. INTRODUCTION 
In earlier studies from this laboratory it has been observed that 
postnuclear fractions and mitochondria from muscle showed a higher produc­
tion of '"'СОг and '"O-labeled perchloric acid-soluble products from 
[l-'^Jpalmitate than from [U-^C] palmi tate (Van Hinsbergh et al., 1978a,b, 
1979, 1980). It was suggested that accumulation of intermediates during the 
ß-oxidation may cause this phenomenon. Accumulation of ß-oxidation inter-
mediates as coenzyme A esters was demonstrated during state 3 oxidation of 
palmitate by rat liver mitochondria (Stanley & Tubbs, 1974, 1975). Carni-
tine esters of these intermediates were observed with liver mitochondria 
after oxidation of palmitate with carnitine and fluorocitrate in the ab-
sence of ADP (Lopes-Cardozo et al., 1978). 
Peroxisomal ß-oxidation is essentially not complete in contrast to 
mitochondrial oxidation (Lazarow, 1978). The former system has a maximal 
activity towards acyl-CoA esters of 12-18 carbon atoms and little towards 
C6 and Ci, acyl-CoA esters (Lazarow, 1978; Osumi & Hashimoto, 1978; Hryb & 
Hogg, 1979). Therefore, the observed incomplete degradation of palmitate 
molecules (Van Hinsbergh et al., 1978a,b, 1979, 1980) may be due to peroxi-
somal release of intermediates, which are not further oxidized within the 
mitochondria. 
In this study we compared the palmitate oxidation capacity and the 
extent of incomplete palmitate degradation in various rat tissues. Assays 
were performed in intact muscles, whole homogenates, 600 χ g supernatants 
and mitochondrial preparations, which may contain different proportions 
of mitochondria and peroxisomes. The peroxisomal contribution to the pal-
* Taken and adapted from Veerkamp et a2. (1983) and Glatz & Veerkamp (1982). 
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mitate oxidation was established in homogenates of rat skeletal muscle by 
use of various inhibitors of mitochondrial oxidation. 
Since skeletal muscle contains a relatively high carnitine concen­
tration (Brooks 4 Mcintosh, 1975; Van Hinsbergh et al., 1980), the accumu­
lation of carnitine esters may"occur under physiological conditions. 
Therefore, we investigated whether carnitine and inhibition of carnitine 
palmitoyltransferase influenced the dependence of the oxidation rate on 
the label position of ['""cjpalraitate in muscle mitochondria and homoge­
nates. The identity of the intermediates was studied by the analysis of 
the acid-soluble and acid-insoluble fractions after incubation of muscle 
and liver homogenates and mitochondria. 
5.2. MATERIALS AND METHODS 
Male random-bred albino Wistar rats were used. The rats weighed 
either 90-120 g (intact muscular preparations) or 180-240 g (cell-free 
systems), and were starved for 18 h before the start of the experiment. 
Biopsies from human m.pectoralis were obtained and handled as described in 
section 2.1. The preparation of the intact muscles and of the various 
cell-free systems is described in section 2.2. 
Assays 
Palmitate oxidation rates of intact muscular preparations were 
measured as described in section 3.2. With cell-free systems, palmitate 
oxidation rates were measured in a total volume of 0.5 ml containing 25 mM 
sucrose, 75 mM Tris-HCl (pH 7.4), 10 mM K 2HP0 4, 5 mM MgCl2 and 1 mM EDTA, 
supplemented with 1 mM NAD , 5 mM ATP, 25 μΜ cytochrome c, 0.1 mM coenzyme 
A, 0.5 mM L-malate and 0.5 mM L-carnitine. 120 μΜ [l-1''С]palmitate bound 
to albumin in a 5:1 molar ratio was used as substrate, unless otherwise 
indicated. A volume of 50-100 μΐ homogenate or 600 χ g supernatant or of 
25 μΐ mitochondrial suspension (100-200 μg protein) was added. Incubation 
was carried out for 15 min (mitochondria) or 30 min at 370C. Oxidation was 
stopped by adding 0.2 ml of 3 M perchloric acid and followed by a second 
incubation for 90 min at 4 С. 1І,С0
г
 produced was bound to 0.2 ml ethanol-
amine/ethyleneglycol (1:2, v/v). Thereafter the acid incubation mixture 
was centrifuged in a Burkard Koolspin microcentrifuge, and 200 pi superna­
tant was assayed for radioactivity. 
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Radioactivity of '"СОг in the trapping solution was determined after 
addition of 10 ml toluene/methanol (2:1, v/v) containing 0.4% Omnifluor. 
Radioactivity of the acid-soluble metabolites was assayed after addition 
of 10 ml Aquasol. 
Protein and citrate synthase activity were assayed as described in 
section 2.3. 
Peroxisomal oxidation of palmitate or palmitoyl-CoA was assayed in a 
modification of the system described by Lazarow (1981b). Production of 
'••C-labeled acid-soluble products was measured after 10 min incubation at 
370C of 100 μΐ rat liver or muscle homogenate in a total volume of 0.5 ml. 
The medium contained 50 mM sucrose, 0.01% Triton X-100, 0.1 mM coenzyme A, 
0.2 tnM NAD+, 10 μΜ FAD, 5 mM ATP, 1 mM dithiothreitol, 73 μΜ antimycin A, 
10 μΜ rotenon and 45 mM Tris-HCl (pH 7.4). Palmitate or palmitoyl-CoA 
and albumin concentrations are indicated in the Table. 
Identification of the acid-insoluble products 
For assay of 1ЦС-1аЬе1еа fatty acids the total acid-insoluble frac­
tion was washed with water and hydrolyzed for 2 h at 80 С in methanol/wa­
ter (1:1, v/v) with 1 M K0H. After evaporation of methanol and acidifica­
tion, fatty acids were extracted with pentane and separated on silanized 
silica gel plates in acetic acid/water (3:1, v/v). The presence of R e ­
labeled hydroxy fatty acids was investigated by thin-layer chromatography 
of the fatty acid fraction before and after methylation (Fleming & 
Haigre, 1973). Chloroform (Hull et ai., 1972) and hexane/diethylether/ace-
tic acid (30:70:1, by vol) were used as solvent systems on silica gel G. 
The '"O-labeled compounds were located by autoradiography and radio­
activity of the individual compounds was determined by liquid scintilla­
tion counting. 
5.3. RESULTS 
All assays were performed under conditions which were optimal with 
respect to time and concentrations of palmitate, malate and of tissue ma­
terial (chapter 3). The intactness of mitochondria in the homogenates was 
checked by assay of released citrate synthase activity. Without sonication 
the relative activity of this mitochondrial matrix enzyme amounted to 
16 ±2 and 17 ±3% (means ± S.D. for 4 and 6 experiments) in the 20,000 χ g 
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Table 5.1. Proportional contribution of ^СОг production to the /2-1Цс/ра2-
mitate oxidation rate by cell-free preparations of rat tissues. 
Tissue Homogenate Mitochondria 
M. quadriceps б ± 3 1 3 + 4 
Diaphragm 12 ± 5 10 ± 2 
Heart 18 ± 3 16 ± 2 
Liver 2 ± 2 1 + 1 
Kidney 8 ± 6 25 ± 5 
Brain 7 ± 2 2 ± 2 
Lung 7 ± 3 
Values are given in % of the total activity of 1ЦС02 and '"'C-labeled acid-
soluble compounds and are means*S.D. of 3-22 experiments. 
supernatant prepared from homogenates of rat heart and m.quadriceps, res­
pectively. The centrifugation procedure did not influence the release, 
since the same percentages were found in 600 χ g supernatants. The mito­
chondrial preparations showed good values of respiratory control index and 
ADP/0 ratio with 1 inM 2-oxoglutarate as substrate (Van Hinsbergh et al., 
1978a, 1980). 
In the following text, ['''CJpalmitate oxidation will always refer to 
its conversion into the sum of '"'СОг and '"'C-labeled acid-soluble products. 
The 1'*С0
г
 production from [l-^CJpalmitate represented 1-25 and 50-60% of 
this sum in rat cell-free systems and intact muscles, respectively (Tables 
5.1 and 5.2). With [іб-^С]- and [U-^C] palmi tate the ^СОг production 
amounted to only 1-2% of the total oxidation rate in heart, muscle and 
lung homogenates, was not detected with other cell-free preparations, but 
represented about 30% with the intact muscles (Table 5.2). 
Table 5.3 (page 76) presents the oxidation rates of palmitate mea­
sured in mitochondrial preparations, 600 χ g supernatants and whole homo­
genates from various rat tissues. The capacity for palraitate oxidation is 
similar and highest in homogenates from heart and liver. Kidney has a 
higher capacity than diaphragm and m.quadriceps. Lung and brain have a low 
palmitate oxidation capacity. The activities of the post-nuclear fraction 
(600 χ g supernatant) do not give quite the same picture, since homogeni-
zation liberates different proportions of the number of mitochondria 
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Table 5.2. Ratio of oxidation rates of /j-14C_/- and [l6-1',c]palmitate by 
intact preparations of human and rat muscle and the contribution 
of ' Ог production. 
Muscle 
Human m.pectoralis fibers 
Rat hemidiaphragm 
ra.soleus 
in.flexor digitorum brevis 
Ratio of 
oxidation rates 
1.00 ± 0.02 
1.01 ± 0.05 
1.01 ± 0.03 
0.98 ± 0.11 
Contribution of ''•СОг 
production 
i-'-c 
31 ± 5 
51 ± 2 
53 + 3 
58 + 3 
(%) 
16-1ЦС 
11 ± 2 
30 ± 2 
29 ± 1 
30 ± 2 
Ratios of oxidation rates were determined in paired experiments with 120 μΜ 
'"•C-labeled palmitate bound to albumin (molar ratio 5:1). In case of m.pec­
toralis teased fibers from the same muscle were used for each experiment. 
The proportional contributions of '''СОг production to the total oxidation 
rate with |l-ll,C|- and | 16-1 ""С]palmitate are given in % of the sum of the 
production of 1ЦС02 and ll,C-labeled acid-soluble compounds. All values re­
present means ±S.D. of 4 experiments. 
present in the various tissues and since the tissue content of protein 
varies. The mitochondria from heart show the highest palmitate oxidation 
rate, those from skeletal muscle, liver and kidney have an intermediate 
activity and those from brain a very low activity. 
In all cell-free systems the oxidation rate was higher with [1- 1 ЦС]-
than with [16-1" Cjpalmitate or [U-^Cjpalmitate (Table 5.3). The ratio of 
oxidation rates was always larger for [l-'^C]- and [іб-^С]- than for 
[l-^C]- and [U-^Cjpalraitate. The highest ratios were observed with the 
post-nuclear fractions. With intact preparations of rat and also of human 
skeletal muscle, however, we did not observe a difference between the oxi­
dation rates with [l-^C]- and [l6-ll,C]palmitate (Table 5.2), despite the 
marked difference of the relative contributions of '''СОг and ''•C-labeled 
acid-soluble products to the total oxidation rate. Identical oxidation 
rates were also found with 1 mM [l-'^C]- and [16-1''Cjpalmitate (data not 
shown). 
75 
Table 5.3. Palmitate oxidation by cell-free preparations of rat tissues. 
Tissue Preparation [l-'^C]Palmitate Ratio of oxidation rates 
oxidation rate 
[1-1*C]-/ [l-^C]-/ 
[Іб-^С]- [U-1-с]. 
palmitate palmitate 
M.quadriceps mitochondria 6.90 ± 1.51 1.60 ±0.22 1.38 ±0.19 
600 χ g supernatant 0.49 ± 0.10 2.13+0.36 1.32 ±0.23 
whole homogenate 113 ±17 1.38±0.14 1.15±0.10 
Diaphragm 600 χ g supernatant 0.82 ± 0.10 1.55+0.11 1.34+0.15 
whole homogenate 192 ±37 1.39±0.17 1.30±0.18 
Heart mitochondria 16.71 ± 3.09 - 1.24±0.11 
600 χ g supernatant 1.48+ 0.26 1.54±0.13 1.20 + 0.13 
whole homogenate 760 ±104 1.18±0.07 1.14+0.06 
Liver mitochondria 6.35 ± 1.76 1.47 ±0.19 1.32±0.16 
600 χ g supernatant 1.11 ± 0.24 1.91 ±0.27 1.54 ±0.14 
whole homogenate 659 ±95 1.54 ±0.21 1.66 ±0.24 
Kidney mitochondria 3.94 ± 0.93 1.46 ± 0 . 1 1 1 .16±0.11 
600 χ g supernatant 0.94 ± 0.15 1.79 ±0.27 1.45 ±0.17 
whole homogenate 303 ±40 1.61 ±0.21 1.55±0.22 
Brian mitochondria 0.59 ± 0.09 2.42 ±0.07 1.62±0.12 
600 χ g supernatant 0.16± 0.03 2 . 9 2 ± 0 . 6 6 1 .69±0.13 
whole homogenate 16.7 ± 2.9 2.22 + 0.25 1.91 ± 0 . 2 2 
Lung whole homogenate 4.5 ± 3.3 1.56 + 0.19 
Values are means ±S.D. of 4-38 preparations. Rates are given in nmol/min 
per mg protein for mitochondrial fractions and 600 χ g supernatants. and 
in nmol/min per g tissue (wet weight) for whole homogenates.120 μΜ ^ C-
labeled palmitate bound to albumin (molar ratio 5:1) was used as substrate. 
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We investigated on m.quadriceps and liver which factors may cause or 
influence the ratio of oxidation rates found with cell-free systems for 
palmitate labeled in different carbon atoms. Disruption of rat muscle mito­
chondria by one cycle of freezing and thawing decreased the oxidation rate 
by 50 ±5%, mean ± S.D., η = 3), but the ratio did not change significantly 
(1.84 ± 0.14 vs. 1.75 ±0.04 for disrupted and intact mitochondria, respec­
tively). More cycles of freezing and thawing or addition of Triton X-100 
decreased the oxidation rate further and increased the ratio to 2-4. Addi­
tion of disrupted mitochondria or a 20,000 χ g supernatant from the homoge-
nate to intact mitochondria or to homogenates did not influence the ratio. 
Influence of various parameters on palmitate oxidation by mitochondrial 
preparations 
The omission of L-carmtine decreased markedly the oxidation rate of 
m.quadriceps mitochondria, but did not influence significantly the ratio 
(Table 5-4; page 78). Increase of the carnitine concentration above 0.5 mM 
had no marked effect. The same was observed with rat liver mitochondria 
(data not shown). The concentration of mitochondrial protein and/or of 
palmitate and the palmitate:albumin molar ratio (at 120 μΜ palmitate) did 
not significantly affect the ratio. The apparent К for L-carmtine was 
m 
80-100 μΜ with muscle mitochondria. The palmitate oxidation rate is nearly 
maximal at 0.5 mM L-carmtine. 
Addition of KCN or antimycin A to muscle mitochondria eliminated all 
^СОг production and decreased markedly less the production of radioactive 
acid-soluble products from [1- 1 ЦС]- than from [l6-'''Cjpalmitate, so that 
the ratio of the oxidation rates becomes much larger (Table 5-4). The 
effect of addition of both antimycin and rotenon was not significantly 
different from that of antimycin alone (data not shown). 
For comparison with omission of carnitine, the effect of malonyl-CoA, 
a specific inhibitor of carnitine palmitoyltransferase (McGarry et al., 
1978a), was also studied. Malonyl-CoA decreased the oxidation rate of 
[l-1L,C]palmitate by about 50%, but less that of [ 16-l"Ό]palmitate, so that 
the rates became about equal. Production of '"'COj and formation of 'Re­
labeled acid-soluble products from [l-'^Cjpalmitate were inhibited to a 
similar extent. Earlier (Veerkamp & Van Moerkerk, 1982) we established 
that the effect of malonyl-CoA on rat skeletal muscle mitochondria was 
maximal at 50 μΜ and not dependent on the nutritional state. 
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Table 5.4. Influence of various parameters on palmitate oxidation by mito­
chondria of rat m.quadriceps. 
Parameter changed Relative oxidation Ratio of oxidation rates 
rate [ W c ] - / [Іб-^С]palmitate 
Carnitine concentration 
Control (0.5 mM) 
0 mM 
0.1 
0.2 
1.0 
2.0 
Protein concentration 
100 ug/ml 
200 
500 
Palmitate concentration 
30 μΜ 
60 
120 
Palmitate:albumin molar ratio 
1:1 
3:1 
5:1 
Addition 
none 
20 mM KCN 
36 μΜ antimycin A 
50 μΜ malonyl-CoA 
100 μΜ malonyl-CoA 
100 
7 
74 
87 
113 
120 
94 
100 
110 
9Θ 
110 
100 
71 
89 
100 
100 
28 
33 
48 
48 
± 
+ 
+ 
+ 
+ 
± 
+ 
± 
+ 
± 
+ 
+ 
± 
+ 
+ 
3 a 
9 a 
7 
Ь 
6 a 
9 
6 
18 
17 
10 
12 
5 a 
11 a 
11 a 
5 a 
1.74 
1.85 
1.79 
1.87 
1.79 
2.21 
1.56 
1.50 
1.74 
1.47 
1.82 
1.78 
1.78 
1.69 
1.51 
1.60 
3.33 
4.40 
1.15 
1.05 
± 
+ 
± 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
± 
+ 
± 
+ 
+ 
± 
+ 
+ 
± 
+ 
0.25 
0.43 
0.27 
0.18 
0.41 
0.27 b 
0.16 
0.16 
0.31 
0.33 
0.28 
0.34 
0.44 
0.20 
0.06 
0.23 
1.18a 
1.38 a 
0.08 a 
0.06 a 
Values are means ±S.D. of 5-12 experiments. Relative oxidation rates of 
[l-^CJpalmitate are given in % of the corresponding control values, set at 
100 (0.5 mM L-carnitine, 120 μΜ palmitate bound to albumin in a 5:1 molar 
ratio and about 200 μg protein per assay). Statistical significance was 
analyzed with Student's t-test for paired data: different from the control 
with aΡ < 0.001, bp < 0.01. 
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Table 5.5. Influence of various parameters on palmitate oxidation by homo-
genates of rat m.quadriceps. 
Omission or addition Relative oxidation Ratio of oxidation rates 
rate [i_i*c]-/ [іб-^С]palmitate 
None 100 1.41 + 0.18 
- NAD+ 94 ± 3 
- L-carnitine 19 ± 12 a 1.37 ± 0.20 
10 mM KCN 41 + θ a 1.88 ± 0.46 b 
20 mM KCN 24 + 5 a 2.72 ± 0.87 a 
4 μΜ antimycin A 19 ± 2 a 3.66 ± 0.44a 
36 μΜ antimycin A 19 ± 5 a 3.71 ± 1.38 a 
50 μΜ malonyl-CoA 53 ± 5 a 1.16 + 0.06a 
100 μΜ malonyl-CoA 47 + 9 a 1.11 ± 0.05 a 
Values are means ±S.D. of 10-15 experiments. Relative oxidation rates of 
[l-'^jpalmitate are given in % of the corresponding control value, set at 
100. Statistical significance for paired data is indicated in Table 5.4. 
Influence of some parameters on palmitate oxidation by homogenates 
Omission of carnitine decreased the oxidation rate less with homoge­
nates (Table 5.5) than with mitochondria (Table 5.4), since endogenous 
carnitine (about 0.02 mM) is present in homogenates. Palmitate oxidation 
was hardly dependent on the carnitine concentration between 0.1 and 2 mM 
(data not shown), as also found with mitochondria (Table 5.4). Omission of 
carnitine had no effect on the ratio. Omission of NAD+ had only a slight 
effect on the oxidation rate, which also demonstrates the intactness of 
the mitochondria. Malonyl-CoA decreased the oxidation rate of [I-1 "»C]palmi­
tate by about 50%, similarly as with mitochondria. The ratio decreased also 
significantly in the presence of malonyl-CoA (Table 5.5). To investigate the 
cause of this latter decrease the oxidation of [l-'^Cjtetradecanoate was 
studied. Malonyl-CoA inhibited the oxidation of this acid (134+21 nmol/min 
per g) by only 35 ±5% (mean ± S.D., 7 experiments). 
No "'СОг production was observed from [1'*c] palmitate in the presence 
of KCN or antimycin A. The ratio of the oxidation rates of [і-^С]- and 
[ló-'^c]palmitate increased markedly in the presence of both inhibitors 
(Table 5.5). Also the ratios with [і-ІЦС]- and [З-^С]- or [U-'-Cjpalmi-
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Table 5.6. Peroxisomal fatty acid oxidation by homogenates of rat liver and 
m.quadriceps. 
Substrate 
[l-^CjPalmitate (albumin) 
[l-^CjPalmitoyl-CoA (albumin) 
Concentrations 
(pM ) 
120 (24) 
20 (1) 
40 (1) 
60 (1) 
80 (1) 
Liver 
30.6 ± 9.8 
24.4 ± 5.6 
37.7 ± 8.4 
46.6 ± 5.3 
51.4 ± 8.9 
M.quadriceps 
2.0 ± 0.5 
9.6 ± 1.0 
15.3 ± 2.5 
17.9 ± 0.5 
18.6 ± 0.6 
Production of '''C-labeled acid-soluble products was assayed in a medium 
containing 0.01% Triton X-100, 0.1 mM coenzyme A, 0.2 mM NAD+, 5 mM ATP, 
73 μΜ antimycin A and 10 μΜ rotenon. Incubation was carried out for 15 m m 
at 37 C. Oxidation rates are given in nmol/min per g tissue as means ±S.D. 
of 3 or 4 experiments. Albumin concentrations are given within parentheses. 
tate were considerably higher in the presence of KCN or antimycin A (data 
not shown). With the 600 χ g supernatant from muscle omission of carnitine 
and addition of 10 mM KCN or 4 yM antimycin A decreased the [і-1цС]ра1ті-
tate oxidation rate to 16 ±1, 29±11 and 14±8%, respectively (means±S.D. 
of 3-5 experiments). Addition of antimycin A to muscle homogenates did not 
affect the low oxidation rates of [l-^C] palmi tate in the absence of car­
nitine, but decreased still more the [l6-'ЦС]palmitate oxidation. The ra­
tio rose from 1.49±0.11 to 4.32±0.69 (means ±S.D. of 4 experiments). 
Peroxisomal palmitate oxidation 
The occurrence of a cyanide- and antimycin-insensitive palmitate 
oxidation in homogenates and mitochondrial fractions even with omission of 
L-carmtine, suggested the existence of a peroxisomal fatty acid oxidation 
system in muscle. In order to establish this, the assay according to the 
method of Lazarow (1981b) was applied in the presence of antimycin and ro­
tenon (Table 5.6). With liver homogenates palmitate and palmitoyl-CoA were 
good substrates. With muscle homogenates palmitoyl-CoA had a 10-fold 
higher oxidation rate, which was comparable with the rate observed in the 
usual assay of palmitate oxidation in the presence of antimycin and rote­
non. We also measured the palmitoyl-CoA-dependent H2O2 production indi-
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A-oxidation 
Си-С
а
асуІ esters \ aadnnsoluble 
^
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 f ƒ intermediates 
A- oxidation 
Cg-Cjocyl esters 
acid-soluble 
intermediates 
calculation of 
oxidation rate 
Fig. 5.1. Stages of palmitate oxidation. Oxidation rates are calculated 
from the production of 1 ЦС0 2 and ^ C-labeled perchloric acid-
soluble products. The latter consist of short-chain acyl-CoA 
and acyl-carnitine esters and citric acid cycle intermediates. 
rectly with the oxidation of methanol to formaldehyde (Mannaerts et ai., 
1979). The rate of formaldehyde production was constant up to 30 min with 
muscle homogenates but varied markedly in separate experiments (7.7 ±4.6 
nmol/min per g, meant S.D. of 4 experiments). The rate of formaldehyde 
production is, however, not equivalent with the H2O2 production and always 
lower than the palmitate oxidation rate (Mannaerts et ai., 1979). 
Analysis of fatty acid oxidation intermediates 
Upon incubation of homogenates of m.quadriceps or of liver with 
[ll,C] palmitate labeled at different positions, the acid-soluble fraction 
(Fig. 5.1) was found to contain, besides citric acid cycle intermediates 
(Van Hinsbergh et ai., 1978a,b, 1979), always only [^Cjacetylcarnitine or 
['"•C]acetic acid (Veerkamp et ai., 1983). 
The lipid composition of the perchloric acid-insoluble fraction (Fig. 
5.1) was investigated to detect to what extent [1ЦС]palmitate was incorpo­
rated or converted to other compounds. After incubation of rat muscle mi­
tochondria with ['"Ό]palmitate free fatty acids represented 95-98% of the 
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Table 5.7. l'*C-labeled oxidation products of fl6-1'tcj- and [l-^^cjpalmitate in homogenstes and mitochondrial 
fractions of rat m.quadriceps and liver. 
Substrate Product(s) Presence of 
antimycin 
Muscle Liver 
Homogenate 
(6) 
Mitochondria 
(3) 
Homogenate Mitochondria 
(3) (3) 
[^-'"CJPalmitate Dodecanoic acid 
Tetradecanoic acid 
CO2 and acid-soluble products 
[l-^c] Palmi tate CO2 and acid-soluble products 
92 ± 60 
74 ± 42 
221 ± 104 
191 ± 75 
1380 ± 120 
84 + 24 
1695 ± 240 
330 ± 75 
1 0 + 4 
11 ± 6 
2Θ ± 6 
36 ± 10 
86 ± 20 
11 ± 3 
118 ± 15 
61 ± 18 
1005 ± 120 
870 ± 210 
2835 ± 525 
2385 + 395 
6735 ± 135 
465 ± 120 
10965 ± 780 
3010 ± 345 
3 ± 1 
n.d. 
17 ± 3 
n.d. 
73 ± 18 
n.d. 
94 ± 14 
n.d. 
Homogenates and mitochondrial fractions were incubated for 15 min with 120 μΜ [1ЦС]palmitate. The concentration 
of antimycin A was 36 μΜ. Amounts of '''C-labeled dodecanoic and tetradecanoic acid were determined by thin-layer 
chromatography after alkaline hydrolysis of the acid-insoluble fraction. Values are means + S.D. for the number 
of experiments given within parentheses and are expressed in nmol/g tissue for homogenates and in nmol/mg pro­
tein for mitochondria, n.d., not determined. 
[ι-«с] [з-1'с] [іб-^ с] [и-"-с] 
Fig. 5.2. Radioautogram of the "'C-labeled fatty acids isolated from the 
acid-insoluble fractions of incubations of rat tn.quadriceps ho-
mogenate with [1'*C] palmi tate labeled in different positions. The 
silanized silica gel plate was developed in acetic acid/water 
(75:25, v/v). 
1
'*C-radioactivity of the neutral lipids. 
For a proper identification and quantitation of intermediates, homo-
genates and mitochondria from rat liver and m.quadriceps were incubated 
with palmitate labeled in different positions. The fatty acids were isola­
ted after alkaline hydrolysis of total isolated lipids and separated by 
thin-layer chromatography. Fig. 5.2 shows a representative autoradiogram 
for experiments with muscle homogenates. Incubation with [3-1'*C] palmitate 
resulted in the appearance of '"O-labeled tetradecanoic acid, whereas incu­
bations with[ U-^CJ- and [l6-' ЦС] palmitate gave also labeled dodecanoic 
and decanoic acids. After incubation with or without antimycin A no R e ­
labeled hydroxy acids could be detected, neither their derived methyl es­
ters after methylation of the lipid fraction. 
The absolute amounts of the chain-shortened fatty acids vary marked­
ly in the different systems and also between the experiments in one system 
(Table 5.7). This is in accordance with the variability of the ratio. The 
amount of decanoic acid was in all cases less than 10% of that of dodeca­
noic acid. The values for tetradecanoic acid were similar after incubation 
with [З-'^С]- or [l6-1ЦС] palmitate. The amount of tetradecanoic acid was 
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about 2-3 -fold of that of dodecanoic acid in all systems investigated. On­
ly with liver mitochondria much more of the former acid was present (Table 
5.7). 
Antimycin A did not significantly influence the amounts of R e ­
labeled chain-shortened fatty acids in contrast to its marked decrease of 
the oxidation of [l6-ll,C]palmitate. These observations explain the conside­
rable increase of the ratio of oxidation rates of [l-^C]- and [іб-1 ''С] pal-
raitate in the presence of antimycin A (Tables 5.4 and 5.5). The amounts of 
chain-shortened fatty acids recovered can nearly account in all systems, 
with and without antimycin, for the differences in the oxidation rates of 
[l-i-C]- and [ló-^Cjpalmitate (Table 5.7). 
5.4. DISCUSSION 
This chapter gives approximate values for the capacity of palmitate 
oxidation in homogenates and in mitochondria of various rat tissues. The 
assay of the sum of 1ЦС02 and 1цС-1аЬе1еа acid-soluble products is a more 
sensitive and accurate method for determination of [l '•C] fatty acid oxida­
tion in these systems than is measurement of '"'СОг alone (cf. chapter 3), 
although the latter method is still applied (e.g. Sumbilla et ai., 1981; 
Okano & Shimojo, 1982; Barakat et ai., 1982, 1983; Shumate et ai., 1982). The 
acid-soluble intermediates represent the predominant products in mitochon­
dria and homogenates of all tissues investigated, as was earlier reported 
for rat liver (McGarry et ai., 1977; Christiansen, 1978; Kawamura & Kishi-
moto, 1981), human and rat muscles (Van Hinsbergh et ai., 1978b, 1979, 1980; 
Shumate & Choksi, 1981) and rat brain ( Kawamura & Kishimoto, 1981). In 
perfused, isolated rat heart (Oram et ai., 1973) ""СОг appeared to be the 
main product of [^C] palmitate oxidation, but at incubation of intact ske­
letal muscle preparations (chapter 3) it also accounts for only a part of 
the palmitate oxidation products. 
Oxidation rates of palmitate in liver homogenates and mitochondria 
are comparable to those observed by other investigators (Lopes-Cardozo & 
Van den Bergh, 1972; McGarry et ai., 1977; 1978c; Mannaerts et ai-, 1979; 
Kawamura & Kishimoto, 1981). Our values with rat heart and kidney homoge­
nates were twice as high as previously reported (McGarry et ai·, 1978c; cf. 
chapter 7), presumably due to a higher palmitate:albumin molar ratio in our 
assays. Capacities of palmitate oxidation in homogenates of other rat tis-
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sues were either not determined earlier or measured with 1I,C02 production 
(Wittels & Bressler, 1965; Baldwin et al., 1972; Engel & Angelini, 1973; 
Warshaw & Terry, 1976; Willner et a2., 1979) or with oxygen consumption 
(Warshaw, 1972; Hooker & Baldwin, 1979). Our values in rat heart and skele-
tal muscle homogenates are comparable with the latter (Hooker & Baldwin, 
1979). The capacity of rat heart homogenates agrees quite well with the 
rate of ß-oxidation (Oram et ai., 1973; Pearce et al., 1979) and oxygen con-
sumption (Taegtmeyer et al., 1980) in the perfused working rat heart. The 
postnuclear fractions and mitochondria from rat brain and especially liver 
had a much higher activity than found at a low palmitate concentration 
(Vignais et al., 1958; Kawamura & Kishimoto, 1981). 
The concentration of L-carnitine necessary for maximal palmitate oxi-
dation appeared to be lower than the normal concentration in rat skeletal 
muscle (Brooks & Mcintosh, 1975; Van Hinsbergh et al., 1980). The apparent 
К of about 100 \iH L-carnitine in muscle mitochondria is comparable with 
the value of 190 μΜ for rat liver mitochondria (Van Tol, 1974). With mito­
chondria from rabbit skeletal muscle the oxidation rate was 40% lower at 
0.2 mM than at 1.5 mM carnitine (Pande, 1971). 
The differences in the oxidation rates observed with differently la­
beled palmitate in cell-free preparations of various rat tissues and also 
of human muscles (Veerkamp et al., 1983) can be caused by various mechanisms. 
Futile cycling by a combination of shortening and elongation of the fatty 
acid chain (Whereat, 1971) does not seem probable. The formation of ['^C]-
octadecanoic acid from [1ЦС] palmitate and of ['''Cjdodecanoic acid from 
[З-'^С]palmitate was not observed. A second possibility is that intermedi­
ates escape from the multienzyme complex of S-oxidation, as was found in 
conditions of state 4 respiration and inhibited citric acid cycle (Lopes-
Cardozo et al., 1978) or respiratory chain (Stanley & Tubbs, 1974, 1975). 
Under normal conditions of state 3 palmitate oxidation, carnitine may 
transport intermediates out of the mitochondrion. Long-chain acyl-carnitine 
hydrolase and acyl-CoA hydrolase (Lin & Kako, 1975; Berge & Dtfssland, 1979) 
can contribute to the formation of free chain-shortened fatty acids. These 
acids were present in both the free fatty acid and the acyl-carnitine frac­
tion, since both fractions showed an inverse ratio in comparison to the 
oxidation products (Veerkamp et al., 1983). A release of ß-oxidation inter-
mediates from the mitochondria does, however, not appear the main cause for 
the increase of the chain-shortened fatty acids. The carnitine concentra-
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tion did not influence the ratio of the oxidation rates in muscle mitochon-
dria and homogenates. Release of carnitine esters from damaged mitochondria 
cannot be the cause, since such preparations showed very low oxidation 
rates, their addition to homogenates had no effect on the ratio, and the 
percentage of damaged mitochondria in the homogenates was low. 
Since KCN and antimycin markedly decreased the oxidation rate and 
increased the ratio, but did not affect the nature and amount of formed in-
termediates, it appears probable that the chain-shortened fatty acids re-
sult from peroxisomal oxidation (Fig. 5·3). The comparable oxidation rates 
in the presence and absence of carnitine and the more direct estimations 
according to the procedure of Lazarow (1981b) and of formaldehyde produc-
tion indicate also that peroxisomal oxidation takes place in rat and human 
muscle. 
The presence of cyanide-insensitive fatty acid oxidation was found in 
liver and kidney of many species (Lazarow & De Duve, 1976; Bronfman et al., 
1979; Tolbert, 1981), in rat brain (Kawamura & Kishimoto, 1981) and also in 
human and rat muscle (Shumate 4 Chokski, 1981). Fatty acid oxidation by 
isolated peroxisomes was only established with rat liver (Lazarow, 1978), 
but acyl-CoA oxidase activity (foCij-producing) was also found in heart and 
skeletal muscle of guinea pigs (Small et al., 1980) and in mouse heart (Con-
nock & Perry, 1983). Cytochemical methods demonstrated the presence of per-
oxisomes in liver, striated muscles and other tissues (Hand, 1974; Christie 
& Steward, 1979; Tolbert, 1981). Very recently, Norseth et al. (1982, 1983) 
reported the isolation and hydrodynamic parameters of microperoxisomes from 
rat heart, and observed the stimulation of microperoxisomal g-oxidation in 
heart by a high-fat diet. 
The production of chain-shortened fatty acids by peroxisomes appears 
probable, since peroxisomal oxidation of palmitoyl-CoA is incomplete and 
involves at the most 5 ß-oxidation cycles (Lazarow, 1978). This maximum was 
never reached with liver peroxisomal fractions (Thomas et ai., 1980) and 
products of the first 2-3 0-oxidation cycles predominate (Osmundsen et ai., 
1980a).The rate of appearance of acid-soluble radioactivity fron [l-^C]-
palmitoyl-CoA was one order of magnitude greater than from [и-1цС]ра1ті-
toyl-CoA (Osmundsen et ai., 1980a).With oleate oxidation shortened acyl-car-
nitines were detected in hepatocytes (Osmundsen et ai., 1980b). We detected 
only saturated chain-shortened fatty acids after incubation of rat muscle 
and liver homogenates and mitochondria with palmitate, also in the presence 
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long-chan fatty acids 
PEROXISOME MITOCHONDRION 
Fig. 5.3. Schematic presentation of long-chain fatty acid degradation. The 
interrelationship between peroxisomes and mitochondria is given. 
C12 and C 1 4 intermediates may escape from the peroxisomal oxida-
tion pathway and accumulate in the medium. A, carnitine long-
chain acyltransferase; B, carnitine short-chain acyltransferase. 
of antimycin A. Terminal respiratory-chain inhibition by cyanide in rabbit 
heart mitochondria (Moore et al., 1982) caused no accumulation of hydroxy 
fatty acids in contrast to inhibition with rotenon in mitochondria from rat 
liver (Stanley & Tubbs, 1975; Bremer & Wojtczak, 1972) and heart (Christo-
phersen & Christiansen, 1975) and rabbit heart (Moore et al., 1982). The 
marked decrease of the ratio by malonyl-CoA is presumably caused by a more 
complete degradation of the peroxisomal chain-shortened fatty acids, since 
oxidation of tetradecanoic acid is less inhibited than that of palmitate. 
The variations in the ratios in the different conditions can be ex-
plained by the extent of interaction of peroxisomal and mitochondrial pal-
mitate oxidation (Fig. 5.3). Important in this respect may be the degree 
of intactness of the peroxisomes and mitochondria (Thomas et al., 1980), 
their relative amounts in the various fractions, and the extent to which 
these organelles cooperate to degrade the long-chain fatty acids to C02 and 
acid-soluble products in the cell-free systems, which are 20-100-fold 
diluted in comparison to the intact cell. Homogenates generally show lower 
ratios and thus a more complete degradation of the palmitate molecule than 
the postnuclear fractions. With intact muscle preparations and heart slices 
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(section 7.3) there is no difference between the oxidation rates with 
[ W c ] - and [iS-^C^palmitate. In hepatocytes (Christiansen, 1978) and in 
well-oxygenated perfused rat heart (Markwell et al., 1976) the ratio was 
also about one. With rat liver mitochondria an equal degradation of [l-^C]-
and [U-^CJpalmitate was found-only at a very high concentration of mito­
chondrial protein (Lopes-Cardozo et al., 1978). At protein concentrations 
from 250 yg to 12 mg per ml, however, accumulation of labeled intermediates 
was observed (Stanley & Tubbs, 1975). The intermediates found in incuba­
tions with mitochondria can originate from peroxisomal oxidation, since 
about 50% of total peroxisomal marker enzyme activities are present in con­
ventional liver mitochondrial preparations (Osmundsen, 1981). 
In conclusion, the results of our experiments indicate that the dif­
ferences between the oxidation rates observed with palmitate labeled in 
different positions are mainly due to variations of the extent of degrada­
tion of peroxisomal oxidation products by mitochondria in the various cell-
free systems. 
5.5. SUMMARY 
The palmitate oxidation capacity has been determined in whole homoge-
nates, postnuclear fractions and mitochondrial fractions of various 
muscles, liver, kidney, brain and lung, and in intact preparations of va­
rious skeletal muscles of the rat. 
The oxidation rate (calculated from the sum of the production of 
1Ц
С02 and '''C-labeled perchloric acid-soluble intermediates) was with 
[l-'"C]palmitate> [U-1ЦС]palmitate> [ 16-'"c]palmitate in all cell-free sys­
tems. With the intact muscular preparations, however, the oxidation rate 
was not dependent on the position of the '''C-label in the palmitate mole­
cule. 
Oxidation capacities were highest in rat heart and liver, interme­
diate in kidney, diaphragm and m.quadriceps, and low in brain and lung. 
Omission of L-carnitine and addition of malonyl-CoA, KCN or antimycin A 
decreased the oxidation rates in whole homogenates and mitochondrial frac­
tions. Antimycin A or KCN increased and malonyl-CoA decreased the ratio 
between the oxidation rates with .[і-1цс]- and [l6-' ''C] palmitate. Omission 
of L-carnitine had no significant effect on the ratio. 
^C-labeled dodecanoic and tetradecanoic acids were identified in 
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homogenates and mitochondrial fractions of m.quadriceps and liver as acid-
insoluble intermediates of [l6-1',C]paltnitate oxidation in the presence and 
absence of antimycin A. Their amounts recovered can account for the dif-
ferences in oxidation rates found with [ W c ] - and [ló-'^Ojpalmitate in 
the cell-free systems. The occurrence of peroxisomal fatty acid oxidation 
was demonstrated in muscle homogenates. 
The incomplete palmitate oxidation in cell-free systems appears to 
be mainly caused by an inadequate mitochondrial degradation of peroxisomal 
oxidation products. 
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CHAPTER 6 
EFFECT OF CLOFIBRATE FEEDING ON PALMTTATE OXIDATION 
IN RAT LIVER AND MUSCLE* 
6.1. INTRODUCTION 
Clofibrate (ethyl 2-(4-chlorophenoxy)2-methylpropanoate) is an effec-
tive hypolipidemic and hypocholestërolemic agent in man and rat (Thorp & 
Waring, 1962; Havel & Kane, 1973). Chronic administration of this drug to 
rodents increases the weight of the liver and its content of mitochondria 
(Kurup et al., 1970; Lipsky & Pedersen, 1982) and peroxisomes (reviewed by 
Reddy et al., 1982). The marked increase of the peroxisomal ß-oxidation of 
fatty acids (Lazarow & De Duve, 1976; Lazarow, 1977) suggested a prominent 
role of this system in the effects of Clofibrate. Both mitochondrial and 
peroxisomal oxidation of palmitate appear, however, to increase markedly in 
hepatocytes and liver homogenates of clofibrate-fed rats (Mannaerts et al., 
1978, 1979; Christiansen et al., 1978; Pande i Parvin, 1980; Bremer et al., 
1981). Perfused livers from such rats showed an increased oleate oxidation, 
but also an increased fatty acid synthesis, measured with 'НгО incorpora­
tion (Laker 4 Mayes, 1979). The drug induces, especially, a series of en­
zymes and proteins involved in hepatic fatty acid metabolism (Bremer et al., 
19Ö1). Oxidation of pyruvate and succinate were unaltered in liver homoge-
nates (Mannaerts et al., 1978), like that of acetate and various citric acid 
cycle intermediates in isolated liver mitochondria from clofibrate-fed rats 
(Cederbaum et al., 1976; Rasheed et al., 1980). The oxidation of palmitoyl-
carmtine by isolated liver mitochondria was reported to decrease (Ceder-
baum et al., 1976), to increase (Mackerer, 1977; Pande & Parvin, 1980) and 
not to change (Christiansen et al., 1978), presumably due to variations in 
conditions of assay or in mitochondrial preparations. 
Clofibrate appeared also to affect occasionally skeletal muscle in 
* Adapted from Glatz et al. (1983a). 
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treated patients (Langer & Levy, 196Θ; Bridgman et al., 1972). This effect 
was partly related to an impaired fatty acid and glucose oxidation by Paul 
& Adibi (1979)· These investigators used, however, 1ЦС02 production as a 
measure for fatty acid oxidation. Since '""СОг forms only a small fraction 
of the oxidation products from ['""Cjpalmitate in homogenates of liver and 
muscle (Mannaerts et al., 1978; Van Hinsbergh et al., '\978а,Ъ·, Pande & Par­
vin, 1980), we reevaluated their data by determining palmitate oxidation 
from the sum of ^СОг and '"'C-labeled acid-soluble products. Simultaneous­
ly, we determined the rate of antimycin-insensitive oxidation in muscle to 
explore possible peroxisomal contribution. These activities were compared 
with the activities of two mitochondrial marker enzymes, citrate synthase 
(EC A.1.3.7) and cytochrome с oxidase (EC 1.9.3.1). 
6.2. MATERIALS AND METHODS 
Male albino Wistar rats of 200-240 g were used. The composition of 
the diet and the administration of Clofibrate were as described in section 
2.1. Whole homogenates of liver (5%, w/v) and m.quadriceps femoralis (10%, 
w/v) were prepared as described in section 2.2. 
The palmitate oxidation rate was measured in a total volume of 0.5 
ml medium, containing 50 μΐ whole homogenate and 25 mM sucrose, 75 mM Tris-
HC1 (pH 7.A), 10 mM КгНРОц, 5 mM MgCl2, 1 mM EDTA, 1 mM NAD
+
, 5 mM ATP, 
25 μΜ cytochrome c, 0.1 mM coenzyme A, 0.5 mM L-malate and 0.5 mM L-carni-
tine. The concentration of [l-'^C]- or [ 16-' '*C] palmitate (bound to albumin 
in a molar ratio of 5:1) was 120 μΜ. In parallel incubations 36 μΜ antimy-
cin A was added to inhibit mitochondrial oxidation. After 30 min incubation 
at 37 С the incubation was stopped by addition of 0.2 ml of 3 M perchloric 
acid. Radioactivity of trapped CO2 and of acid-soluble products was mea­
sured as described in section 3.2. 
The assay procedures for cytochrome с oxidase and citrate synthase 
activities are described in section 2.3. 
All activities were calculated per g tissue (wet weight). Statistical 
significance was analyzed with Student's t-test for unpaired data. 
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6.3. RESULTS 
All assays were established to be proportional with time of incuba­
tion and amount of tissue material. The concentrations of substrates, co­
enzymes and cofactors were optimal (Van Hinsbergh et al., 1978a,b). Clofi­
brate treatment had no effect on rat weights. 
Both Clofibrate feeding and short starvation increased very signifi­
cantly the total palmitate oxidation capacity per g wet weight of rat liver 
homogenates (Table 6.1). Since starvation caused a decrease of the liver 
weight by 23% (from 10.2 + 0.A to 7.9 ±0.5 g, η = 5), the total oxidation ca­
pacity expressed per whole liver increased by about 50%. Based on cyto­
chrome с oxidase and citrate synthase activity the palmitate oxidation 
rates increased in liver homogenates at 18 h starvation by 38 and 41%, res­
pectively. 
Table 6.1. Effect of Clofibrate treatment and short starvation on total and 
antimycin-insensitive palmitate oxidation in liver and muscle 
homogenates. 
Tissue Condition Palmitate oxidation 
Total Antimycin-insensitive 
(nmol/min (nmol/min (% of total) 
per g) per g) 
Liver Fed (5) 
Clofibrate-fed (10) 
Starved 18 h (8) 
Muscle Fed (10) 
Clofibrate-fed (10) 
Starved 18 h (11) 
366 ± 28 
978 ± 255 a 
713 ± 92 a 
130 ± 24 
125 ± 27 
115 ± 19 
142 ± 17 
390 ± 74 a 
165 ± 16 
15 ± 2 
15 ± 2 
1 6 + 5 
39 ± 5 
37 ± 5 
23 ± 2 
11 ± 2 
11 ± 1 
14 ± 3 
Values are means! S.D. of the number of animals given within parentheses. 
Total palmitate oxidation was determined from 1ЦС02 and '''C-labeled acid-
soluble products formed with [l-1 ""C]palmitate as substrate. Antimycin-
insensitive palmitate oxidation was calculated as the difference in oxida­
tion rates of [і- і цс]- and [lo-'^Ojpalmitate in the presence of 36 μΜ 
antimycin A . a P versus fed animals < 0.001. 
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Table 6.2. Effect of Clofibrate treatment and short starvation on activi­
ties of citrate synthase and cytochrome с oxidase in liver and 
muscle homogenates. 
Tissue Condition Citrate synthase Cytochrome с oxidase 
Liver Fed 11.7 ± 1.2 (10) 286 ± Al (7) 
355 ± 38 (10) 
317 ± 98 (30) 
 
Clofibrate-fed 
Starved 18 h 
Fed 
Clofibrate-fed 
Starved 18 h 
13.8 ± 1.8 
15.4 ± 2.0a 
11.9 ± 2.6 
8.5 ± 1.0a 
13.5 + 2.6 
) 
(10) 
(AD 
(12) 
(10) 
(56) 
Muscle  2.6  81 ± 12 (9) 
67 ± 7 b (9) 
68 ± 20 (Al) 
Values are given in units per g wet weight tissue and represent means ±S.D. 
of the number of animals given within parentheses. 
Ρ versus fed animals: a<0.001 ; b<0.01 
1Ц
С02 production was only about 6, A and 1% of the total oxidation 
rate of [l-1 ',C]palmitate with liver homogenates from fed, clofibrate-fed 
and 18 h-starved rats, respectively. The rate of '''СОг production was, 
therefore, also higher in liver homogenates with clofibrate-fed rats than 
with fed animals, but lower with 18 h-starved animals. 
Antimycin completely inhibited ^СОг production from [l-^C]- and 
[lö-^Cjpalmitate and decreased the acid-soluble products from [іб-^С]-
palmitate to about 10% (cf. Table 5.5). The latter values were applied to 
correct the rate of [l-'^CJpalmitate oxidation in the presence of antimy­
cin for mitochondrial contribution. Starvation increased only the antimy-
cin-sensitive, or mitochondrial, oxidation, while Clofibrate treatment in­
creased also the antymicin-insensitive oxidation in liver homogenates 
(Table 6.1). 
In muscle homogenates '"'СОг was in all three conditions about A-6% of 
the sum of '''СОг and radioactive acid-soluble products. ^ СОг production 
rates were lower with clofibrate-fed rats than with fed animals (A.I ± 1.0 
(n= 10) versus 7-5±2.6 (n=9) nmol/min per g wet weight). The latter ob­
servations are similar to those of Paul & Adibi (1979). When palmitate oxi­
dation rates were, however, calculated from the sum of '''СОг and 1цС-1аЬе-
led acid-soluble products, no differences were observed between the muscle 
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homogenates from rats in all three conditions (Table 6.1). The contribution 
of the antimycin-insensitive palmitate oxidation was also not influenced in 
muscle homogenates by the condition of the rat. 
In liver homogenates Clofibrate treatment did not change the activi­
ties of citrate synthase or of cytochrome с oxidase (Table 6.2). The only 
significant effect of Clofibrate on muscle was a decrease of the activities 
of these mitochondrial marker enzymes. Short starvation only increased the 
citrate synthase activity in liver. 
The same homogenates were also used to measure the oxidation rates of 
pyruvate, leucine and the branched-chain 2-oxo-acids derived from leucine 
(A-methyl-2-oxopentanoate) and valine (3-methyl-2-oxobutanoate). With these 
substrates significant alterations in the clofibrate-treated and the star­
ved rats were also predominantly observed in the liver. The results of 
these investigations are described elsewhere (Glatz et al., 1983c). 
6.4. DISCUSSION 
A simultaneous estimation of the effect of Clofibrate feeding on the 
palmitate oxidation capacity in liver and muscle homogenates was not ear­
lier reported. Together with palmitate oxidation, both mitochondrial and 
peroxisomal (Lazarow & De Duve, 1976; Lazarow, 1977; Mannaerts et al., 1978, 
1979; Bremer et ai., 1981) (Table 6.1), also pyruvate and 4-methyl-2-oxo-
pentanoate oxidation increased in liver homogenates, but 3-methyl-2-oxo-
butanoate oxidation and the activities of citrate synthase and cytochrome 
с oxidase were not changed (Glatz et a J., 1983c). The latter observations 
establish that not all mitochondrial activities increase, as was earlier 
also found with isolated liver mitochondria (Cederbaum et al., 1976; Ras-
heed et al., 1980). The unchanged cytochrome с oxidase activity was also 
reported by Mannaerts et al. (1978) in combination with an increased glu­
tamate dehydrogenase activity. Lazarow & De Duve (1976) and Lazarow (1977) 
noted a variability in the effects of Clofibrate on cytochrome с oxidase 
activity. The lower concentration of cytochrome ааэ in liver mitochondria 
from clofibrate-treated rats (Reddy et al., 1982) is in accordance with the 
simultaneous increase of mitochondrial protein (Reddy et al., 1982) and the 
unchanged cytochrome с oxidase activity. 
Our observations on the effect of Clofibrate feeding on fatty acid 
oxidation in liver are in accordance with earlier results (Christiansen et 
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ai., 1978; Mannaerts et al., 1978, 1979; Pande & Parvin, 1980; Bremer et al., 
1981). With our assay of '''СОг and '""C-labeled acid-soluble products we did 
not find a decrease of palmitate oxidation in muscle homogenates as deduced 
by Paul & Adibì (1979) from 1 Ц С 0 2 production. No effect of Clofibrate admi­
nistration was also observed on the oxygen consumption of muscle mitochon­
dria with palmitoyl-L-carnitine as substrate (Cederbaum et al., 1976). In 
perfused rat heart and isolated rat heart mitochondria (Norseth, 1980) Clo­
fibrate feeding appeared to increase palmitate oxidation by about 25 and 
48%, respectively. 
Starvation for only 15-24 h increases fatty acid oxidation in liver 
homogenates, when it is based on wet weight (McGarry et al., 1977; Table 
6.1). In contrast to McGarry et al. (1977) we found also an increase of the 
of oxidation capacity for whole liver. In hepatocytes this process is also 
increased (Ontko, 1972; McGarry et al., 1978b). No increase was observed 
with liver mitochondria (Ontko & Johns, 1980; Cook et al., 1980; McGarry & 
Foster, 1981), muscle homogenates (Tables 3.2 and 6.1) and mitochondria 
(Veerkamp & Van Moerkerk, 1982) or intact muscle preparations (Table 3.2). 
The mitochondrial content of liver from starved rats shows only a small in­
crease, when based on citrate synthase (Table 6.2), in contrast to the re­
ported 60% increase, based on glutamate dehydrogenase activity (McGarry et 
al., 1977). In muscle homogenates from clofibrate-treated rats we observed 
only a slight decrease of the activities of citrate synthase and cyto­
chrome с oxidase, but these enzymes are not rate-limiting in oxidative me­
tabolism. 
The present results, combined with those reported elsewhere (Glatz et 
al., 1983c) do not sustain the conclusions of Paul & Adibì (1979, 1980) 
that fatty acid and glucose oxidation are impaired and leucine and bran-
ched-chain 2-oxo acid oxidation are increased in muscle of clofibrate-fed 
rats. The effects of Clofibrate feeding on liver metabolism can, however, 
indirectly influence muscle metabolism in vivo. Clofibric acid (2-(4-chlo-
rophenoxy)2-methylpropanoate), which is present in a high concentration in 
the plasma during Clofibrate treatment (Laker & Mayes, 1979) may also in-
fluence the uptake of metabolites, their oxidative metabolism in muscle 
and/or the membrane characteristics of muscle, and induce in this way myo-
pathic phenomena. Clofibric acid may displace other organic ligands from 
plasma albumin into tissues, as suggested already by Thorp in 1963 (Thorp, 
1963). It interferes with the binding of fatty acids (Spector & Santos,1973). 
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An interesting observation is that in liver Clofibrate treatment also 
markedly increases the concentrations of long-chain acyl-CoA and of total 
coenzyme A (Ball et ai., 1979; Skrede & Halvorsen, 1979; Voltti & Hassinen, 
1980), and the concentration of carnitine and the activities of carnitine 
acyltransferases (Pande & Parvin, 1980; Kerner & Bieter, 1982). In addition, 
the hepatic content of the fatty acid-binding protein (FABP), which binds 
acyl-CoA esters (Mishkin & Turcotte, 1974), increases after Clofibrate 
treatment (Fleischner et al., 1975; Renaud et a2., 1978; Kawashima et al., 
1982). Since the palmitate oxidation capacity rises simultaneously (Table 
6.1), these findings strongly suggest that FABP is involved in the regula­
tion of fatty acid oxidation (cf. chapter 10). 
6.5. SUMMARY 
Total and antimycin-insensitive palmitate oxidation rates and the 
activities of two mitochondrial marker enzymes (citrate synthase and cyto­
chrome с oxidase) have been assayed in liver and muscle homogenates of fed, 
clofibrate-fed and 18 h-starved rats. 
Significant alterations in the clofibrate-treated and the starved 
rats are predominantly observed in the liver. Clofibrate feeding increases 
antimycin-insensitive (peroxisomal) and antimycin-sensitive (mitochondrial) 
palmitate oxidation in liver. In muscle only the activities of citrate syn­
thase and cytochrome с oxidase decrease slightly. Short starvation only 
increases antimycin-sensitive palmitate oxidation in liver. 
Our results suggest that myopathic phenomena observed after chronic 
Clofibrate administration are not related to changes in the capacity of 
oxidative metabolism of muscle. 
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CHAPTER/ 
PALMUATE OXIDATION IN HUMAN AND RAT HEART: COMPARISON OF 
CELL-FREE AND CELLULAR SYSTEMS* 
7.1. INTRODUCTION 
Free fatty acids constitute the main energy source of the heart under 
aerobic conditions (Neely & Morgan, 1974). For the in vitro study of myo­
cardial fatty acid metabolism several tissue preparations can be used. Dis­
tinction should first be made between preparations that contain intact 
cells (cellular systems) and those in which the cells have been disrupted 
(cell-free systems). Studies with cellular systems have long been hampered 
by the lack of a suitable procedure for the isolation of viable and 
calcium-tolerant heart cells. Now that several of such procedures have been 
described (Vahouny et al., 1979; Altschuld et al., 1980; Frangakis et al., 
1980; Haworth et al., 1980; Dow et al., 1981; reviewed by Farmer et al., 1983), 
these cells have also become an important model system for biochemical 
studies. 
In all investigations reported on fatty acid oxidation in myocytes 
and in most studies in other preparations oxidation rates were based on the 
measurement of 1ЦС02 production. Since ^СОг forms only a fraction of the 
oxidation products from ['"Ό] fatty acids in cell-free (Van Hinsbergh et al., 
1978a, 1979) as well as in cellular (chapter 3) systems of heart and ske­
letal muscle and other tissues, we use a more accurate and sensitive pro­
cedure in which the sum of '"СОг and '''C-labeled acid-soluble products is 
measured. Previously (Van Hinsbergh et al., 1979) the palmitate oxidation 
rates in the postnuclear fraction (600 χ g supernatant) and isolated mito­
chondria of human and rat heart have been determined. The capacity of this 
oxidation process can, however, more adequately be studied in whole homo-
genates than in these systems, since homogenization and differential cen-
* Adapted from Glatz et al. (1983c). 
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trifugation procedures may select certain populations of mitochondria (Pal­
mer et ai., 1977). The aim of the present study is to compare the metabolic 
characteristics of cell-free and cellular systems of heart and also to com­
pare palmitate oxidation rates of human and rat heart. In this chapter we 
report palmitate oxidation rates and activities of mitochondrial marker en­
zymes measured in mitochondria, whole homogenates and slices of human and 
rat heart and in rat cardiac myocytes. 
In order to further examine the differences between human and rat 
heart we calculated their mitochondrial contents from the data of oxidation 
rates and activities of cytochrome с oxidase and citrate synthase in whole 
homogenates and mitochondria. Since carnitine is not synthesized in the 
heart (Rebouche, 1982) we have studied the effect of its addition to cellu­
lar systems on the fatty acid oxidation. Furthermore, special attention has 
been paid to the significance of endogenous lipolysis and the contribution 
of damaged cells to the fatty acid oxidation in the cellular systems. The 
observed differences between human and rat heart and the characteristic 
properties of the various systems are discussed. 
7.2. MATERIALS AND METHODS 
Preparation of cell-free and cellular systems 
Biopsies (200-500 rag) of the right auricle of adult human heart were 
obtained and handled as described in section 2.1. Rat heart was obtained 
from male random-bred albino Wistar rats (180-240 g), which had been fasted 
for 18 h. The preparation of heart slices and whole homogenates and the 
isolation of mitochondria are described in section 2.2. 
Rat cardiac myocytes were isolated by perfusion of the heart with 
collagenase essentially according to the procedure of Altschuld et ai. 
(1980) with some modifications. The heart was perfused in vitro through the 
aorta at 37 С with a nominally calcium-free Krebs-Ringer bicarbonate buffer, 
composed of 119 mM NaCl, 5 mM KCl, 1.2 mM КН2Р0ц, 1.2 mM MgS04 and 25 mM 
NaHCOa (pH 7.2), gassed with O2/CO2 (95:5) and supplemented with 11 mM glu­
cose. After a washout period of 5-10 rain a recirculating perfusion was 
started with 25 ml of the same buffer supplemented with 0.1% (w/v) collage­
nase. Perfusion was continued for 45-60 min. The softened heart then was 
placed in 10 ml perfusion medium without collagenase but containing 1% 
(w/v) fatty acid-free albumin, minced with scissors and incubated for an 
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additional 10 min at 30 С. During incubation the cells were gently dis­
persed with a pipet. The resultant dispersion was sieved through 300-pm 
nylon mesh and centrifuged for 1 min at 50 χ д. After discarding the super­
natant, the cells were washed once. Finally, they were suspended in cal­
cium-free Krebs-Ringer bicarbonate buffer (pH 7.2), gassed with 02/C02 
(95:5). The cells were counted with a hemocytometer and their viability 
judged by determination of the percentage of myocytes excluding trypan 
blue. In some experiments viable and non-viable cells were separated by 
isopycnic centrifugation on a Percoli gradient for 3 min at 400 χ g accor­
ding to Maisch et ai. (1961), with the modification that an isotonic Per­
coli solution was used. 
Assay of palmitate oxidation 
With homogenates and isolated mitochondria, the fatty acid oxidation 
rate was measured radiochemically at 37 С in 20-ml incubation vials in a 
medium containing 25 mM sucrose, 30 mM KCl, 10 mM K-phosphate, 5 mM MgCl2, 
1 mM EDTA, 75 mM Tris-HCl (pH 7.4) supplemented with 5 mM ATP, 1 mM NAD+, 
25 μΜ cytochrome c, 0.1 mM coenzyme A, 0.5 mM L-malate and 0.5 mM L-carni-
tine. The final incubation volume was 0.5 ml, containing 25-50 μΐ homoge-
nate (1.3-2.5 mg muscle) or 25 μΐ mitochondrial suspension (100-200 pg 
protein). The vials were equipped with polypropylene center wells and 
sealed with rubber stoppers. After 5 min preincubation at 37 С the reaction 
was started by the addition of 120 μΜ [l-1ЦС]palmitate bound to fatty acid-
free albumin (molar ratio 5:1), unless otherwise indicated. The oxidation 
proceeded for 30 min (homogenates) or 15 min (mitochondria) at 37 С and 
was terminated by the addition of 0.2 ml 3 M perchloric acid to the medium, 
followed by a second incubation for 75 min at 4 С. The released '""СОг was 
trapped in 0.3 ml ethanolamine/ethylene glycol (1:2, v/v) injected into the 
center well. Thereafter, the acid incubation mixture was centrifuged in a 
Burkard Koolspin microcentrifuge (1 min, 10,000 χ g), and an aliquot of the 
supernatant was assayed for radioactivity by liquid scintillation counting 
in 10 ml of Aqualuma. Radioactivity of '"'СОг was measured in 10 ml toluene/ 
methanol (2:1, v/v) containing 0.4% Omnifluor. Palmitate oxidation rates 
were calculated from the production of '""СОг and '"O-labeled acid-soluble 
products. 
With mitochondria palmitate oxidation was additionally determined 
polarographically in the same medium at 37 С with a Clark oxygen electrode 
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as described by Van Hinsbergh et ai. (1978a). 
Palmitate oxidation by heart slices and isolated heart cells was 
measured in calcium-free Krebs-Ringer bicarbonate buffer (pH 7.2), gassed 
with 02/C02 (95:5). The final incubation volume was 2.5 ml, containing 40-
70 mg muscle (slices) or 0.6-1.5 mg protein (myocytes). Incubations were 
carried out essentially as described above, except that the incubation time 
was 90 min, 0.5 ml 3 M perchloric acid was used and the second incubation 
lasted for 18 h at 40C. 
Assay of lipolysis 
The rate of endogenous lipolysis in heart slices was determined from 
the release of glycerol. Heart slices were incubated for A0 min under the 
same conditions as described for the assay of palmitate oxidation. Aliquots 
of the medium were taken at the end of each incubation. Glycerol was deter­
mined as described in section 2.3. 
Other assays 
Assays of protein and of the activities of cytochrome с oxidase, ci­
trate synthase and creatine kinase are described in section 2.3. 
Statistics 
Statistical significance was analyzed by Student's t-test. 
7.3. RESULTS 
Palmitate oxidation by cell-free systems 
Functional intactness of the isolated mitochondria from both human 
and rat heart was confirmed by good respiratory control index values (4 or 
higher) and ADP/O ratios (2.2-2.5), when measured with an oxygen polaro-
graph and 1 mM 2-oxoglutarate or L-glutamate as substrate. Possible injury 
of the mitochondria during homogenization was assayed by the release of 
citrate synthase activity into the medium. Without sonication, the relative 
activity of this mitochondrial matrix enzyme, determined in the 20,000 χ g 
supernatant prepared from rat heart homogenates, was only 16±2% (mean±S.D. 
of A preparations). These results show that the cell-free preparations 
contain functionally and structurally intact mitochondria. With our isola­
tion procedure the yield of mitochondria ranged from 12 to 20% (both human 
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Table 7.1. Proportional contribution of 1ЦС02 to /ì-l'*cjpalmitate oxidation 
rate. 
Species and system Contribution of ll,C02 
Human heart mitochondria (5) A ± 1 
homogenate (15) A + 2 
slices (7) 33 ± 6 
Rat heart mitochondria (7) 1Θ + 5 
homogenate (16) 19 ± A 
slices (25) 66 ± 8 
myocytes (10) 68 ± 7 
Values are given in % of the sum of '"'СОг and 1ЦС-1аЬе1еа acid-soluble pro­
ducts and are means ±S.D. of the number of experiments given within paren­
theses . 
and rat heart), similar to the results of others (Idell-Wenger et al., 1978; 
Feuvray & Plouët, 1981). The preparations should predominantly contain mi-
tochondria from subsarcolemmal origin, since no proteolytic enzyme was used. 
The oxygen uptake by rat heart mitochondria at АО, 90 and 120 μΜ pal-
mitate amounted to AA6 + 35, A13 + A1 and A16±35 natom oxygen/min per mg 
protein, respectively (means±S.D. of 3 preparations). Based on a theoreti­
cal consumption of A6 natoms oxygen per nmol palmitate these values corres­
pond to oxidation rates of 9-10 nmol palmitate/min per mg protein. The oxy­
gen uptake values are comparable with or higher than those observed by 
others (Christophersen & Christiansen, 1975; Hansford, 1978; Man & Brosnan, 
1982; Olowe & Schulz, 1982) and almost twice as high as for human heart 
mitochondria (Van Hinsbergh et al., 1979). 
With the radiochemical assay, ^СОг production represented only about 
A and 18% of the total palmitate oxidation rate of human and rat heart 
cell-free preparations, respectively (Table 7.1). In all preparations fatty 
acid oxidation proceeded at a constant rate during incubation and was pro­
portional to the amount of tissue material. Substrates, coenzymes and co-
factors were present at concentrations assuring maximal oxidation rates 
(Van Hinsbergh et ai., 1978a, 1979)- When palmitate bound to albumin in a 
5:1 molar ratio was used as substrate, the oxidation rate with rat heart 
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Fig. 7.1. Concentration dependence of palmitate oxidation by rat heart ho-
raogenates at 0.4 mM albumin. Values are means ± S.D. of A prepara­
tions. All concentrations were corrected for substrate utiliza­
tion according to the method of Lee & Wilson, 1971). Inset figure 
shows the reciprocal of the palmitate oxidation rate versus the 
reciprocal of the palmitate concentration. 
homogenate did not show much dependence on the palmitate concentration in 
the range of 60-500 μΜ, but was maximal at 120 μΜ palmitate. This observa­
tion indicates that in homogenates oxidation of fatty acids of endogenous 
origin hardly influences the radiochemical assay. At a fixed albumin con­
centration of 0.4 mM, however, palmitate oxidation rose with increasing 
fatty acid concentration (Fig. 7.1). From the corresponding Lineweaver-Burk 
plot (inset of Fig. 7.1) the apparent К for palmitate was calculated to be 
m 
273 ±35 μΜ and the maximal oxidation rate 891 ± 100 nmol/min per g (means + 
S.D. of k determinations). The apparent к is comparable to that found with 
homogenates of diaphragm and of m.quadriceps under these conditions (Fig. 
3.6). The maximal oxidation rate appears of the same order of magnitude as 
that observed with 120 μΜ palmitate bound to 24 μΜ albumin (Table 7.2). 
The palmitate oxidation rate was in rat heart mitochondria 2.5 -fold 
and in homogenates 6-fold as high as in the corresponding human heart pre­
parations, when expressed per mg protein and per g muscle, respectively 
(Table 7.2). The activities of the mitochondrial enzymes cytochrome с oxi­
dase and citrate synthase also showed marked differences between human and 
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Гаііе 7.2. Palmitate oxidation by cell-free systems of human and rat heart. 
System Species Oxidation rate 
(nmol/min) 
/mg protein 
or 
/g muscle 
/unit 
cytochrome с 
oxidase 
/unit 
citrate 
synthase 
Mitochondria 
Homogenates 
Man 
Bat 
Man 
Rat 
(5) 
(4-7) 
(11-15) 
(10-16) 
6 . 6 8 + 1.22 
17.91 ± 1.60 l 
118± 23 
760 ± 107 a 
2.86 ± 0 . 5 8 6.67 ± 0 . 7 2 
2.Al ± 0 . 3 5 10.25 ± 0 . 6 0 
2 . 2 2 ± 0 . 8 0 7 . 1 6 ± 1 . 4 6 
2.30 ± 0 . 4 1 9.67 ± 1 . 7 4 ' 
Oxidation rates were measured with 90 μΜ (human mitochondria) or 120 μΜ 
(other systems) [l-'^C]palmitate (bound to albumin in a 5:1 molar ratio). 
Rates are expressed in nmol/min per mg protein (mitochondria) or per g 
muscle (homogenates), or relative to the cytochrome с oxidase or citrate 
synthase activity. Values represent means ±S.D. of the number of experiments 
given within parentheses. 
a P < 0.001, human versus rat heart. 
Table 7.3. Activities of mitochondrial enzymes of human and rat heart. 
System 
Mitochondria 
Homogenates 
Species 
Man 
Rat 
Man 
Rat 
¡ 
(5) 
(7-15) 
(20-29) 
(28-58) 
Cytochrome с 
oxidase 
2.35±0.28 
7.85± 1.04 
47.9 ±12.2 
327 ± 44 
Citrate 
synthase 
1.02±0.23 
1.59 ±0.24 
17.0±4.1 
77.9±8.3 
Cytochrome с 
oxidase / citrate 
synthase 
ratio 
2.38±0.42 
5.22± 1.61 
3.00 ±0.95 
4.12 ±0.64 
Enzyme activities are given in units (μπιοΐ/πιϊη) per mg protein (mitochondria) 
or per g muscle (homogenates) and represent means ± S.D. of the number of 
preparations given within parentheses. All values obtained with the rat 
heart preparations are significantly different from those of human heart 
( P<0.001). 
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rat heart (Table 7.3). The differences were larger for cytochrome с oxidase 
than for citrate synthase. 
Comparison of the ratio of activities of the inner membrane enzyme 
cytochrome с oxidase and the matrix enzyme citrate synthase in homogenates 
and mitochondria gives an indication for the intactness of the mitochon­
dria. This ratio did not appear significantly different between mitochon­
dria and homogenates in both species (Table 7.3). Normalization of fatty 
acid oxidation to mitochondrial marker enzymes is useful since it permits 
the comparison of this metabolic activity in various cell-free and cellular 
systems. This normalized activity is also not dependent upon the purity of 
the mitochondrial preparation. For both species the oxidation rates expres­
sed on the basis of cytochrome с oxidase or citrate synthase did not signi­
ficantly differ between homogenates and mitochondria(Table 7.2). These data 
confirm that the mitochondria retain their metabolic activity during iso­
lation. 
The mitochondrial protein content of human and rat heart can be cal­
culated by comparing the mitochondrial parameters determined in whole homo­
genates and isolated mitochondria. For rat heart we always used part of the 
whole homogenate for the isolation of mitochondria, in order to allow a di­
rect comparison. For human heart this was not possible, due to the small 
size of the biopsies. Mitochondrial content was calculated from the palmi-
tate oxidation rates and cytochrome с oxidase and citrate synthase activi­
ties (Table 7.4). It appears that the values obtained by means of each of 
the three parameters are in good agreement with each other and that rat 
heart has a 2.5 -fold higher mitochondrial protein content than human heart. 
The mitochondrial content of human heart has to our knowledge not yet been 
reported. For rat heart our values of mitochondrial content are consistent 
with those reported by others (Abu-Erreisch & Sanadi, 1978; Idell-Wenger et 
al., 1978; Feuvray & Plouët, 1981)), who used the same enzymes as mitochon-
drial markers. However, they differ from the higher values calculated on 
the basis of cytochrome content (Kinnula & Hassinen, 1977). 
Characteristics of the cellular systems 
The intactness of human and rat heart slices was estimated from the 
leakage of soluble (cytosolic) creatine kinase during the incubation 
(Wagenmakers & Veerkamp, 1982). After 90 min about 70% of the total soluble 
creatine kinase activity was still present in the heart slices, indicating 
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Table 7.4. Mitochondrial content of Ьшлал and rat heart. 
Parameter Man Rat 
Palmitate oxidation 17.7 АО.5 ± A.5 
Cytochrome с oxidase activity 20.3 43.7± 8.5 
Citrate synthase activity 16.7 49.4 + 10.7 
Mitochondrial protein content was calculated as tissue capacity divided by 
mitochondrial activity of the specific parameters and is given in mg pro-
tein/g muscle (wet weight). The values for rat heart represent means ±S.D. 
of 4 experiments in which part of the whole homogenate was used for the 
isolation of mitochondria. The mitochondrial content of human heart was 
calculated using the values given in Tables 7.2 and 7.3. 
a small damage of the cells. Estimated by trypan blue exclusion, the in-
tactness of the isolated myocyte preparations was 60-80%. The yield amoun­
ted to 2-6 χ 10s cells (10-30 mg protein) per g heart tissue. Microscopic 
examination revealed that 90-95% of the viable cells were elongated, 
quiescent myocytes, similar in morphology to those found in the intact 
heart (cf. Fig. 1.2). Cell size ranged from 100 to 150 ym in length and 30 
to 40 \im in width. Upon addition of 0.5-1 mM Ca 2 +, the cells virtually 
all maintained their elongated form. After separation on a Percoli gradient 
about 90% of the cells excluded trypan blue, but in the subsequent centri-
fugation step, necessary for the collection of the cells, their viability 
diminished to about 80%. Suspensions of 60-80% viable myocytes were usual­
ly applied for the oxidation experiments. For the purpose of comparison, we 
also studied disrupted myocytes, isolated from the Percoli gradient or pre­
pared by vortexing intact cells. 
We tried to establish the percentage of intact (viable) cardiac myo­
cytes in our preparations from the ratio of creatine kinase to citrate syn­
thase activity. During the isolation procedure the myocytes were transfer­
red several times to fresh media, so that cytosolic enzymes (e.g. creatine 
kinase) from damaged cells are likely to be washed away. Assuming that most 
of the mitochondria will still remain associated with the myocyte after its 
disruption (Dow et al., 1981b; Murphy et al., 1982), we determined the ratio 
of these enzymes in preparations that contained predominantly either viable 
or non-viable myocytes (based on trypan blue exclusion and separated by 
density centrifugation). In total heart homogenate the enzyme ratio amoun-
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ted to 21.6 ±0.8, in isolated non-viable myocytes (Percoli gradient) to 
13.7 ±5.6 (means ±S.D. of 6 and 3 preparations, respectively) and in myo-
cyte preparations containing 70 and 75% viable cells to 18.3 and 19.3, 
respectively. The mean values for non-viable myocytes and total heart homo-
genate are compatible with the observation that 48% of the cellular crea-
tine kinase resides in the cytosol (Schölte, 1973a). The large variability 
in the enzyme ratio makes it unsuitable as a viability parameter. This 
variability may be associated with mechanical damage of our non-viable pre-
parations, since Murphy et al. (1982) recently found that cells incubated 
under anoxic and substrate-deprived conditions released soluble cytoplas-
mic enzymes in close correlation to trypan blue uptake. 
The oxidation rates of llfC-labeled succinate and L-malate by viable 
and disrupted myocytes did not differ significantly (data not shown). Such 
differences were neither observed by Jolly et al. (1979) in comparing myo-
cytes and homogenates. These results are not necessarily indicative for 
cell damage, because the oxidation rates in damaged cells are most likely 
underestimated due to disruption of citric acid cycle activity, whereas in 
intact cells the slowly penetrating substrates are completely oxidized 
(Piper et ai., 1982) . 
Palmitate oxidation by cellular systems 
Both human and rat heart slices and rat cardiac myocytes oxidized 
palmitate at a constant rate for at least 90 min (Fig. 7.2). The oxidation 
rates were not dependent on the amount of tissue material up to 100 mg 
muscle (slices) or 2 mg protein (myocytes). The contribution of the 1ЦС02 
production to the total rate of palmitate oxidation amounted to 33, 66 and 
68% for human and rat heart slices and rat cardiac myocytes, respectively 
(Table 7.1). 
Rat heart slices showed higher palmitate oxidation rates than human 
heart slices, when calculated per g muscle (Table 7.5; page 110). The re­
verse was found when the rates were expressed relative to the citrate syn­
thase activity, due to the much higher activity of this enzyme in rat 
heart. The oxidation rates were increased with both human and rat heart 
slices when higher palmitate:albumin (5:1) concentrations were used (Table 
7.5), as earlier observed for rat hemidiaphragm (chapter 3). At a constant 
albumin concentration of 0.3 mM the oxidation rate by rat heart slices also 
rose with increasing fatty acid concentration. The apparent 1С for palmi-
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Fig. 7.2. Effect of incubation time and amount of tissue material on the 
oxidation of 120 yM [l-l''C]palmitate bound to albumin (molar 
ratio 5:1) by human and rat heart slices and rat heart cells. 
Results of representative experiments out of three are shown. 
tate was calculated to be 1.45±0.41 mM and the maximal oxidation rate 
17.3 ±4.6 nmol/min per g (means±S.D. of 3 determinations). 
The rat cardiac myocyte preparations oxidized palmitate at a rate 
which was not dependent on the fatty acid concentration and which, when 
based on the citrate synthase activity, was much higher than with rat heart 
slices (Table 7-5). With disrupted myocytes, the palmitate oxidation was 
rather variable (15-35 pmol/min per mg protein) but did not differ for pre-
parations obtained by vortexing or from the Percoli gradient. Because of 
loss of cytosolic proteins, comparison of the oxidation rates of prepara-
tions of intact and disrupted myocytes can better be performed on the basis 
of citrate synthase activity. Even rounded myocytes retain this enzyme ac-
tivity (Dow et al., 1981b; Murphy et al., 1982). With disrupted myocytes the 
palmitate oxidation rate on this basis was about 10% of that for prepara-
tions of 60-80% intact myocytes (Table 7.5). This result is similar to fin-
dings on myocytes from dog heart (Long et al., 1980). For our cell prepara-
tions, containing 60-80% viable cells, the contribution of the non-viable 
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Table 7.5. Palmitate oxidation by cellular systems of human and rat heart. 
Species 
Man 
Rat 
System 
S l i c e s 
S l i c e s 
Myocytes 
Concen­
t r a t i o n 
(mM) 
0.12 
0.12 
1.5 
0.12 
0.6 
Disrupted 0.12 
myocytes b 
(7) 
(22) 
(3) 
(7) 
(3) 
(5) 
Oxidation r a t e 
(nmol/min) 
/g muscle 
or 
/mg p r o t e i n 
0.91 
1.44 
8.12 
0.31 
0.27 
0.025 
± 0 . 0 8 
± 0 . 2 3 ° 
± 0 . 5 3 
± 0 . 0 7 
± 0 . 0 3 
±0.009 
/uni t 
c i t r a t e 
synthase 
0.054 ±0.005 
0.019 ±0.003 C 
0.108±0.007 
0.41 ±0.08 
0.35 ±0.06 
0.041 ±0.004 
Oxidation rates were measured with [l-'^C]palmitate bound to albumin (molar 
ratio 5:1) and are expressed in nmol/min per g muscle (slices) or per mg 
protein (myocytes), or relative to the citrate synthase activity. Values 
represent means±S.D. of the number of experiments given within parentheses. 
a
 Preparations that contain 60-80% viable cells (based on trypan blue 
exclusion. 
b
 Disrupted by vortexing or obtained from the Percoli gradient. 
c
 Ρ< 0.001, human versus rat heart slices. 
cells to the total palmitate oxidation rate will, therefore, only amount to 
2-4%. Because of the lack of a good viability standard, no attempt was made 
to recalculate the oxidation rates of myocytes by extrapolation to 100% 
viability, as suggested by Long et al. (1980), so that our values were 
slightly underestimated. 
Various factors, involved in fatty acid oxidation, were tested for 
their effect on palmitate oxidation by the cellular preparations (Table 
7.6). Carnitine, with or without coenzyme A, stimulated the oxidation in 
slices, myocytes and disrupted myocytes by about 40%, similar to our obser­
vations with intact skeletal muscle preparations (chapter 3). Addition of 
ATP gave a comparable stimulation. When these three factors were simultane­
ously present, the palmitate oxidation rate was dramatically increased with 
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Table 7.6. Effect of various additions on palmitate oxidation by heart 
slices and cardiac myocytes. 
Addition Human 
heart 
slices 
Rat heart 
Slices Myocytes a Disrupted 
myocytes b 
None 
4 mM D.L-carnitine and 
0.1 mM CoASH 
100 100 100 100 
143 ±16 139 ± 18 146 ± 39 
5 mM ATP _ 140 ±26 125+ 5 167 ± 22 
1 mM L-malate _ _ 63 ± 15 61 ± 27 
4 mM D,L-carnitine, 0.1 mM CoASH 200 ±40 435±31 809 ± 103 3650 ± 324 
and 5 mM ATP 
4 mM D.L-carnitine, 0.1 mM CoASH, - - 897 ± 108 5181 ± 1030 
5 mM ATP and 1 mM L-malate 
Relative oxidation rates are given in % of the corresponding control and 
are means ±S.D. of 3-7 paired experiments. The control values were 
0.96+0.06 and 1.44 ±0.24 nmol/min per g muscle for human and rat heart 
slices, respectively, and 0.31 ±0.07 and 0.028 ±0.006 nmol/min per mg pro-
tein for myocytes and disrupted myocytes, respectively (means ±S.D. of 3, 
20, 7 and 4 preparations). 
a
 Preparations that contain 60-80% viable cells (based on trypan blue 
exclusion 
Disrupted by vortexing or obtained by gradient centrifugation on Percoli. 
all preparations, but especially with disrupted myocytes. With myocytes and 
disrupted myocytes this increase was even larger when L-malate was also 
added to the medium. This synergistic effect most likely relates to palmi-
tate activation and supply of citric acid cycle metabolites, since especial-
ly the production of '"C-labeled acid-soluble intermediates increased (da-
ta not shown). The 8-fold increase of palmitate oxidation observed with 
myocyte preparations, containing 60-80% trypan blue-excluding cells, can 
only partly be attributed to a higher oxidation rate in the damaged cells. 
If carnitine, coenzyme A and ATP are added to the medium, the contribution of 
the non-viable cells to the total palmitate oxidation rate of these prepa-
rations can be calculated to rise to 8-16%. Apparently, the viable myocytes 
also oxidize palmitate at a higher rate (6-7-fold) when the three cofactors 
are added. It is known that both carnitine and ATP, which may have been re-
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leased during the isolation of the cells, can be taken up by intact cardiac 
myocytes (Bahl et ai., 1980; Chaudry, 1982). Liu & Spitzer (1978) and Long 
et al. (1980) also reported a stimulatory effect of carnitine on the '"COz 
production from [WOjpalmitate by viable dog heart myocytes. The observed 
effect of ATP is not exerted by supplying adenosine nor inosine as these 
compounds did not stimulate the oxidation rates in rat heart slices, not 
even in the presence of carnitine and coenzyme A. 
Lipolysis studies 
In order to estimate to what extent fatty acids of endogenous origin 
may influence the oxidation of exogenous substrates, we measured the rate 
of endogenous fatty acid production m rat heart slices. This rate can be 
approximated by assay of the glycerol release into the medium, since endo­
genous fatty acids are mainly derived from intermyofibnllar tnacylglyce-
rol pools and glycerol kinase activity is almost absent in the heart (News-
holme & Taylor, 1969). Glycerol was released at a constant rate for at 
least АО m m . At 0 С the release was less than 20% of that measured at 
37 С. In the absence of added substrate the glycerol release amounted to 
20.5 ±2.5 nmol/min per g (meant S.D. of 3 preparations). This value is 
twice as high as found in perfused rat hearts (Hulsmann et al., 1981). The 
release was not affected by the addition of 11 mM glucose to the incubation 
medium, but was lower with 120 μΜ palmitate. The relative values were 
101 ±4 and 85 ±6%, respectively (means! S.D. of 3 paired experiments). When 
the palmitate oxidation rate was measured in heart slices, which had first 
been used for the release experiments, a comparable oxidation rate was ob­
served as without such preincubation. The inhibitory effect of palmitate 
appears rather small when compared to studies with perfused heart (Crass et 
al., 1975) or purified lipase preparations (Severson & Hurley, 1982). This 
may be due to a hampered diffusion of the fatty acid within the heart sli­
ces and to the absence of hormones. Endogenous fatty acids are produced at 
a sufficiently high rate to cause label dilution of the added 11',C| palmi-
tate and hence underestimation of the fatty acid oxidation rate. The line­
arity with time indicates a nearly immediate equilibration of the pools of 
external and endogenously formed fatty acids. 
112 
7.4. DISCUSSION 
The four in vitro systems investigated in this study, homogenates, 
isolated mitochondria, slices and cardiac myocytes, differ considerably 
with respect to ease of preparation, complexity and, as was shown, metabo­
lic properties. They all appeared to be valid in vitro systems. The cell-
free systems were established to contain functionally intact mitochondria. 
In the cellular systems a small part of the cells is not intact, but from 
the observed linearity of the fatty acid oxidation with time it appears 
that the cells retain their viability for sufficient periods of time to 
permit valid metabolic studies. 
With isolated rat heart mitochondria fatty acid oxidation was mea­
sured polarographically as well as radiochemically with non-limiting 
amounts of fatty acids. Under these conditions palmitate molecules are not 
completely degraded to CO2 and hence accumulation occurs of oxidation in­
termediates, mainly citric acid cycle metabolites and short-chain acylcar-
nitines (Christophersen & Christiansen, 1975; Van Hinsbergh et al., 1978a, 
1979; cf. Fig. 5.1 on page 81). When only '''СОг production (3.2 nmol/min 
per mg protein) is considered the palmitate oxidation rate is about 30% of 
that calculated from oxygen uptake (9-10 nmol/min per mg protein). The pal­
mitate oxidation rate estimated from the sum of 1 ЦС0 2 and '"O-labeled acid-
soluble products (18 nmol/min per mog protein) is about 80% higher than 
when calculated from oxygen uptake. This discrepancy may be explained by 
the fact that in the radiochemical assay all oxidation intermediates are 
equally considered, whereas in the polarographical assay the intermediates 
are quantified dependent on the amount of reducing equivalents released du­
ring their formation. We conclude that in measuring the (3-oxidation of 
['""C] fatty acids the sum of '""СОг and '""C-labeled acid-soluble products is 
a more accurate and sensitive index than the 1',C02 production alone. Fur­
thermore, when calculating palmitate oxidation rates from the rate of oxy­
gen uptake, the conversion factor to be used is generally lower than 46. 
Comparison of the oxygen uptake rate (430 natom/min per mg protein) and the 
radiochemically determined oxidation rate (18 nmol/min per mg protein) 
shows that with rat heart mitochondria about 24 natom oxygen are consumed 
per nmol palmitate oxidized under our conditions. 
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The palmitate oxidation rates measured in cell-free systems represent 
the best approximation of values of the fatty acid oxidation capacity. The 
oxidation capacities of human heart have previously not been determined. 
The palmitate oxidation capacity of rat heart homogenates is somewhat 
higher than the values based on oxygen consumption in homogenates (Hooker 
& Baldwin, 1979) and perfused non-working heart (Hülsmann et al., 1982), but 
it agrees quite well with the rate of ß-oxidation (Oram et al., 1973; Pearce 
et al., 1979) and of oxygen consumption (Taegtmeyer et al., 1980) in the per-
fused working rat heart. A lower oxidation rate was reported for oleate in 
rat heart homogenate (McGarry et al., 1978a). Earlier we determined palmi-
tate oxidation rates in mitochondrial preparations of human heart muscle 
which were obtained from patients with tetralogy of Fallot (Van Hinsbergh 
et ai., 1979)· Since our present values, measured in heart auricular biop-
sies, are not different from those previously reported, we confirm that 
tetralogy of Fallot does not seem to be accompanied by dysfunction of car-
diac mitochondria (Lentz et al., 1978). 
Our values for the cytochrome с oxidase and citrate synthase activi­
ties in rat heart are comparable to those found by others in mitochondria 
(Palmer et al., 1977; Idell-Wenger et al., 1978; Feuvray & Plouët, 1981; 
Matlib et ai., 1981) and homogenates (Baldwin et ai., 1977; Idell-Wenger et 
ai., 1978; Feuvray & Plouët, 1981; Hansford 4 Castro, 1982). 
At comparison of our values for human and rat heart one has to keep 
in mind possible effects of sample bias, i.e. human auricular biopsy versus 
entire rat heart. Ventricular myocardial cells of the rat were reported to 
contain a larger mitochondrial volume than atrial cells (Hirakow et ai., 
1980), although earlier no differences were found (Nakata, 1977). The free 
fatty acid concentration in dog right auricular appendages was higher than 
in their left ventricular wall, suggesting a lower metabolic activity in 
the former (Van der Vusse et ai., 1983). The percentage of non-muscle cells 
may also differ in the human and rat heart preparations. The concentrations 
of collagen and RNA in the atria of heart are considerably greater than 
those in the ventricles (Caspari et ai., 1975; Smith & Sugden, 1983). 
The 6-fold higher palmitate oxidation rate in homogenates of total 
rat heart muscle in comparison to human atrial muscle is not only due to a 
2.5-fold higher content of mitochondrial protein but also to a 2.5-fold 
higher mitochondrial activity. The relatively low contribution of 14C02 
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production to the total rate of palmitate oxidation in cell-free systems 
in human heart compared to rat heart (Table 7.1) indicates that the limita­
tion of the citric acid cycle with respect to the rate of g-oxidation is 
more prominent in human heart. 
We are not familiar with fatty acid oxidation rates in heart slices. 
Reported values for oxidation rates by cardiac myocytes were always only 
based on 1ЦС02 production. Our values for "'СОг production from [і-1цС]pal­
mitate by rat cardiac myocytes (0.18-0.22 nmol/min per mg protein) agree 
quite well with the results of most other investigators (e.g. Grosso et ai., 
1977; De Creila & Light, 1980b; Frangakis et al., 1980), but are lower than 
found by Montini et al. (1981). Myocytes from dog heart show а '''СОг produc­
tion of 0.10-0.14 nmol/min per mg protein (Liu & Spitzer, 1978; Vahouny et 
al., 1979; Long et al., 1980). Recently, Tamboli et al. (1983) reported a 
'"•СОг production from [і-1цС]oleate by rat cardiac myocytes of 0.08 nmol/ 
min per mg protein. From their data we calculated the production of l',C-
labeled water-soluble products and thus found the total oleate oxidation 
rate to be 0.14 nmol/min per mg protein, the '""СОг production of which is 
58%. The latter percentage agrees with our findings for palmitate. 
Fatty acid oxidation rates of cell-free and cellular systems can be 
compared, when they are expressed relative to the citrate synthase activi­
ty. On this basis the oxidation rates of the cellular systems are only a 
few percent of those of the cell-free preparations (Tables 7.2 and 7.5). 
This difference is related to an underestimation of the oxidation rates of 
the cellular systems due to label dilution by endogenous fatty acid and to 
the low metabolic activity of these resting cellular preparations (Taegt-
meyer et al., 1980). The lowest oxidation rates were measured in heart sli­
ces. This can be explained by slow diffusion of the fatty acid in the tis­
sue, since with slices the oxidation rate increases with the fatty acid 
concentration, in contrast to cardiac myocytes of dog (Liu & Spitzer, 1978) 
and rat (Table 7.5). 
In addition, we found less difference between the oxidation rates in 
slices and myocytes for pyruvate than for palmitate (data not shown). The 
diffusion and/or the presence of stored lipids appeared to affect more the 
palmitate oxidation rates in rat than in human heart slices, since the rate 
bsed on citrate synthase activity is lower in rat heart slices (Table 7.5) 
but significantly higher in homogenates (Table 7.2) than in the correspon-
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ding human preparations. 
Cell-free systems are useful for the study of metabolic capacities of 
tissues and of regulatory phenomena at the subcellular level. Mainly be­
cause of the large dilution of the cytoplasmic pool m these preparations, 
endogenous substrates hardly influence the oxidation of exogenously added 
substrates. This dilution effect probably also explains why fatty acids are 
less completely degraded in cell-free than in cellular systems, as follows 
from the observation that the contribution of the '"'СОг production to the 
total palmitate oxidation rate was much smaller in cell-free systems (Table 
7.1). 
Effects of endogenously derived substrates should be considered, when 
studying cellular systems. Investigations on the fatty acid oxidation in 
slices appeared to be hampered by intercellular transport of the fatty acid 
and possibly also by contributions of non-muscle cells. Isolated myocytes 
appear to be the most useful for the investigation of metabolic regulatory 
mechanisms at the cellular level. For the elucidation of the regulation of 
fatty acid metabolism in human heart muscle, further comparative studies, 
using isolated myocytes and homogenates, will be fruitful. At the moment 
the amounts of tissue available still impair the isolation of sufficient 
quantities of intact human heart cells. 
7.5. SUMMARY 
Palmitate oxidation rates and activities of the mitochondrial marker 
enzymes cytochrome с oxidase and citrate synthase have been determined m 
homogenates, isolated mitochondria and slices of human and rat heart and in 
calcium-tolerant rat cardiac myocytes. Homogenates and mitochondria from 
rat heart showed a 6- and 2.5-fold higher palmitate oxidation rate than the 
corresponding preparations from human heart. 
From the palmitate oxidation rates and cytochrome с oxidase and ci­
trate synthase activities as parameters, the mitochondrial protein contents 
of human and rat heart were calculated to be about 18 and 45 mg/g wet 
weight, respectively. 
Based on citrate synthase activities, the palmitate oxidation rates 
were about the same in homogenates and isolated mitochondria, much lower in 
myocytes and lowest in slices. Palmitate oxidation rates were concentration 
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dependent in slices but not with myocytes. 
With the cellular systems palmitate oxidation was synergistically 
stimulated by the addition of carnitine, coenzyme A and ATP to the medium. 
This stimulation could only partly be attributed to an increased oxidation 
in damaged cells. 
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CHAPTERS 
A RADIOCHEMICAL PROCEDURE TOR THE ASSAY OF 
FATTY ACID BINDING BY PROTEINS* 
8.1. INTRODUCTION 
The cytosol of many eucaryotic cells contains one or more fatty acid-
binding proteins, which exhibit a high affinity for long-chain fatty acids 
and are assumed to participate in the intracellular transport of fatty 
acids (Ockner et al., 1972; Mishkin et al., 1972). These proteins are usually 
detected by coelution of labeled fatty acids from a gel-filtration column. 
This technique, however, is not very sensitive, since fatty acids also bind 
with a high affinity to the gel itself (cf. Mishkin et al., 1975). There-
fore, a more useful and sensitive method for the detection of fatty acid-
binding proteins is greatly needed. 
Dahlberg et al. (1980) recently described the use of Lipidex 1000 (a 
10% (w/w) substituted hydroxyalkoxypropyl derivative of Sephadex G-25) 
(Dyfverman & Sjövall, 1978) to remove unbound as well as protein-bound hy-
drophobic molecules from aqueous solutions in a temperature-dependent man-
ner according to the kinetics of protein-lipid interaction. Lipidex 1000 
treatment at 2-4 С resulted in the separation of unbound steroids from pro­
tein-steroid complexes, whereas at 45 С all steroids were removed (Dahlberg 
et al., 1980). In the present work we show that Lipidex 1000 can also be 
used for the temperature-dependent removal of fatty acids from protein-
fatty acid complexes and for the detection and assay of fatty acid-binding 
proteins. The procedure was applied to assay the fatty acid binding of some 
proteins and the maximal binding capacity of bovine serum albumin and of 
cytosolic proteins from rat liver. 
* Adapted and extended from Glatz & Veerkamp (1983a). 
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8.2. MATERIALS AND METHODS 
Methods 
Lipidex 1000 was washed free of methanol in a column by elution with 
10 bed volumes of 10 mM K-phosphate (pH 7.A), containing 0.01% NaNs. The 
gel was transferred to a glass vial and stored at 4 С as a Lipidex-buffer 
suspension (1:1, v/v) containing about 100 mg dry Lipidex/ml buffer. 
Del'ipidation by Lipidex chromatography 
The removal of protein-bound fatty acids by Lipidex was examined with 
complexes of [і-1цС]palmitate and bovine serum albumin and of palmitate and 
[1ЦС]methylated bovine serum albumin, both in a 5:1 molar ratio. The pro­
tein sample was applied to a column of Lipidex (0.7 χ 6 cm), equilibrated 
with 10 mM K-phosphate buffer (pH 7.4) at 37 С (thermostated column; flow 
rate, 12 ral/h). Elution was performed with 4 bed volumes of the same buffer, 
whereafter methanol was used to elute adsorbed compounds. 
Assay of fatty acid binding 
An aqueous solution of about 5 μΜ [l-^Cjpalmitate (pH 8) was prepa­
red fresh. In a round-bottom flask, 50 nmol [l-^C]palmitate (2.8 yCi) was 
dissolved in 8 ml ethanol and mixed with 8 ml water. The pH of the solution 
was adjusted to 8 with 0.2 M КОН. Ethanol was removed by rotary evaporation 
under low pressure at 25 C. About 4 ml of water was added to compensate for 
its loss by evaporation. The ethanol content of the resulting solution was 
determined with a Boehringer Test Combination (Boehringer, Mannheim, F.R.G.) 
and kept below 0.5%. 
For the standard assay of fatty acid binding, protein samples were 
incubated in 1.5-ml polyethylene vials in 10 mM K-phosphate (pH 7.4) with 
1 yM [l-^Cjpalmitate. The total volume was 0.45 ml. After incubation for 
10 min at 37 С the vials were cooled in ice and 0.05 ml of ice-cold stir­
ring Lipidex-buffer suspension was added to remove the unbound fatty acids. 
The samples were mixed thoroughly, incubated for 10 min at 0 С and centri-
fuged in a Burkard Koolspin microcentrifuge (2 min, 10,000 χ g) at 4 С. An 
aliquot of the supernatant was assayed for radioactivity by liquid scintil­
lation counting in Opti-Fluor. Fatty acid binding was calculated from the 
amount of radioactivity present in the supernatant and is expressed as 
pmol/yg protein. For comparison, samples were in some experiments treated 
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with 0.05 ml of a buffer suspension of dextran-coated charcoal (2% (w/v) 
charcoal, 0.2% (w/v) Dextran T-70). 
Preparation of rat iiver cytosol 
Rat liver cytosol was prepared as described in section 2.3 and freed 
of residual albumin by passage through an affinity column of the immuno­
globulin G fraction of rabbit anti-rat albumin antiserum coupled to Protein 
A-Sepharose CL-4B. For delipidation, A ml of the cytosol, containing about 
30 mg protein, was subjected to chromatography on Lipidex 1000 at 37 С es­
sentially as described above, except that the column used was 1 χ 15 cm and 
the flow rate 20 ml/h. The resulting delipidated protein samples were 
stored at -20 C. Protein content was determined as described in section 2.3. 
Θ.3. RESULTS 
rejTiperature-dependent interaction of palmitate-albumin complexes and Lipi­
dex 1000 
When an aqueous solution of bovine serum albumin and [l-^C] palmitate 
was incubated with Lipidex at 0 C, a fixed amount of palmitate (about 35% 
of the added fatty acid) could not be precipitated by the gel, even after a 
60-min incubation (Fig. 8.1). This portion presumably represents albumin-
bound palmitate. However, when the incubation was performed at 37 or 45 C, 
88-94% of this amount of palmitate was bound by Lipidex after 60 min (Fig. 
8.1), indicating that at these temperatures albumin-bound fatty acids were 
also removed from the solution. These observations extend those of Dahlberg 
et ai. (1980) in that Lipidex 1000 is also suitable for the removal of un­
bound and/or protein-bound fatty acids from aqueous solutions in a tempera­
ture-dependent way. 
The removal of protein-bound fatty acids was also studied using a 
column of Lipidex 1000 at 370C. [l-^c]Palmitate (30 nmol) complexed to bo­
vine serum albumin (molar ratio 5:1) was applied to the column and elution 
performed with buffer and subsequently methanol. The buffer fraction con­
tained only 2.2 + 0.5% of the applied radioactivity while the methanol frac­
tion contained 95.8±0.8% (means±S.D. of 3 experiments). 
Recovery of protein from the column was examined by chromatography 
at 370C of a complex of 2 nmol palmitate to 0.4 nmol М-^С]methylated bo­
vine serum albumin. The buffer and methanol fractions contained 98 ± 10 and 
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Fig. 8.1. Temperature dependence of the removal of fatty acids from albumin 
and binding to Lipidex 1000. The binding of 1 yM [l-^Ojpalmitate 
to 5 VS bovine serum albumin was measured with the standard assay 
except that after addition of Lipidex the samples were incubated 
at О С (·), 370C (о) or A50C (Δ). The amount of palraitate bound 
to albumin after 10 min at 0oC (32 pmol/pg albumin) was set at 
100%. Values are means+S.D. of 3 experiments. 
0.4 ±0.2% of the applied radioactivity, respectively (means+S.D. of 4 de­
terminations). The recovery of native bovine serum albumin after Lipidex 
chromatography at 370C amounted to 94.3 ±3.1% (mean ±S.D. of 4 determina­
tions). Also, with a rat liver 105,000 χ g supernatant, protein recovery 
after chromatography was 91 and 96% (2 determinations). These results show 
that delipidation of protein-fatty acid complexes can be performed effecti­
vely by Lipidex 1000 chromatography at 370C, without loss of protein. A 
temperature of 370C is preferred over 450C (Dahlberg et ai., 1980) to mini­
mize possible conformation changes or denaturation of protein. 
Assay of fatty acid binding: comparison of the use of Lipidex 1000 and 
dextran-coated charcoal 
For the assay of fatty acid binding, protein samóles were incubated 
with 1 μΜ [l-^Cjpalmitate at 370C. This relatively low concentration of 
palmitate was chosen because of its low solubility in aqueous solutions. 
After equilibration the unbound fatty acids were removed from the aqueous 
solution using Lipidex at 0 С Under our standard assay conditions, a li­
near correlation between the amount of fatty acid bound and the amount of 
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Fig. θ.2. Effect of the amount of bovine serum albumin on palmitate binding. 
Determinations were carried out with the standard assay. Various 
amounts of albumin were incubated with 1 μΜ [l-'^C]palmitate for 
10 min at 370C, followed by an incubation with Lipidex 1000 (·) 
or dextran-coated charcoal (o) for 10 m m at 0oC. Results of one 
representative experiment out of three are shown. 
protein was observed up to about 10 \¡g albumin, or 50-60% of the added pal-
mitate (Fig. 8.2). Fatty acid binding was not influenced by the amount of 
Lipidex used (Fig. 8.3). The blank value amounted only to 15-25 pmol (Fig. 
8.2), indicating that 95-97% of the unbound fatty acids can be removed from 
aqueous solutions. The polyethylene vial could interfere with the assay by 
also binding palmitate, but this binding is negligible at short incubation 
times and at pH values above 7 (Sallee, 1974). Under our assay conditions 
(10-min incubation and pH 7.4), fatty acid binding to the polyethylene ap-
peared to be low, since the recovery of [l-^cjpalmitate from an assay mix-
ture without protein amounted to 91 ±5% (meant S.D. of 11 determinations). 
In the presence of 5 and 10 pg serum albumin the recovery was 93±2 and 
95 ±3%, respectively (means±S.D. of 4 determinations), indicating that the 
polyethylene-bound fatty acids are still available for binding by protein. 
The palmitate-bmding capacity of Lipidex at 0 С was 0.7-0.8 nmol/50 μΐ 
Lipidex-buffer suspension (28-32 nmol/ml packed gel). 
For comparison, properties of dextran-coated charcoal were also in­
vestigated. This material is commonly used for the separation of protein-
bound and unbound hydrophobic molecules (Warner & Neims, 1975; Benassayag 
123 
75 100 
Added volume [μ\) 
Fig. Θ.3. Effect of the amount of Lipidex 1000 (·) or dextran-coated char­
coal (o) suspension on the binding of palmitate by bovine serum 
albumin, as measured with the standard assay. After incubation of 
5 vig protein with 1 μΜ [l-^Cjpalmitate for 10 min at 370C, va­
rious amounts of Lipidex 1000 or dextran-coated charcoal were ad­
ded and the solutions were incubated for 10 min at 0oC. Values 
are means +S.D. of 3 experiments. 
et al., 1977; Dahlberg et al., 1980). The dextran-coated charcoal suspension 
used was chosen so that its palraitate-binding capacity per ml was compara­
ble to that of the Lipidex-buffer suspension. With dextran-coated charcoal 
we observed a similar linear dependence on the amount of protein as with 
Lipidex (Fig. 8.2). The amount of bound palmitate recovered in the superna­
tant was, however, about 30% lower and decreased considerably when larger 
quantities of dextran-coated charcoal were used (Fig. 8.3). 
To examine the possible binding of protein to Lipidex and dextran-
coated charcoal at 0 C, assays were performed with #-[1цС]methylated bovine 
serum albumin and W-f^c]methylated ovalbumin, in the presence or absence 
of unlabeled palmitate. The hydrophobic properties of bovine serum albumin 
were hardly affected by methylation of the free amino groups (O'Hare & 
Nice, 1979). Table 8.1 shows that when no palmitate was present, the reco­
very of protein was 90-99% for Lipidex (both with albumin and ovalbumin), 
but only 66-87% for dextran-coated charcoal (albumin). In the presence of 
1 μΜ palmitate the recovery of 5 pg ['''C] methylated bovine serum albumin 
was 4.76 ±0.17 and 3.74 ±0.22 pg for Lipidex and dextran-coated charcoal, 
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Table 8.1. Recovery of protein after treatment with Lipidex 1000 or dextran-
coated charcoal. 
Added Added Lipidex Recovered protein (pg) 
protein or charcoal
 B o v i n e s e p m i a l b u m i n Ovalbumin 
suspension 
Lipidex 1000 Dextran-coated Lipidex 1000 
(yg) (μΐ) charcoal 
1 
2.5 
5 
5 
5 
5 
10 
50 
50 
25 
50 
75 
100 
50 
0.95 ± 0.03 
2.44 ± 0.28 
4.55 ± 0.07 
4.77 ± 0.41 
4.82 ± 0.14 
4.81 ± 0.07 
9.86 ± 0.09 
0.82 ± 0.04 
1.99 ± 0.35 
3.69 ± 0.10 
4.02 ± 0.62 
3.77 ± 0.66 
3.31 ± 0.11 
8.71 ± 0.38 
0.93 ± 0.08 
2.24 ± 0.06 
4.49 ± 0.10 
4.44 ± 0.16 
4.74 ± 0.09 
4.61 ± 0.10 
9.51 ± 0.31 
Various quantities of W-[ 1 ЦС]methylated bovine serum albumin or А7-[1ЦС]те-
thylated ovalbumin were incubated in 10 mM K-phosphate buffer (pH 7.4) for 
10 min at 370C. After cooling in ice an amount of a Lipidex or dextran-
coated charcoal suspension in buffer was added to make a final volume of 
0.5 ml. The sample was mixed thoroughly, incubated for 10 min at 0oC, and 
centrifuged (2 min, 10,000 χ g). The recovery of protein was calculated 
from the amount of '"'C radioactivity present in the supernatant. Values re­
present means ±S.D. of 4 experiments. 
respectively (means ±S.D. of 3 experiments). 
Thus, at 0 C, Lipidex 1000 selectively binds unbound fatty acids with 
a high effectiveness, whereas with dextran-coated charcoal the selectivity 
and effectiveness are much less. 
Fatty acid binding of some proteins 
Human, bovine and rat serum albumins show similar binding properties 
for palmitate (Table 8.2). The binding of [l-'^C]oleate was also similar 
for human and bovine serum, but was lower for rat serum albumin (Table 8.2). 
Human and bovine serum albumin have earlier been found to exhibit a slight­
ly higher affinity for oleate than for palmitate (Spector, 1975). The capa­
city of myoglobin to bind palmitate is comparatively low. Therefore, the 
suggestion of Gloster & Harris (1977) that myoglobin serves as a fatty acid 
carrier in muscle appears improbable (cf. chapter 11). The fatty acid bin-
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Table 8.2. Palmitate and oieate binding by various proteins. 
Protein Source Fatty acid binding (pmol/yg) 
Palmitate Oleate 
Albumin Human serum 32.1 ±1.9 38.1 ± 1.7 
Bovine serum 32.9 ± 1.6 37.7 ± 1.7 
Rat serum 30.1 ± 2.7 27.7+1.7 
Myoglobin Horse heart 3.5 ± 1.4 
Horse skeletal muscle 3.0 ± 1.0 
Binding measurements were performed with the standard assay, using 1 μΜ 
[l-1 "Ό]palmitate or [і-1цС]oleate and 5 ug protein per assay. Values repre­
sent means+S.D. of at least 4 experiments. 
ding of bovine serum albumin is hardly dependent on the composition of the 
assay medium at pH 7-8.b, but is substantially lower at pH 5.8 (Table 8.3). 
Estimation of the maximal binding capacity of bovine serum albumin and of 
cytosolic proteins of rat liver 
The described assay procedure was employed to examine the maximal ca­
pacity of fatty acid binding by bovine serum albumin. Assays were performed 
with a fixed amount of protein (0.5-5 pg) at various concentrations of 
Table .З. Effect of the assay medium on palmitate binding by albumin. 
Assay medium Palmitate binding (pmol/yg) 
10 mM K-phosphate, pH 7.4 32.9 + 1.6 
50 mM K-phosphate, pH5.8 21.6 ± 1.7 
pH 6.5 27.8 ± 3.4 
pH 7.4 33.5 ± 3.0 
pH 8.5 33.4 ± 4.3 
0.25 M sucrose, 2 mM EDTA, 10 mM Tris-HCl, pH 7.4 39.3 ± 3.7 
154 mM NaCl 34.2 ± 3.6 
The binding of 1 μΜ [Т-'^С]palmitate to 5 pg bovine serum albumin was mea­
sured with the standard assay, using the indicated media. Values are means 
±S.D. of at least 4 experiments. 
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Fig. 8.4. Palmitate binding by bovine serum albumin as a function of the 
total palmitate concentration. Assays were performed with 1 ug 
protein and various concentrations of [l-'^C]palmitate, according 
to the standard procedure, as described under Materials and 
Methods. The binding curve (left) was analyzed by the method of 
Scatchard (1949) (right). The concentration of free fatty acids 
was calculated from the initial concentration and the amount of 
protein-bound fatty acid. No correction was applied for fatty 
acid binding to the polyethylene vial. The results are shown of a 
representative experiment out of eight. 
[l-^C]palmitate (0.1-3 μΜ) and binding data were analyzed by the method 
of Scatchard (1949) (Fig. 8.4). The curvilinear Scatchard plot is comparable 
to the one obtained by equilibrium-dialysis studies (Spector, 1975). The 
apparent dissociation constants were calculated to range from 0.3 to 1.2 μΜ 
(8 experiments), which correlates with the values reported for the indivi­
dual fatty acid-binding sites of albumin (Spector, 1975). The results show 
that with the present assay relevant fatty acid-binding data can be ob­
tained . 
The fatty acid-binding capacity of dealbuminized rat liver cytosol 
was investigated in the same way. Fatty acid binding proceeded linearly 
with the amount of protein (cf. Fig. 10.1) and did not decrease after sto­
rage at -20 С (up to 6 months). Scatchard plot analysis (Fig. 8.5) revealed 
an apparent dissociation constant fC. of 1.01 +0.16 μΜ and a maximum palmi­
tate binding of 4.39 ±0.26 pmol/^g protein (means ±S.D. of 5 preparations, 
using 20-30 \ig protein per assay). 
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Fig. 8.5. Palmitate binding by the dealbuminized and delipidated 105,000 χ g 
supernatant of rat liver as a function of the total palmitate 
concentration. Assays were performed and analyzed as described in 
the legend to Fig. 8.A, except that the amount of protein used 
per assay was 23 yg. The results of a representative experiment 
are shown. The correlation coefficient r and the apparent disso­
ciation constant K^ were 0.93±0.06 and 1.01 ±0.16 μΜ, respecti­
vely (means ±S.D. of 5 preparations). 
Fatty acid binding by cytosolic protein was significantly lower with­
out delipidation when assayed at 0.2 μΜ, but not at 1 μΜ [Wc]palmitate 
(Table 8.A). The competition of endogenous fatty acids is more pronounced 
at a low palmitate concentration. Owing to this effect we obtained curvi­
linear Scatchard plots with cytosol preparations that had not been delipi­
dated (cf. Fig. 10.2). A similar effect of delipidation was observed with 
steroid receptor studies (Dahlberg et al., 1980). After a second delipida­
tion the fatty acid binding did not change further at both palmitate con­
centrations (data not shown), indicating that the binding capacity of the 
protein samples was not influenced by delipidation. 
8.4. DISCUSSION 
Lipidex 1000 is a derivative of Sephadex G-25 which contains a suf­
ficiently large number of alkyl chains to give it the properties of an or­
ganic solvent or nonpolar adsorbent, while still being sufficiently polar 
to be wetted by water (Ellingboe et al., 1970; Dyfverman & Sjövall, 1978). 
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Table 8.4. Effect of delipidation on palmitate binding by rat liver cyto-
solic proteins. 
Palmitate concentration Palmitate binding 
(pmol/pg protein) 
(цМ) 
Before delipidation After delipidation 
0.2 0.68 ± 0.15 0.92 ± 0.17 a 
1.0 2.17 ± 0.38 2.27 ± 0.27 b 
Dealbuminized rat liver cytosol was delipidated by Lipidex 1000 chromato­
graphy at 370C. Binding measurements were performed with the standard assay, 
using 0.2 or 1 yM [l-1 "Ό]palmitate and 20-30 yg cytosolic protein. Values 
are means* S.D. of 6 preparations. Values obtained before and after delipi­
dation are compared by the unpaired t-test. 
a P < 0.05 
b
 Not significant 
The gel was found to exhibit a high affinity for unbound long-chain fatty 
acids at both 0 and 37 C, and also showed an affinity for protein-bound 
fatty acids, but only at 37 or 45 С These observations are explained by 
the kinetics of protein-lipid interaction, according to which protein-bound 
fatty acids are more available for removal at a higher temperature. We ap­
plied this property of Lipidex for the delipidation of protein samples as 
well as for the assay of fatty acid binding by proteins, as is schematical­
ly illustrated in Fig. 8.6. 
For delipidation of protein samples, Lipidex 1000 appears superior to 
dextran-coated charcoal, since it does not bind protein. Therefore it can 
be adequately used for the preparation of fatty acid-free serum albumin 
(chapter 9). The assay of fatty acid-binding capacities with Lipidex 1000 
is also much more specific and accurate than with Sephadex G-25 (Ockner & 
Manning, 1974) or dextran-coated charcoal. The method appears particularly 
suitable for following purification of fatty acid-binding proteins (chapter 
11) and for studying detergent binding to membrane proteins more rapidly 
than with gel-filtration or equilibrium-dialysis techniques. 
During the course of these studies, several other investigators have 
presented alternative procedures for the assay of fatty acid binding by 
proteins. Morrow & Martin (1983) described a method, which in principal is 
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Fig. Θ.6. Schematic presentation of the use of Lipidex 1000 at 37 С for the 
delipidation of protein samples and at 0oC for the separation of 
protein-bound and unbound fatty acids. FA, endogenous fatty acid; 
*FA, labeled fatty acid. 
comparable to ours, but uses dextran-gelatin-coated charcoal for the sepa­
ration of unbound and protein-bound fatty acids. As demonstrated in this 
chapter, however, dextran-coated charcoal is disadvantageous over Lipidex, 
because of its binding properties for protein (Table 8.1; Fig. 8.3). This 
protein binding also explains the observed loss of assay sensitivity and 
linearity when the binding proteins were exposed to unsedimented charcoal 
for periods longer than 3-4 min (Morrow & Martin, 1983) (cf. Fig. 8.1). Al­
though these workers found a similar palmitate binding by bovine serum al­
bumin, when compared to our data with dextran-coated charcoal, their assay 
appears less sensitive as they apply at least 10 yg of albumin (cf. Fig. 
8.2). 
Smith et al. (1983) presented an electrophoretic technique and Keuper 
et al. (1983) a modified equilibrium-dialysis method, but both procedures 
appear more complicated and time-consuming than our assay. Fournier et al. 
(1983a(b) studied the binding capacity of pig heart FABP for spin-labeled 
fatty acid (12-doxylstearate) by electron spin resonance spectroscopy. The 
spectral changes induced by binding of the ligand were found to be of suf­
ficient amplitude to make detailed investigations possible. Although promi-
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sing, this technique appears not suitable for the routine assay of fatty 
acid binding by proteins. 
With our method we found an apparent К for palmitate binding by li­
ver cytosolic proteins, which is identical to that observed for palmitate 
with equilibrium-dialysis studies (Ketterer et al., 1976), but 3-fold lower 
than reported for oleate on the basis of coelution with cytosolic proteins 
from a gel-filtration column (Mishkin et al., 1972). Our value for К is 
also of comparable magnitude to that reported for the M 16,000 sterol 
carrier protein from rat liver (Daum & Dempsey, 1980), which protein might 
be identical to the fatty acid-binding protein (Dempsey et al., 1981; Bill-
heimer & Gaylor, 1980) (cf. chapters 10 and 11). Palmitoyl-CoA was found to 
bind to low-M cytosolic proteins with a much higher affinity than palmi­
tate (Mishkin & Turcotte, 197A; Ketterer et al., 1976). With equilibrium-
dialysis the total fatty acid-binding capacity of the liver cytosol was 
found to be only 0.1 pmol/pg protein (Ketterer et al., 1976). 
If we assume that the fatty acid binding by the cytosolic proteins 
can entirely be attributed to the M 12,000 fatty acid-binding protein 
(FABP) and that the number of fatty acid-binding sites on this protein is 
one, it appears from the maximal fatty acid binding that the cytosolic FABP 
concentration is 4.39 χ 12 = 53 pg/ing protein. By quantitative radial immu­
nodiffusion, Ockner et al. (1982) recently found the rat liver cytosol to 
contain 40-50 pg FABP/mg protein. Comparison of these values establishes 
that FABP possesses only one binding site for long-chain fatty acids per 
protein molecule (cf. chapter 11). This calculation is in accordance with 
the observations that the number of endogenous fatty acids associated with 
one molecule of the protein never exceeds one (Burnett et al., 1979; Rüstow 
et al., 1982). 
8.5. SUMMARY 
Protein-bound and unbound fatty acids can be efficiently separated at 
0oC using Lipidex 1000, a hydrophobic column-packing material, just as this 
substance can separate protein-bound and unbound steroids (Dahlberg et al., 
1980). Protein-bound fatty acids are also removed by Lipidex 1000 when 
treatment is performed at 37 C. 
Lipidex 1000 does not exhibit binding properties for soluble proteins 
at 0 and 37 С, in contrast to dextran-coated charcoal. It appears useful 
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for the delipidation of protein samples at 37 С and for a radiochemical 
assay of fatty acid binding by pg-amounts of protein at 0 C. With this 
assay we have obtained results on palmitate binding to serum albumin simi­
lar to those reported on the basis of equilibrium-dialysis. 
Delipidated proteins from dealbuminized rat liver cytosol maximally 
bind about A nmol palmitate/mg protein with а К of 1 yM. 
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CHAPTER 9 
REMOVAL OF FATIY ACIDS FROM SERUM ALBUMIN BY 
UPIDEX 1000 CHROMATOGRAPHT 
9.1. INTRODUCTION 
Defatting of serum albumin is usually performed by treatment with ac­
tivated charcoal at pH 3 and 0 C, according to the method of Chen (1967). 
Although by this procedure the protein remains native, as judged by a num­
ber of criteria (Chen, 1967), the treatment at low pH leads to an artifi­
cial broadening of the microheterogeneity of the serum albumins, probably 
as a result of some deamidation of the protein (Sogami & Foster, 1968). 
Certain irreversible changes in the albumin molecule were also observed 
after acid-charcoal treatment (Steinhardt et al., 1972). Furthermore, at pH 
around 3 a dimerization of albumin was reported to occur (Williams & Fos­
ter, I960). 
In the previous chapter we have shown that Lipidex 1000 (a 10% (w/w) 
substituted hydroxyalkoxypropyl derivative of Sephadex G-25) can be used 
for the temperature-dependent removal of fatty acids from a protein-fatty 
acid complex and for the detection and assay of fatty acid-binding pro­
teins. In this chapter we report that serum albumin can be conveniently 
freed from fatty acids by a single passage through a column of Lipidex 1000 
at 370C. 
The removal of fatty acids was studied by determining the fatty acid 
content of the albumin preparations before and after treatment. To investi­
gate fatty acid binding by the protein, we used the described radiochemical 
assay procedure in which Lipidex is applied at 0 С (chapter 8). 
* Adapted from Glatz & Veerkamp (1983b). 
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9.2. MATERIALS AND METHODS 
Treatment of Lipidex 1000 
Lipidex 1000 was washed free of methanol in a column by elution with 
10 bed volumes of 10 mM K-phosphate (pH 7.4), containing 0.01% NaNs. For 
fatty acid binding experiments the gel was transferred to a glass vial and 
stored at А С as a Lipidex-buffer suspension (1:1, v/v) containing about 
100 mg dry Lipidex/ml buffer. 
Delipidation of serum albumin 
Serum albumin was defatted as described by Chen (1967) or by Lipidex 
1000 chromatography. For the latter 0.5 g of serum albumin was dissolved in 
5 ml of distilled water and applied to a column of Lipidex (3.0 χ 15 cm) 
equilibrated with water at 37 С (thermostated column; flow rate, 150 ml/h). 
Elution of the protein was performed with water, and the protein was re­
covered in the void volume. The protein content of the eluant was deter­
mined as described in section 2.3. 
The column was reused after thorough washing with methanol (chapter 
8). After defatting, the serum albumin preparations were dialyzed against 
physiological saline (60 h) and distilled water (6 h) in order to remove 
the relatively large amounts of citrate, present in commercial albumin (Lo-
pes-Cardozo & Van den Bergh, 1972; Hanson & Ballard, 1968). The prepara­
tions were neutralized with 0.2 M К0Н, if necessary, and lyophilized. 
détermination of fatty acid content and of fatty acid binding 
For determination of the fatty acid content, portions of 100 mg of 
the preparations were dissolved in 1 ml of distilled water and subjected 
to lipid extraction according to Dole & Meinertz (section 2.3). Fatty acids 
were assayed radiochemically using 63Ni as tracer, as described in section 
2.3 . Fatty acid content was calculated on the basis of a molecular weight 
of bovine serum albumin of 68,000. 
Samples of 2 or 5 pg albumin were assayed for fatty acid binding 
according to the procedure described in chapter 8. The binding of [l-'^Cj-
palmitate was measured at 0.1, 1 and b μΜ, and is expressed as pmol/pg pro­
tein. 
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Table 9.1. Removal of fatty acids from bovine serum albumin by acid-charcoal 
treatment or Lipidex chromatography. 
Preparation Fatty acid content 
(mol/mol protein) 
Palmitate binding 
(pmol/pg protein) 
0.1 μΜ 
palmitate 
1 μΜ 
palmitate 
Α μΜ 
palmitate 
Fraction V, Sigma 
Lot 80 F-0508 
(untreated) 
0.496 ±0.070 
After charcoal t reatment 0.036 ±0.009 
a t pH 3 and 0OC 
After Lipidex 1000 chro- 0.049 ±0.010 
matography a t 37 С 
14.3±1.0 35.5±2.2 75.9±4.3 
1A.4±1.3 35.0 + 3.1 79.7 + 4.6 
15.4 + 0.7 39.4 + 2.1 89.3±10.6 
Fatty acids were extracted from the protein samples and assayed radiochemi-
cally with the use of 6 3Ni as tracer. The binding of [l-1 "Ό]palmitate was 
measured at 0.1 μΜ with 2 μg albumin and at 1 and 4 μΜ with 5 μg albumin. 
Values represent means! S.D. of 4 experiments. 
9.3. RESULTS AND DISCUSSION 
Untreated serum albumin was found to contain about 0.5 mol fatty acid 
per mol protein (Table 9.1). This content is comparable to that reported 
previously for various commercial albumin preparations (Chen, 1967) '. After 
charcoal treatment and also after Lipidex 1000 chromatography at least 90% 
of the fatty acids were removed (Table 9.1), indicating that both methods 
are suitable for defatting serum albumin. Lipidex 1000 chromatography at 
37 С has, however, some advantages over the acid-charcoal treatment proce­
dure. The former procedure is milder and more rapid, since the harmful low 
pH step and the centrifugation step are avoided. Furthermore, with charcoal 
1
 Bovine serum albumin obtained from Merck (Darmstadt, F.R.G.; Lot 0072449) 
was found to contain 3.14 + 0.43 mol fatty acid per mol protein (mean ± S.D., 
3 determinations). We have not attempted to delipidate this preparation by 
either procedure. 
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treatment protein recovery was in our hands 75-80%, as also reported by 
Soagami 4 Foster (1968). With Lipidex 1000 chromatography the recovery 
amounted to 94 ± 3% (meant S.D. of 4 determinations). A comparable protein 
recovery was obtained after chromatography on Lipidex of w-[14C]methylated 
bovine serum albumin (section 8.3). 
The maximal fatty acid-binding capacity of Lipidex was estimated by 
chromatography at 37 С of a complex of [WOjpalmitate to bovine serum al­
bumin (molar ratio 1:1) and found to be 40-50 nmol/ml packed gel. Other 
lipid impurities, such as phospholipids and cholesterol, present in most 
commercially available albumin preparations (Fainaru et al., 1981), will 
also be removed by Lipidex chromatography, since the gel shows high affini­
ty for lipids and steroids (Dahlberg et al., 1980). 
The ability of serum albumin to bind fatty acids was determined with 
the assay procedure described in chapter 8. At the palmitate concentrations 
tested (0.1, 1 and 4 yM) the fatty acid binding did not change significant­
ly after charcoal treatment nor after Lipidex chromatography, when compared 
to the binding by untreated albumin (Table 9.1). Also after a second pas­
sage through the Lipidex column identical fatty acid-binding values were 
obtained at the three palmitate concentrations (data not shown), indicating 
that the binding capacity of the albumin preparation was not influenced by 
the chromatographic procedure. The values obtained at Α μΜ palmitate cor­
respond to a palmitate¡albumin molar ratio of 5-6, which is comparable to 
the ratio measured with equilibrium-dialysis (Spector, 1975). 
A lower fatty acid binding with the untreated albumin preparation, 
especially at a lower palmitate concentration, would be expected due to 
competition of endogenous fatty acids. With rat liver cytosolic proteins 
fatty acid binding was significantly lower before delipidation, when as-
sayed at 0.2 μΜ, but not at 1 μΜ [l-'^C]palmitate (Table 8.4, page 129). 
However, this competition can not be detected with the commercial albumin 
preparation, since the amount of endogenous fatty acids present (0.5 mol/ 
mol protein, Table 9.1) was relatively low. Also, due to its high fatty 
acid-binding capacity, the amount of albumin which can be applied in the 
assay is restricted in relation to the free fatty acid concentration in or­
der to maintain a linear dependence in the assay. 
The results show that fatty.acids can be adequately removed from se­
rum albumin preparations by chromatography at 37 С on a column of Lipidex 
1000 without loss of protein and with maintenance of the fatty acid-binding 
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capacity. If desired, the adsorbed fatty acids can be eluted with methanol 
(Dahlberg et al., 1980; chapter θ) for further analysis. The method also ap­
pears to be useful for delipidation of other lipid-binding or lipid-trans-
ferring proteins and membrane proteins, and is of value particularly when 
the availability of protein is limited. 
Recently, Nakano et al. (1983) described the use of activated carbon 
beads for the chromatographic removal of residual fatty acids from albumin. 
Although it was shown that albumin is not retained by the beads, a low pH 
was still necessary for the complete removal of the fatty acids. 
9.4. SUMMARY 
Fatty acids can be effectively removed from serum albumin prepara­
tions by a single passage through a column of Lipidex 1000 at 37 C. The 
procedure is easier and milder and shows a better (nearly quantitative) 
recovery of protein than acid-charcoal treatment. The ability for fatty 
acid binding by the protein is not affected by either procedure. 
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CHAPTER 10 
DIURNAL VARIATION OF CYTOSOUC FATTY ACID-BINDING PROTEIN 
CONTENT AND OF РАШІГАТЕ OXIDATION IN RAT LIVER AND HEART, 
AND THE EFFECT OF CHOLESTYRAMINE FEEDING* 
10.1. INTRODUCTION 
Fatty acid-binding protein (FABP), which is found in the cytosol of 
many eucaryotic cells, exhibits a high affinity for long-chain fatty acids 
and their corresponding coenzyme A thioesters and therefore is considered 
to function in the intracellular fatty acid utilization (Ockner et al., 
1972; Mishkin et ai., 1972). The rather high concentration of this M 12,000 
protein in liver (Ockner et ai., 1982) suggests that it may also serve for 
storage of fatty acids and their derivatives. In liver and intestine, modu­
lations of the rates of fatty acid uptake or utilization, in response to 
nutritional, hormonal and pharmacological manipulations, correlated with 
changes in the cytosolic content of FABP (Mishkin et ai., 1975; Fleischner 
et ai., 1975; Renaud et ai., 1978; Burnett et ai., 1979; Ockner et ai., 1979, 
1980). There is a growing amount of evidence that FABP is similar, if not 
identical, to sterol carrier proteinι (SCP!) in physical and molecular pro­
perties and in tissue distribution (Billheimer & Gaylor, 1980; Dempsey et 
ai., 1981). SC?i is required for activation of membrane-bound enzymes cata­
lyzing cholesterol synthesis and metabolism to bile acids and steroid hor­
mones (Dempsey, 1974; Snkantaiah et ai., 1976; Billheimer & Gaylor, 1980; 
Song & Dempsey, 1981). Recently, Dempsey et ai. (1980) reported that in li­
ver SCPj undergoes a significant diurnal variation corresponding in time 
to that of major enzymes in lipid metabolism, such as hydroxymethylgluta-
ryl-CoA reductase (Shapiro & Rodwell, 1969; Rodwell et ai., 1976) and methyl 
sterol oxidase (Spence & Gaylor, 1977). The hepatic SCP1 content varied 
from 1 to 10% of the total cytosolic protein during a 24 h light-dark cycle 
* Adapted from Glatz et ai. (1983b) and Kempen et ai. (1983b). 
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and is probably regulated at the level of translation of SCP1-mRNA (McGuire 
et al., 1983). 
In this chapter we show that rat heart cytosol contains a previously 
unrecognized fatty acid-binding capacity, which is similar to that of liver 
cytosol, and furthermore that this capacity exhibits a diurnal rhythm in 
both heart and liver, being about 2-fold higher at the mid-dark than at the 
mid-light phase of the light cycle. In concert, the palmitate oxidation ca-
pacity and the citrate synthase activity were significantly elevated during 
the dark period in both tissues. The results provide further evidence for a 
potential role of FABP in cellular fatty acid utilization and for its simi-
larity with SCPx. 
In addition, we also studied the effect of cholestyramine feeding on 
the fatty acid-binding capacity of the liver cytosol and its diurnal varia-
tion. The bile salt séquestrant cholestyramine not only increases the rate 
of hepatic cholesterol and bile acid synthesis (e.g. Kempen et al., 1982, 
1983a), but also increases the plasma level and the hepatic synthesis of 
triacylglycerols and of very low density lipoproteins (Nestel & Grundy, 
1976; Witztum et al., 1976; Angelin et al., 1978; Adler et al., 1978; Kempen 
et al., 1982). It appeared plausible to us that this effect of cholestyrami-
ne feeding is mediated by a rise in the cytosolic content of FABP, because 
of the above-mentioned similarity of FABP with SCPi, and since FABP stimu-
lates hepatic synthesis of triacylglycerols in cell-free systems (O'Doherty 
& Kuksis, 1975; Burnett et al., 1979; Iritani et ai., 1982). 
10.2. MATERIALS AND METHODS 
Preparation of cytosol 
Male albino Wistar rats, weighing 180-220 g, were mainained on a cycle 
of alternating 12-h periods of light and darkness and were sacrificed at 
the midpoint of the light or of the dark period. The rats were fed ad libi-
tum on a control or cholestyramine-containing diet, as described in section 
2.1. Hat liver and heart cytosol were prepared as described in section 2.2. 
The amount of residual albumin present in the liver cytosol prepara-
tions was found to be negligible, as judged by cross-over electrophoresis 
against rabbit anti-rat albumin antiserum. The heart cytosol preparations, 
however, initially still contained some albumin, which was removed by pas-
sage at 4 С through an affinity column of the immunoglobulin G fraction of 
140 
í Dealbuminized су 
RA Ra /alb 
Untreated cytosol 
Fig. 10.1. Immunoelectrophoresis of cytosolic proteins from rat heart, be­
fore and after dealbuminization. About 1 yg of protein was 
placed in the center well and subjected to electrophoresis (pH 
8.2). Rabbit anti-rat albumin antiserum (RARa/alb) was then 
placed in the trough and allowed to diffuse in the direction of 
the separated proteins. The precipitin line indicates the pre­
sence of rat albumin. The results are shown of a representative 
experiment. 
rabbit anti-rat albumin antiserum bound to Protein A-Sepharose CL-4B. The 
complete removal of albumin after this treatment was confirmed by both 
cross-over electrophoresis and Immunoelectrophoresis (Fig. 10.1). 
For delipidation of the cytosolic proteins, portions of about 30 mg 
protein were subjected to chromatography on a column of Lipidex (1 χ 15 cm), 
equilibrated with 10 mM K-phosphate buffer (pH 7.4) at 37 C. Elution was 
performed with the same buffer (flow rate 20 ml/h). All protein was present 
in the void volume. 
Assays 
Fatty acid binding by cytosolic protein was assayed according to the 
method described in chapter 8. Protein samples were incubated in 10 mM K-
phosphate buffer (pH 7.4) with various concentrations of [l-^CJpalmitate. 
Fatty acid binding is expressed as pmol/pg protein. The binding curves were 
analyzed by the method of Scatchard (1949). The concentration of free fatty 
acids was calculated from the initial concentration and the amount of pro­
tein-bound fatty acid. No correction was applied for fatty acid binding to 
the polyethylene vial (cf. section 8.3). 
Palmitate oxidation was measured with 25 μΐ (heart) or 50 yl (liver) 
whole homogenate (5%, w/v) as described in section 3.2. Assays of protein 
and of citrate synthase activity are described in section 2.3. 
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10.3. BESULTS 
Palmitate binding by cytosolic protein 
The binding of palmitate increased proportional to the amount of pro­
tein at both 0.2 and 1 μΜ [і-ІЦС]palmitate (up to the binding of about 
50-60% of the available palmitate; cf. Fig. 8.2), only when delipidated 
protein samples were used (Fig. 10.2). With cytosol preparations that had 
not been delipidated a non-linear relationship was observed, and at a 
higher amount of protein the palmitate binding was underestimated to an in­
creasing extent. This underestimation is due to label dilution by endoge­
nous fatty acids and possibly also to competition by endogenous ligands, 
other than fatty acids, which were also found to be associated with cytoso-
0.2 JL/M PALMITATE 1.0 μΜ PALMITATE 
Cytosolic protein (μς) 
Fig. 10.2. Effect of delipidation on the dependence of palmitate binding on 
the amount of cytosolic protein. Various amounts of non-delipi-
dated (·) and of delipidated (o) liver cytosolic protein were 
assayed for palmitate binding in the presence of 0.2 μΜ (left) 
and 1.0 μΜ (right) [і-1цС]palmitate. The results are shown of 
one representative experiment out of three, using the liver cy­
tosol obtained from rats sacrificed at the mid-dark phase of the 
light cycle. With cytosol preparations from rat heart similar 
results were obtained (data not shown). 
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Fig. 10.3. Scatchard analysis of the binding of palmitate by delipidated 
liver cytosol from control (left) and cholestyramine-fed (right) 
rats sacrificed at the mid-dark (o) or at the mid-light (·) 
phase of the light cycle. Cytosolic protein samples were incu­
bated with 0.1-3 μΜ [l-^Cj palmitate an after equilibration 
protein-bound and unbound palmitate were separated by the use of 
Lipidex at 0oC. The results are shown of representative experi­
ments, in which 20 pg (control diet) and 18 pg (cholestyramine 
diet) of protein were used per assay. 
lie FABP (Burnett et al., 1979; Ockner et al., 1982; Rüstow et al., 1982). 
This competition is more pronounced at higher protein and lower palmitate 
concentrations (Fig. 10.2). Palmitate binding did not decrease after sto-
rage of the protein samples at -20 С (up to 6 months). 
With the delipidated cytosol of liver and heart, obtained from rats 
sacrificed at the mid-dark or at the mid-light phase of the light cycle, we 
studied the binding of palmitate by cytosolic protein as a function of the 
total palmitate concentration. Scatchard plot analysis of the binding iso­
therms revealed the presence of a single class of saturable binding sites 
on the cytosolic proteins from both tissues (Figs. 10.3 and 10.4). At the 
mid-dark phase both the liver and heart cytosol contain a significantly 
higher capacity for palmitate binding per yg protein than at the mid-light 
period (Figs. 10.3 and 10.A; Table 10.1). With both types of cytosol prepa­
rations, however, half-maximal saturation is reached at the same palmitate 
concentration (1 and 0.8 yM for rat liver and heart, respectively). These 
findings suggest that at the mid-dark phase the liver and heart cytosol 
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Table 10.1. Diurnal variation of palmitate binding by cytosolic protein and 
of endogenous fatty acid content of the cytosol in rat liver 
and heart. 
Tissue Diet Condition Palmitate binding Endogenous 
free fatty acid 
content 
B_ Apparent K. max r^ d 
(pmol/pg protein) (μΜ) (pmol/pg protein) 
Liver Control Light (3) 3.92 ± 0.38 1.04 ± 0.15 1.47 ± 0.25 
Dark (3) 7.20 + 0.39 0.98 ± 0.14 1.68 ± 0.53 
Cholesty- Light (7) 6 . 0 3 ± 0 . 6 7 1.06 ± 0 . 2 2 1 . 8 1 + 0 . 2 3 
ramine Dark (4) 6.79 ± 0.48 0.90 ± 0.10 1.37 ± 0.53 
Heart Control Light (4) 3.49 ± 0.39 0.83 ±0.11 1.91 ± 0.22 
Dark (3) 8.02±0.70 b 0.80 ±0.25 2.87±0.18 ; 
Data on palmitate binding are derived from Scatchard analysis of individual 
binding isotherms, as shown in Fig. 10.3 (liver) and Fig. 10.4 (heart). The 
amounts of delipidated protein used per assay were 15-25 pg. 
For determination of the endogenous free fatty acid content, samples of 20-
40 mg cytosolic protein were subjected to lipid extraction according to the 
method of Dole & Meinertz (I960). Phospholipids then were removed from the, 
free fatty acids by binding to silicic acid. Thereafter the fatty acids 
were assayed radiochemically using 6 3Ni as tracer, as described in section 
2.3. For comparison, the fatty acid content is also expressed as pmol/yg 
protein. 
All values represent means ±S.D. of the number of separate preparations 
given within parentheses. Values are compared by the unpaired t-test. 
aP< 0.01, dark versus light 
P< 0.001, dark versus light 
c
 Ρ< 0.001, cholestyramine diet versus control diet (light period). 
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Fig. 10.A. Scatchard analysis of the binding of palmitate by the dealbumi-
nized and delipidated heart cytosol from rats sacrificed at the 
mid-dark (o) or at the mid-light (·) phase of the light cycle. 
The results are shown of representative experiments, using 18 pg 
of protein per assay. For further experimental details, see the 
legend to Fig. 10.3. 
contain 1.8- and 2.3-fold more binding sites, respectively, but on the 
same molecular species (Table 10.1). Since at the mid-dark phase of the 
light cycle the rat liver weight is about 1.5 -fold higher than at the mid-
light phase (Seifert, 1980), the total amount of fatty acid-binding sites 
expressed per whole liver even shows a 2.7 -fold diurnal variation. 
When the cytosolic proteins were fractionated by chromatography on 
Sephadex G-75, the major fatty acid-binding fraction eluted at the same po­
sition with all preparations examined (Fig. 10.5). This fraction corres­
ponds to M 12,000-14,000 and contains FABP (Fournier et ai., 1978; Ockner 
et al., 1982). The specific palmitate binding activity of this fraction was 
also 1.5-2-fold higher in the cytosol preparations from rats sacrificed 
at the mid-dark compared to the mid-light phase, amounting to 28-36 and 
20-23 pmol/yg protein, respectively, for the liver cytosol, and to 10-12 
and 6-8 pmol/yg protein, respectively, for the heart cytosol. The specific 
binding capacities are under both conditions lower in heart than in liver, 
due to the relatively higher content of low-M proteins (e.g. myoglobin) 
of heart muscle (Fig. 10.5). The small fatty acid-binding fraction of н 
г 
1500-2000, which contains a fatty acid-binding peptide (Suzue & Marcel, 
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Gel-filtration on Sephadex G-75 (1.6 χ Θ5 cm) of 10 and 5 mg 
delipidated cytosolic protein from liver (this page) and from 
heart (facing page), respectively, of rats sacrificed at the 
mid-dark or at the mid-light phase of the light cycle. 
Elution was performed at 40C with 10 mM K-phosphate buffer (pH 
7.4). The flow rate was 20 ml/h and the fraction volume 3.7 ml. 
All fractions were assayed for protein (·) and for palmitate 
binding (о). For the latter 50-200-μΐ samples and 1 μΜ [l-^C]-
palmitate were used. 
Arrows indicate the elution positions of calibration proteins: 
A, rat serum albumin; B, ct-chymotrypsinogen; C, horse skeletal 
muscle myoglobin and D, horse heart cytochrome c. 
The recoveries of protein as well as of fatty acid-binding acti­
vity from the column were 85-95%. The results are shown of one 
representative experiment out of three. 
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1975; Rüstow et al., 1978, 1979), did not show a significant diurnal rhythm 
(Fig. 10.5). These results show that the higher palmitate binding capacity 
per \ig of protein of both the rat liver and heart cytosol during the dark 
relative to the light period can be attributed to a higher content of FABP 
or to an increased availability of the fatty acid-binding site(3) on this 
protein. The former possibility is most likely since modulation of the he-
patic content of FABP is known to occur in several conditions involving 
nutritional, hormonal and pharmacological manipulations (Mishkin et al., 
1975; Fleischner et al., 1975; Renaud et al., 1978; Burnett et al., 1979; Ock-
ner et al., 1979, 1980), whereas no evidence is available on the regulation 
147 
04 
0 3 
Q2-
cholestyramine diet 
f-ISOO 
1000 
20 30 40 50 
500 
о 
control diet 
0 
HSOO 
-1000 
500 
H1 
С 
-δ 
οι 
о 
f 
40 50 
Fraction number 
Fig. 10.6. Gel-filtration on Sephadex G-75 of 10 mg liver cytosolic protein 
from control and cholestyramine-fed rats sacrificed at the mid-
light phase of the light cycle. 
All fractions were assayed for protein (·) and for palmitate 
binding (o). The results are representative for three indepen­
dent experiments with each group of rats. 
See the legend to Fig. 10.5 (page 144) for further details. 
148 
of the availability of the fatty acid-binding sitéis) of FABP. 
By comparison of the maximal fatty acid binding by rat liver cytoso-
lic proteins with the cytosolic FABP concentration as found by Ockner et al. 
(1982) on basis of quantitative radial immunodiffusion studies, we esta-
blished (section 8.4) that FABP possesses only one fatty acid-binding site 
per protein molecule (cf. section 11.3). As FABP accounts for 75-85% of the 
fatty acid binding of our cytosol preparations (Fig. 10.5) and has а м of 
12,000 (Ockner et al., 1982), the cytosolic FABP concentration can be esti­
mated from the maximal fatty acid binding (Table 10.1). It appears that in 
liver the cytosolic FABP concentration amounts to about 40 and 70 yg/mg 
protein at the mid-light and the mid-dark phase of the light cycle, respec­
tively, and in heart to about 35 and 80 μg/mg protein, respectively. 
Effect of cholestyramine feeding 
Cholestyramine feeding increased the palmitate binding capacity of 
the delipidated liver cytosol at the mid-light phase about 1.5 -fold (Fig. 
10.3; Table 10.1). Sephadex G-75 chromatography of the cytosolic proteins 
revealed that this increase can also be attributed to an elevation of the 
content or binding activity of FABP (Fig. 10.6). Cholestyramine feeding 
did, however, not further increase the palmitate binding capacity of the 
liver cytosol at the mid-dark phase, so that with this diet there is no 
significant diurnal variation of hepatic FABP activity. It is plausible 
that the levels of palmitate binding capacity reached during the dark 
period or after cholestyramine feeding represent a maximum. 
Endogenous fatty acid content 
Since endogenous fatty acids are considered to be mainly present as­
sociated with FABP, we also examined the possible diurnal variation of the 
fatty acid content of liver and heart cytosol. In liver the cytosolic 
fatty acid content did not differ between the dark and the light period, 
nor between cholestyramine-fed and control animals, and amounted to 1.4-
1.8 nmol/mg protein (Table 10.1). Burnett et al. (1979) also reported a 
fatty acid content of 1.4 nmol/mg protein for liver cytosol of rats sacri­
ficed during the light period. The cytosolic fatty acid content of heart 
was at the mid-light phase of the cycle comparable to that of liver, but 
significantly higher at the mid-dark phase (Table 10.1). Comparison of 
these values with the palmitate binding capacity of the various prepara-
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tions (Table 10.1) reveals that under all conditions examined the degree of 
occupancy of the available binding sites did never exceed 50%. In liver, 
the degree of occupancy drops to about 20% at the mid-dark period of the 
light cycle. 
The yield of cytosolic protein amounted to 25-35 and 15-20 mg/g wet 
weight tissue for rat liver and heart, respectively, so that at the mid-
light phase the endogenous fatty acid content is about 40-55 and 30-40 nmol 
/g wet weight tissue, respectively. For heart this value is of the same or-
der of magnitude as the nonesterified fatty acid concentration reported by 
others (Garland & Rändle, 1963; Kramer & Hulan, 1978; Van der Vusse et al., 
1980). 
Table 10.2. Diurnal variation of palmitate oxidation and citrate synthase 
activity in rat liver and heart. 
Tissue Condition Palmitate oxidation Citrate synthase 
activity 
/g wet wt /unit citrate unit/g wet wt 
synthase 
Liver Light (5) 
Dark (7) 
366 ± 28 
508 t 39' 
31.7 ± 3.1 
32.5 ± 1.9 
11.6 ± 0.4 
15.6 ± 1.1 
Heart Light (7) 
Dark (7) 
733 ± 47 
824 ± 31 
10.04 + 1.03 
8.88 ± 0.63 
71.6 ± 4.9 
93.0 ± 5-9' 
Oxidation rates were measured with 120 μΜ [l-'^C]palmitate bound to albumin 
(molar ratio 5:1), and were calculated from the sum of the production of 
'••СОг and 1цС-1аЬе1еа acid-soluble products. Values represent means ± S.D. 
of the number of preparations given within parentheses. Values are compared 
by the unpaired t-test. 
a P < 0.001, dark versus light 
P< 0.01, dark versus light 
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Palmitate oxidation and citrate synthase activity 
With homogenates of rat liver and heart palmitate oxidation proceeded 
proportional with time of incubation and amount of tissue material. The 
oxidation was measured at concentrations of substrate, coenzymes and cofac-
tors that gave maximal oxidation rates (Van Hinsbergh et al., 1978a; section 
3.3). In both liver and heart the palmitate oxidation capacity, expressed 
per g of tissue, was significantly increased at the mid-dark compared to 
the mid-light phase of the light cycle (Table 10.2). The citrate synthase 
activity showed a similar increase in both tissues, so that when the oxida­
tion rates are expressed relative to this mitochondrial marker enzyme, 
hardly any diurnal changes are observed (Table 10.2). These results indi­
cate that the diurnal fluctuations of the palmitate oxidation capacity are 
related to fluctuations of total mitochondrial activity in both tissues. 
10.4. DISCUSSION 
Both immunochemical and non-immunochemical methods have been applied 
for the estimation of the total fatty acid-binding capacity of the cytosol 
or the quantitation of FABP (cf. Ockner et al., 1980, 1982). The former pro­
cedure requires the availability of precipitating antibodies reactive to 
all forms of FABP that may be present in the cytosol. There is now evi­
dence, however, for molecular heterogeneity of FABP in liver (Ketterer et 
ai., 1976; Trulzsch & Arias, 1981; Morrow & Martin, 1980, 1983). Although 
some forms of FABP cross-reacted with monospecific antibodies raised 
against them (Trulzsch & Arias, 1981), at least one hepatic form was found 
to be not highly antigenic (Morrow & Martin, 1983). The various forms may 
furthermore exhibit a different affinity for long-chain fatty acids (cf. 
Ketterer et al., 1976; Trulzsch Ь Arias, 1981). A non-immunochemical method, 
such as the assay used in this study, may be of more physiological inte­
rest, since it provides a functional quantitation of the cytosolic fatty 
acid-binding activity. 
Few laboratories have to date reported on FABP of heart cytosol 
(Mishkin et al., 1972; Fournier et al., 1978, 1983a,b; Rüstow et al., 1982), 
although its presence in heart muscle was established already in the first 
report on FABP (Ockner et al., 1972). Quantitative data on cardiac FABP were 
only presented in two papers (Mishkin et al., 1972; Rüstow et al., 1982). 
Miskin et al. (1972) reported that the relative amount of oleic acid that 
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coelutes with the FABP-containing fraction upon gel-filtration of cytoao-
lic proteins was for rat heart about 30% of that of rat liver. This com-
parison is, however, of only limited value since the preparations may have 
contained different amounts of albumin and, as delipidation was omitted, of 
endogenous ligands, and since the applied assay method is rather inaccurate 
due to the high affinity of the fatty acids for the gel itself. Rüstow et 
al. (1982) used an antibody raised against purified rat liver FABP and es-
timated that rat heart cytosol contains a 10-fold lower amount of FABP than 
liver cytosol. The former amount has likely been underestimated since the 
physical and molecular properties of FABP from rat heart and liver are dif-
ferent (chapter 11), and immunochemical cross-reactivity might therefore be 
low. Myoglobin has also been suggested to act as a fatty acid-binding pro-
tein in muscle (Gloster & Harris, 1977; Harris et al., 1980), but this ap-
pears unlikely because of its low fatty acid-binding affinity (Table 8.2, 
page 124) and the fact that upon ion-exchange chromatography of rat heart 
cytosol, FABP (M 12,000) is completely separated from myoglobin (Fournier 
et al., 1978; chapter 11). Using albumin-free and delipidated rat heart cy-
tosol preparations we found with our assay a similar palmitate binding ca-
pacity as in liver cytosol in both phases of the light cycle. As the pal-
mitate binding could almost entirely be attributed to proteins of M 
12,000-14,000, it was calculated that FABP will make up about 4-8% of the 
rat heart soluble proteins. This abundance of FABP as well as its known 
properties support the view that also in heart muscle this protein plays an 
important regulatory role in lipid metabolism. In heart FABP may act as a 
protector for the detrimental effects of high intracellular levels of long-
chain fatty acids and fatty acyl-CoA thioesters that occur during ischaemia 
and hypoxia (Severson, 1979; Katz & Messineo, 1982). 
The apparent dissociation constant of palmitate binding by liver cy-
tosolic protein of about 1 μΜ is identical to that observed with equili­
brium-dialysis studies (Ketterer et al., 1976), but is threefold lower than 
that reported for oleate on the basis of gel-filtration experiments (Mish-
kin et al., 1972). With equilibrium-dialysis, the total fatty acid-binding 
capacity of liver cytosol was found to be only 0.1 pmol/yg protein (Kette­
rer et al., 1976). Purified FABP from pig heart showed an apparent dissocia­
tion constant for palmitate of 0.85 μΜ, as measured by electron spin reso­
nance spectroscopy (Fournier et ai., 1983a). This value is similar to that 
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found for rat heart cytosol (Table 10.1). 
The simultaneous rise of the capacities of cytosolic fatty acid bin­
ding and of palmitate oxidation during the dark relative to the light 
period in both liver and heart corresponds to the concomitant changes of 
these parameters in various other conditions. The higher FABP concentration 
in cytosol from livers of female compared to male rats (Ockner et al., 1980, 
1982) correlated with a higher oleate oxidation by hepatocytes obtained 
from the female rats (Ockner et al., 1980). The 2-fold rise of the hepatic 
FABP concentration observed after Clofibrate administration (Fleischner et 
ai., 1975; Renaud et al., 1978; Kawashima et ai., 1982) is also paralleled by 
a 2.5 -fold rise of the palmitate oxidation capacity (chapter 6). Finally, 
during diabetes or starvation, both the total capacity of oleate binding 
to liver cytosolic proteins (Brandes & Arad, 1983) and the hepatic fatty 
acid oxidation (McGarry et ai., 1975; chapter 6) increase markedly. We found, 
however, no evidence for the presence of a fatty acid-binding component of 
M 400,000 during the dark period, as observed during diabetes or starva­
tion (Brandes & Arad, 1983). 
The 2-fold diurnal variations of the cytosolic FABP content in liver 
and heart (Table 10.1) are smaller than the 10-fold diurnal fluctuation 
found for SCPi in liver (McGuire et ai., 1983). However, the maximum levels 
are of comparable magnitude, amounting to 70-80 (FABP) and about 100 (SCP1; 
McGuire et ai., 1983) pg/rag protein. Feeding rats a cholestyramine contai­
ning diet results in an increase of both the rate of triacylglycerol syn­
thesis from [и-1ЦС]palmitate and from [1,3-3H]glycerol in hepatocytes 
(Kempen et ai., 1983b), and of the FABP content of liver cytosol, when the 
rats are sacrificed during the light period (Table 10.1). This suggests 
that the binding protein is involved in modulation of fatty acid incorpo­
ration into triacylglycerols. 
Recently. Morin et ai. (1982) showed that feeding of cholestyramine 
to adult rats increased the activities of hepatic SCPi and SCP2. Further­
more, Dempsey et ai. (198O) found an increase of similar size in SCPi level 
induced by partial ileal bypass, a manoeuvre also resulting in breaking the 
bile salt enterohepatic circulation. The virtual disappearance of the diur­
nal rhythm of the amount of FABP upon cholestyramine administration may 
relate to the finding that the amplitude of the diurnal rhythm of hepatic 
cholesterogenesis was markedly decreased after cholestyramine feeding (Weis 
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& Dietschy, 1975). All these results are compatible with the idea that FABP 
and SCPi are closely related or identical proteins, as suggested already by 
others (Billheimer & Gaylor, 1980; Dempsey et ai., 1981; Ockner et al., 1982). 
In heart, the diurnal fluctuation of the cytosolic content of FABP is 
accompanied by a change in that of endogenous fatty acids. In liver, we did 
not observe such a combination, as the cytosolic fatty acid content did not 
differ between the dark and the light period. This may be due to the bin-
ding by FABP of other lipidie compounds, such as mono-, di- and triacylgly-
cerols and cholesterol and its precursors (Burnett et al., 1979; Ockner et 
al., 1932; Rüstow et al., 1982). Evidence for the binding of compounds other 
than fatty acids is also obtained from a comparison of the palmitate bin-
ding by delipidated and non-delipidated cytosolic proteins (Fig. 10.2). If 
fatty acids were the only endogenous ligands present on FABP, their amount 
can be estimated from the observed degree of label dilution to be about 2 
nmol/mg protein in liver cytosol, which amount is higher than the measured 
value (1.4-1.7 nmol/mg protein). 
Diurnal changes of palmitate oxidation capacity and of citrate syn-
thase activity, as we observed in liver and to a lesser extent also in 
heart, were to our knowledge not earlier reported. A diurnal variation of 
the triacylglycerol and free fatty acid content of total rat heart has been 
found by Garthwaite et al. (1979), but with maximal levels at the very be-
ginning of the dark period and no differences between the mid-dark and mid-
light levels. Hepatic fatty acid synthesis is known to show a diurnal 
rhythm with a peak activity during the dark period (Kimura et al., 1970). 
The established correlation between the fatty acid oxidation capacity and 
the FABP content, and the demonstration that FABP-bound fatty acids can be 
transferred to the mitochondrial 0-oxidative system (Fournier et al., 1978) 
indicate that FABP participates in the regulation of fatty acid metabolism 
and especially of oxidation. The high fatty acid-binding capacity in both 
liver and heart suggests that further studies on the role of FABP in these 
metabolically different tissues are of much interest. 
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10.5. SUMMARY 
Delipidated proteins from albumin-free liver and heart cytoaol ob­
tained from rats sacrificed at the mid-dark or the mid-light phase of the 
light cycle were assayed for their palmitate binding capacity. In both tis­
sues a marked variation of this binding capacity was observed from about 
3-4 nmol/mg protein in the mid-light phase of the cycle to about 7-8 nmol/ 
mg protein in the mid-dark phase. 
Sephadex G-75 chromatography of the cytosolic proteins revealed that 
the palmitate binding could in all cases almost entirely be attributed to 
proteins of M 12,000-IA,000, suggesting that the observed diurnal varia­
tions are related to differences in the content of fatty acid-binding pro­
tein (FABP). In both rat liver and heart FABP represents about к (mid-
light) to 8% (mid-dark) of the total soluble proteins. 
Cholestyramine feeding increased the FABP content of liver cytosol 
from rats sacrificed at the mid-light phase, but not in those sacrificed 
at the mid-dark phase, in such a way that the diurnal variation of the FABP 
content virtually disappeared. 
The palmitate oxidation capacity and citrate synthase activity also 
exhibited a concomitant diurnal periodicity in rat liver and, to a lesser 
extent, in rat heart. 
The results provide additional evidence for an important role of FABP 
in cellular fatty acid metabolism in both liver and heart and for the simi­
larity of FABP with sterol carrier protein. 
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CHAPTER 11 
PURIFICATION AND CHARACTERIZATION OF FATTY ACID-BINDING 
PROTEIN FROM RAT HEART AND UVER 
11.1. INTRODUCTION 
Fatty acid-binding protein (FABP) has now been purified and characte-
rized from a number of tissues of several animal species and man, although 
most attention was paid to the protein from rat liver (see section 1.5). 
All proteins studied so far were found to have a similar molecular weight 
(11,000-15,000), but showed isoelectric points varying from 4.8 to 7.6 
(Table 1.3). In addition, several groups reported that purified rat liver 
FABP preparations comprise three proteins with an identical M , but with 
different pi values (Ketterer et al., 1976; Billheimer & Gaylor, 1980; 
Trulzsch & Arias, 1981). However, evidence is accumulating that rat liver 
FABP is a virtually neutral protein (pi 7.0-7.5) and that the acidic forms 
represent denatured protein or arise from the binding of various kinds of 
ligands (Dempsey et ai., 1981; Trulzsch & Arias, 1981). Binding of long-
chain fatty acids to bovine liver FABP (Haunerland 4 Spener, 1980) and hu-
man serum albumin (Basu et ai., 1978) was reported to be accompanied by a 
low pi value. Therefore, delipidation of the proteins appears to be an im-
portant prerequisite for the proper characterization of FABP. 
Immunochemical cross-reactivity of FABPs from different tissues has 
been observed. An antiserum raised agianst purified rat liver FABP was re-
active with the cytosol of intestine, adipose tissue, heart, skeletal 
muscle, kidney and testis (Ockner & Manning, 1974; Ketterer et ai., 1976; 
Rüstow et ai., 1982), and that against rat jejunal FABP was reactive with 
the M 12,000 fraction of liver, adipose tissue and heart cytosol (Ockner & 
Manning, 1974). However, the FABPs from human liver and adipose tissue are 
immunochemically different from those in the corresponding rat tissues 
(Rüstow et ai., 1982; Ul-Haq et ai., 1983). The possibility that other close-
ly related but immunochemically distinct FABPs are also present in the va-
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rious tissues is, however, not excluded. 
In the previous chapter we showed that rat heart cytosol exhibits a 
fatty acid-binding capacity of similar magnitude to that of liver. FABP from 
rat and pig heart has only been studied by Fournier and co-workers (1978, 
1983a,b). In order to compare the molecular properties of rat heart and li­
ver FABP we purified and partially characterized FABP from both tissues. 
The results indicate that heart and liver FABP have a similar H as deduced 
r 
from SDS-polyacrylamide gel electrophoresis, but show different ρJ values. 
11.2. MATERIALS AND METHODS 
Purification of FABP 
Male albino Wistar rats, weighing 180-220 g, were used. The rats were 
fed ad libitum and sacrificed during the light phase of the diurnal cycle 
(chapter 10). Rat liver and heart cytosol were prepared as described in 
section 2.2. No attempt was made to remove residual albumin, which is pre­
sent in the heart cytosol, but not in the liver cytosol (section 10.2). The 
cytosolic proteins were delipidated by chromatography on Lipidex at 37 C, 
as described in section 10.2, and stored at -20 С until use. All further 
steps in the purification of FABP were performed at 4 C. The delipidated 
cytosol (40-100 mg protein) was applied to a column of Sephadex G-75 (1.6 χ 
85 cm), equilibrated with 30 mM Tris-HCl (pH 8.0). The flow rate was 20 
ml/h and 3.7 -ml fractions were collected. Fractions containing FABP acti­
vity (no. 31-36; Fig. 10.5, page 146) were combined, concentrated by ultra­
filtration using a Diaflo UM-2 or PM-10 membrane (Amicon Corporation, Lex­
ington, MA, U.S.A.), and applied to a DEAE-Sephacel column (1.8 χ 12 cm), 
equilibrated with 30 mM Tris-HCl (pH 8.0). The flow rate was 35 ml/h and 
the fraction volume 3.8 ml. The column was washed with the same buffer un­
til the first protein peak was completely eluted (Fig. 11.1). Retained pro­
tein was then eluted with a linear gradient (2 χ 70 ml) of 0-0.3 M KCl in 
30 mM Tris-HCl (pH 8.0). 
Protein was located in chromatographic fractions by measuring the 
Агво and quantitated as described in section 2.3. Assay of palmitate bin­
ding was performed as described in section 8.2, using 50-200-μΐ samples and 
1 μΜ [1-1 ',C]palmitate. 
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Polyacrylamide slab gel electrophoresis 
FABP-containing fractions at various stages of purification were sub-
jected to Polyacrylamide slab gel electrophoresis in SDS (15% (w/v) acryl-
amide, of which 3% (w/v) bisacrylamide, and 0.1% (w/v) sodium dodecyl sul-
phate at pH 8.8) according to the method of Laemmli (1970). The Pharmacia 
Gel Electrophoresis Apparatus GE-2/4 was used (Pharmacia Fine Chemicals, 
Uppsala, Sweden). Each slot was loaded with about 5-25 VS of protein. Gels 
were stained with 0.2% Coomassie Brilliant Blue R-250 (Merck, Darmstadt, 
F.R.G.) in methanol/acetic acid/water (50:7:43, by vol) and destained with 
methanol/acetic acid/water (5:7:88, by vol). 
Isoelectric focusing 
Isoelectric focusing was carried out in gel rods using the same ap-
paratus as for gel electrophoresis and Parmalyte ampholytes (pH 3 to 10; 
Pharmacia Fine Chemicals, Uppsala, Sweden). The anode and cathode solutions 
were 10 mM phosphoric acid and 20 mM NaOH, respectively. Protein samples 
(5-10 yg per gel rod) were subjected to focusing at 400 V. The gel rods 
were stained with 0.1% Coomassie Brilliant Blue R-250 in ethanol/acetic 
acid/water (25:8:67, by vol) and destained with the same solution without 
the dye. 
11.3. RESULTS 
Purification of FABP from rat heart and liver 
Fatty acid-binding protein was purified from the delipidated cytosol 
of rat heart and liver by gel-filtration and ion-exchange chromatography. 
Following fractionation on Sephadex G-75, fatty acid-binding activity was 
with both preparations mainly present m fractions corresponding to a mo-
lecular weight of 10,000-15,000, but some activity was also found in the 
region of M 1500-2000 (elution profiles are shown in Fig. 10.5, pages 146 
and 147). The latter fractions, that contain a fatty acid-bindmg peptide 
(Suzue & Marcel, 1975; Rustow et al., 1978, 1979), were not further studied. 
With rat heart cytosol, fatty acid-binding activity was usually also pre-
sent m the high-M region ( >M 50,000), due to the presence of residual 
r r 
albumin (cf. chapter 10). This activity peak was, however, always complete-
ly separated from the FABP-containing fractions (M 10,000-20,000 proteins). 
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Fig. 11.1. Purification of FABP from rat heart and liver on DEAE-Sephacel. 
The combined, FABP-containing fractions of the Sephadex G-75 
column were chromatographed on DEAE-Sephacel with 30 mM Tris-HCl, 
pH 8.0 (up to fraction 36) and subsequently with a linear gra­
dient of 0-0.3 M KCl in the same buffer, as described in sec­
tion 11.2. 
Fractions were assayed for protein by measuring A2ia (—) and 
for palmitate binding (o). In order to trace myoglobin, the 
protein fractions from heart were also measured at 434 nm. 
Absorbance at this wavelength was only found with fractions 
18-23. 
The results are shown of representative experiments, in which 
1.6 mg (heart) and 2.9 mg (liver) of protein were applied to the 
column. 
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The combined FABP-containing fractions were further purified by an-
ion-exchange chromatography on DEAE-Sephacel at pH 8.0. As shown in Fig. 
11.1, liver FABP was not retained by the column in contrast to heart FABP. 
The latter protein could be eluted from the column by applying a linear 
gradient of KCl. These observations indicate that liver FABP is a basic 
protein that has a pi which is higher than that of heart FABP. 
Table 11.1. gives a summary of the purification procedure. For liver 
Table 11.1. Purification of fatty acid-binding protein from rat heart and 
liver. 
Protein Specific Recovery Purification 
fatty acid- of 
binding binding 
activity activity 
(mg) (pmol/yg protein) ( % ) (-fold) 
HEART 
Delipidated 105, 
supernatant 
Sephadex G-75 b 
DEAE-Sephacel b 
LIVER 
Delipidated 105, 
supernatant 
Sephadex G-75 b 
DEAE-Sephacel b 
,000 χ 
,000 χ 
9 
9 
39.7 
11.4 
2.0 
129 
8.4 
2.2 
3.6 C 
4.3 
18.4 
2.3 
19.3 
41.7 
100 
35 
26 
100 
55 
31 
1 
1.2 
5.2 
1 
8.4 
18.1 
Heart and liver cytosol were obtained from rats sacrificed during the light 
phase of the diurnal cycle. The results given are representative for four 
independent experiments with each tissue. 
Determined with 1 μΜ [l-^Cjpalmitate. 
The concentrating of the samples prior to chromatography gave a loss of 
protein of 20-25%. 
Fatty acid binding is also due to the presence of residual albumin in this 
preparation (see text). 
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FABP a final purification factor of 1Θ was obtained and the overall reco­
very was 31% with respect to the delipidated cytosolic proteins. This puri­
fication factor is in accordance with the hepatic content of FABP (during 
the light phase of the light cycle) of about k-5% of the cytosolic proteins 
(Ockner et al., 1962; sections 8.4 and 10.3). For heart FABP the purifica­
tion factor is much lower, although the cytosolic content of FABP in this 
tissue appears comparable to that of liver (section 10.3). This lower value 
can partly be explained by underestimation of the purification factor, due 
to the presence of albumin in the cytosol preparation. As the palmitate 
binding activity of dealbuminized heart cytosol is 2.02 ±0.30 pmol/yg pro­
tein (meant S.D. of 3 determinations; taken from chapter 10), the corrected 
purification factor would amount to about (18/2:) 9. Hence, contaminating 
proteins are still present in the FABP preparation, or some loss of func­
tional activity has occurred during the purification procedure, 
The FABP-containing fractions at various stages of purification were 
examined by SDS Polyacrylamide gel electrophoresis at pH 8.8. The fractions 
obtained after Sephadex G-75 chromatography of both the heart and liver cy­
tosol showed only a few protein bands (Fig. 11.2, slot 3 and 7). After fur­
ther purification on DEAE-Sephacel, heart FABP showed a single band on the 
gel, corresponding to M 12,000 (Fig. 11.2. slot 5). The latter value is in 
agreement with observations by Fournier et al. (1978). The protein fraction 
not retained by the DEAE-Sephacel column at pH 8.0 mainly comprises myoglo­
bin, as judged by gel electrophoresis (Fig. 11.2, slot A) but also by its 
specific absorption at 434 nm (Fig. 11.1). The chromatographic behaviour 
corresponds to the reported ρJ values (7.5-8.5) for myoglobin from other 
animal species (Righetti & Caravaggio, 1976; Righetti et ai., 1981). Gel 
electrophoresis of the purified liver FABP, obtained after DEAE-Sephacel 
chromatography, revealed a major protein band corresponding to M 12,000, 
which represents FABP (Ockner et al., 1982; section 1.5), and some minor 
bands (Fig. 11.2, slot 8). 
When purified heart and liver FABP were subjected to isoelectric 
focusing, single bands were observed at approximately pH 7.0 and 8.0, res­
pectively (results not shown). These values are consistent with the beha­
viour of the proteins on DEAE-Sephacel chromatography. 
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HEART LIVER 
1 2 3 Д 5 6 7 8 
2. Polyacrylamide slab gel electrophoresis in SDS at pH 8.8 of 
FABP-containing fractions from rat heart (slot 2-5) and liver 
(slot 7 and 8) at various stages of purification. 
The numbers correspond to: 
1, calibration proteins (withM
r
): Phosphorylase a (93,000), 
bovine serum albumin (68,000), leucine aminopeptidase 
(54,000), ovalbumin (45,000), a-chymotrypsinogen A (26,000), 
A2 chain of calf a-crystallin (20,000), myoglobin (17,000) 
and cytochrome с (12,400). 
2, delipidated heart cytosol (25 pg protein). 
3, combined FABP-containing fractions after Sephadex G-75 chro­
matography (25 \ig protein). 
4, fraction 20 from DEAE-Sephacel column (10 pg protein). 
5, fraction 41 from DEAE-Sephacel column (7 yg protein). 
6, calibration proteins (see 1), 
7, combined FABP-containing fractions after Sephadex G-75 chro­
matography (5 ug protein). 
8, fraction 21 from DEAE-Sephacel column (5 pg protein). 
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Fatty acid binding by the purified FABP preparations 
The binding of palmitate by FABP from heart аз well as from liver was 
proportional to the amount of protein up to the binding of about 40-50% of 
the available fatty acid (Fig. 11.3), as was also observed with albumin 
(Fig. 8.2) and delipidated cytosolic proteins of both tissues (Fig. 10.2). 
In contrast to cytosolic protein preparations (chapter 10), palmitate bin­
ding activity of purified FABP decreased upon storage of the protein sam­
ples at -20 C, either lyophilized or in buffer solution (10 raM K-phosphate, 
pH 7.4) with or without 10% (v/v) glycerol. Loss of functional activity oc­
curred sooner with heart FABP than with liver FABP. 
When palmitate binding to FABP was studied as a function of the total 
palmitate concentration and the binding isotherms analyzed by means of a 
Scatchard plot (cf. chapter 10), a single class of saturable binding sites 
was observed (data not shown). With freshly purified heart FABP the appa­
rent К for palmitate was calculated to be 0.47 yM and the binding capacity 
53 pmol/yg FABP (one preparation, tested in triplicate) . For liver FABP the 
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Fig. 11.3. Effect of the amount of purified FABP from rat liver (·) and 
heart (o) on the binding of palmitate. Measurements were perfor­
med with 1 yM [l-'^C]palmitate according to the procedure des­
cribed in chapter 8. The results are shown of one representative 
experiment out of three. 
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apparent К was 0.65 ±0.06 μΜ and the binding capacity 79±6 pmol/pg FABP 
(means ± S.D. for 3 fresh preparations). Since both FABPs have a « of ap­
proximately 12,000 (Fig. 11.2), the binding capacity is about 0.6 and 
0.95±0.07 mol/mol FABP (heart and liver, respectively). The value for li­
ver FABP indicates the presence of one fatty acid-binding site per protein 
molecule, as was earlier suggested (section 8.4). The binding capacity 
found for heart FABP will have been underestimated, due to loss of binding 
activity during purification. 
11.A. DISCUSSION 
The fatty acid-binding proteins isolated from heart and liver were 
found to have virtually identical molecular weights, as determined by SDS-
polyacrylamide gel electrophoresis (M about 12,000), but behaved distinct-
ly on anion-exchange chromatography at pH 8.0. FABP from liver appeared to 
be a basic protein with a pi of approximately 8.0, which is higher than 
that of heart FABP (pJ approximately 7.0). Our pJ value for liver FABP is 
higher than the values reported by most other laboratories (Ketterer et al., 
1976; Matsushita et al., 1977; Trulzsch & Arias, 1981; Ockner et ai., 1982; 
cf. Table 1.3, page 25). This difference is most likely caused by the ab­
sence of endogenous fatty acids in our preparations, since defatted prepa­
rations of bovine liver FABP (Haunerland & Spener, 1980) and of human serum 
albumin (Basu et al., 1978) show a higher pJ value than non-defatted sam­
ples. The acidic forms of FABP may also arise from the binding of endoge­
nous ligands (Trulzsch & Arias, 1981; Ockner et ai., 1982). FABP from deli-
pidated rat heart cytosol was, however, earlier reported to have a pi of 
5.0 (Fournier et al., 1978), but the delipidation procedure (treatment with 
20% (v/v) butanol) used by these investigators is denaturing for FABP 
(Trulzsch & Arias, 1981). 
One of the difficulties with the purification of heart FABP is its 
separation from myoglobin, which is present in relatively large quantities 
in rat heart (about 0.2-0.3 pmol/g wet weight tissue; Reynafarje, 1963; 
Schuder et al., 1979), and also has a low molecular weight (M 16,400). Be­
cause of the high pX value of myoglobin, complete separation of the two 
proteins could be achieved on anion-exchange chromatography at pH 8.0, as 
was also observed by Fournier et al. (1978). The purity of heart FABP was 
demonstrated on SDS-polyacrylamide gels, but did not appear from the palmi-
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tate binding capacity (assuming one fatty acid-binding site per protein 
molecule), nor from the observed purification factor, when based on a cyto-
solic FABP content of about 4% (chapter 10). Therefore, purification of the 
protein was accompanied by loss of functional activity . 
For both purified heart and liver FABP the apparent К for palmitate 
is lower than that observed with the corresponding cytosolic protein sam­
ples (about 0.8 and 1.0 μΜ for heart and liver cytosolic protein, respec­
tively; chapter 10). This may relate to a hampered fatty acid binding by 
the latter preparations, due to the presence of large amounts of contamina­
ting proteins. The observed apparent dissociation constants are slightly 
lower than found for purified rat liver FABP by equilibrium-dialysis stu­
dies {K = 1 μΜ; Ketterer et a2., 1976) and for purified pig heart FABP by 
electron spin resonance spectroscopy {K = 0.85 μΜ; Fournier et ai., 1983a). 
The affinity of FABP for palmitate appears of the same order of magnitude 
as that reported for the high-affinity binding sites of albumin (Spector, 
1975). 
It is clear that further studies are necessary to define the condi­
tions under which FABP does not loose its functional property during and 
after purification, and to more completely characterize the proteins from 
rat heart and liver. An additional purification step may also be considered 
to remove the few contaminating proteins that were found to be still pre­
sent in the liver FABP preparation (Fig. 10.2). Amino acid analyses and 
cross-reactivity of antibodies raised against the liver and heart FABP may 
reveal similarities and differences between the two proteins. Finally, 
purified FABP preparations can be used as a tool for the study of its role 
in cellular fatty acid metabolism. 
11.5. SUMMARY 
Fatty acid-binding protein (FABP) was purified from the delipidated 
cytosol of rat heart and liver by gel-filtration on Sephadex G-75 and ion-
exchange chromatography on DEAE-Sephacel at pH 8.0. 
The homogeneity of heart FABP was demonstrated by a single band on 
SDS-polyacrylamide gels. In the liver FABP preparation some contaminating 
proteins were still present. 
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The heart and liver FABP have almost identical molecular weights (W 
approximately 12,000; found with SDS-polyacrylamide gel electrophoresis), 
but the liver FABP is more basic (pr approximately 8.0) than the heart FABP 
(pi approximately 7.0). 
Functional activity of FABP appeared to decrease during and after pu-
rification from liver and, especially, from heart. 
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CHAPTER 12 
SURVEY AND SUMMARY 
12.1. INTRODUCTION 
Fatty acids represent the main fuel for energy production in both 
skeletal muscle and heart, especially during rest and prolonged exercise, 
and after fasting (section 1.3). Increasing our understanding of the path­
way of fatty acid oxidation and its regulation will provide a better in­
sight in the functioning of normal and pathological muscle. The biochemical 
investigations described in this thesis deal with two aspects of fatty acid 
oxidation in muscle: a comparison of the use of cell-free and cellular sys­
tems for oxidation measurements (chapters 3-7), and studies on the assay 
and the role of the fatty acid-binding protein in fatty acid metabolism 
(chapters 8-11). 
12.2. FATTY ACID OXIDATION IN SKELETAL AND CARDIAC MUSCLE 
With isolated mitochondria fatty acid oxidation rates can accu­
rately be measured by Polarographie determination of the oxygen consump­
tion. For whole homogenates or cellular systems, however, this method ap­
pears unsuitable because of the interference of endogenous substrates and 
of the oxygen binding protein myoglobin. Therefore, with the latter systems 
fatty acid oxidation rates are usually determined radiochemically from the 
production of 1'tC02 from ['''C]fatty acids. In earlier studies from this la­
boratory (Van Hinsbergh et al., 1978a,b, 1979, 1980), in which the Polaro­
graphie and radiochemical assay were compared for muscle mitochondria, it 
was established that '''СОг production can not be taken as an accurate mea­
sure for fatty acid oxidation rates. Calculation of the oxidation rate from 
the sum of l',C0z and '''C-labeled acid-soluble products, formed during oxi­
dation of [1Цс]fatty acids, was found to agree better with the polarogra-
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phically determined rate and to be more sensitive. The latter radiochemical 
assay procedure appeared also suitable for the measurement of fatty acid 
oxidation rates in muscle whole homogenates and cellular systems (chapters 
3 and 7). The contribution of the ^ СОг production to the total oxidation 
rate was generally higher with the cellular than with the cell-free systems 
(Table 12.1). 
Table 12.1. Proportional contribution of 1ЧС02 production to the /i-'^cj-
palmitate oxidation rate by rat skeletal and cardiac muscle. 
System Diaphragm Heart 
Mitochondria 1 0 + 2 1 6 + 2 
Homogenate 12 ± 5 18 ± 3 
Slices / intact muscle 53 + 3 66 ± 8 
Myocytes - 68 ± 7 
Values are given in % of the total sum of ' ''ССЬ and ' l,C-labeled acid-soluble 
products and are means ± S.D. of 5-25 experiments. 
Although it is clear from the present and previous studies that fatty 
acid oxidation rates can not accurately be determined only from the produc­
tion of '''СОг from ['^C]fatty acids, this method is still being used by va­
rious investigators (Paul & Adibi, 1979; Sumbilla et al., 1981; Okano & 
Shimojo, 1982; Barakat et al., 1982, 1983; Shumate et al., 1982; Carroll et 
al., 1983; Menon & Dhopeshwarkar, 1983). Comparison of '"СОг production 
rates from ['""С]fatty acids may in some cases (e.g. perfused heart prepara­
tion) permit valid conclusions, but in many cases results do not appear 
meaningful. 
Feeding of Clofibrate, an effective hypolipidemic and hypocholestero-
lemic drug, to rats was found to predominantly affect oxidative metabolism 
in rat liver and hardly in skeletal muscle (chapter 6). These observations 
disprove those of Paul & Adibi (1979, 1980), who based their conclusions on 
'"•СОг production rates, and indicate that myopathic phenomena observed af­
ter chronic Clofibrate administration are not related to changes in the ca­
pacity of oxidative metabolism of muscle. 
170 
The developed assay for fatty acid oxidation was applied to study the 
postnatal development of palmitate oxidation in both intact preparations of 
rat skeletal muscle and homogenates of skeletal and cardiac muscle (chapter 
4). Palmitate oxidation by hemidiaphragm and intact m.flexor digitorum bre-
vis gradually decreases with development to adult values which are about 
35% of those at birth. The oxidation capacities of diaphragm, m.quadriceps 
and, particularly, of heart increase steadily during development, together 
with the activities of the mitochondrial marker enzymes cytochrome с oxi­
dase and citrate synthase. In heart the increase of the oxidative capacity 
results from an increase of both mitochondrial content and mitochondrial 
activity, but in diaphragm and m.quadriceps only from a change of the mito­
chondrial activity. 
With cell-free preparations it was previously observed (Van Hinsbergh 
et al., 1978a,b, 1979, 1980) that the oxidation rate of ['"c]palmitate de­
pends upon the position of the '''C-label in the palmitate molecule. [l-'^C]-
palmitate delivers a larger amount of '"'СОг and 1ЦС-1аЬе1еа acid-soluble 
products than [U-'^C]- or [16-1^C]palmitate, which indicates incomplete 
oxidation of the palmitate molecule and hence accumulation of ß-oxidation 
intermediates. Analysis of the oxidation products of incubations with 
[і6-1цС]palmitate by homogenates and mitochondria of rat m.quadriceps and 
liver revealed that mainly dodecanoic and tetradecanoic acid and their es­
ters accumulate (chapter 5). Their amounts recovered can account for the 
differences in oxidation rates with [l-^C]- and [ló-'^Jpalmitate. With 
intact muscular preparations, however, the oxidation rate was not dependent 
on the position of the 1цС-1аЬе1 in the palmitate molecule. From experi­
ments in which we studied the influence of various parameters on the oxida­
tion of [і- 1 цС]- and [l6-'''C]palmitate, and the demonstration of the occur­
rence of peroxisomal fatty acid oxidation in muscle, it appears that the 
incomplete palmitate oxidation in cell-free systems is mainly caused by an 
inadequate mitochondrial oxidation of peroxisomal oxidation products. 
With rat hemidiaphragm the palmitate oxidation rate increases consi­
derably with the external palmitate concentration and the palmitate¡albumin 
molar ratio throughout the range of physiologically relevant concentrations 
(chapter 3). Palmitate oxidation rates were also concentration dependent in 
human and rat heart slices, but not with calcium-tolerant rat cardiac myo-
cytes (chapter 7). When measured at O.A mM albumin, the apparent К for 
palmitate oxidation was with hemidiaphragm from 18-h starved rats 2.8 mM 
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Table 12.2. Kinetic parameters of the concentration dependence of palmitate 
oxidation in rat muscle. 
System Apparent κ ν 
'
 к
 га max (mM) (nmol/min per g) 
Heart homogenate , 0.27 891 
Heart slices 1Л5 17 
M.quadriceps homogenate 0.36 249 
Diaphragm homogenate 0.37 701 
Hemidiaphragm 2.76 32 
Hemidiaphragm (3 days starved) 0.98 25 
Parameters were calculated from Lineweaver-Burk plots of oxidation rates 
measured at 0.4 mM albumin (with heart slices at 0.3 mM albumin). 
and decreased after prolonged starvation of the animals (Table 12.2). The 
К values were generally lower in homogenates of skeletal and cardiac 
m 
muscle than in intact cellular systems. These differences can largely be 
explained by variations in the degree of label dilution of the added [ 1 ЦС]-
palmitate with free fatty acids derived from endogenous lipid stores (chap­
ters 3 and 7). The maximal rate of palmitate oxidation by hemidiaphragm de­
pends hardly on the albumin concentration in the medium, does not change 
after prolonged starvation, and is about equal to the rate of endogenous 
free fatty acid consumption, determined from the release of glycerol (25-30 
nmol/min per g in all cases). Palmitate oxidation by intact muscles appears 
to be hampered by a slow diffusion of substrate in the muscle, since the 
oxidation rates, when based on citrate synthase activities, are much higher 
with isolated rat cardiac myocytes than in heart slices. The oxidation ca­
pacities of various rat skeletal muscles and of human and rat heart, deter­
mined with whole homogenates, are severalfold higher than the oxidation 
rates with intact preparations (Table 12.2). 
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12.2. FATTY ACID-BINDING PROTEIN OF RAT HEART AND LIVER 
Fatty acid-binding protein (FABP) has been identified in many tissues 
that utilize fatty acids (section 1.5). This protein of M 12,000 is as-
sumed to participate in the intracellular transport and/or storage of fatty 
acids, much like albumin does extracellularly. FABP may thus function in 
mitochondrial and peroxisomal fatty acid oxidation, triacylglycerol synthe-
sis and degradation and hepatic cholesterol esterification (Fig. 12.1), but 
also inhibit the detrimental effects exerted by fatty acids and their deri-
vatives (Severson, 1979). In heart, high intracellular levels of fatty 
acids and fatty acyl-CoA esters, occurring during hypoxia and ischaemia, 
have been demonstrated to be involved in the disruption and distorion of 
various cellular membrane processes related to energy metabolism and Ca 2 + 
homeostasis, such as the inhibition of the mitochondrial adenine nucleotide 
translocase. 
PEROXISOME 
- -OMtyl-CoA / i / f n c O 
MITOCHONDRION 
3 —» acyl-CoA j 
no 
C'fattyaad^\ synthetasej 
ENDOTHELIAL WlSSUE CEIL 
CELL ^ 
Fig. 12.1. Putative role of fatty acid-binding protein (FABP) in the cellu-
lar metabolism of long-chain fatty acids. 
VLDL, very low density lipoproteins; chylos, chylomicrons; LPL, 
lipoprotein lipase; (F)FA, (free) fatty acid; ECF, extracellular 
fluid. 
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A radiochemical procedure was developed for the sensitive assay of 
fatty acid binding by proteins (chapter 8). In this assay protein-bound and 
unbound fatty acids are separated by binding the latter to a hydrophobic 
column-packing material, Lipidex 1000, at 0 С This low temperature ap­
peared essential since at a higher temperature protein-bound fatty acids 
are also removed from the solution, in accordance with the protein-lipid 
interaction kinetics. This latter property could, however, favourably be 
applied for the effective delipidation of protein samples (chapter 8) and 
the defatting of commercial preparations of serum albumin (chapter 9). Li­
pidex is particularly suitable since it does not bino4 protein, in contrast 
to charcoal. 
With the radiochemical assay we obtained results on palmitate binding 
to serum albumin similar to those reported on the basis of equilibrium-dia­
lysis (chapter 8). Palmitate binding by cytosolic proteins from rat heart 
and liver was proportional to the amount of protein, only when delipidated 
protein samples were used (chapter 10). Furthermore, after delipidation the 
palmitate binding per yg protein was higher than with non-delipidated sam­
ples, when measured at a low fatty acid concentration. The observations 
show that delipidation is important for the accurate determination of fatty 
acid-binding activities and that Lipidex is well suitable for this treat­
ment. 
The palmitate binding capacity of delipidated proteins from albumin-
free rat heart and liver cytosol was about 2-fold higher when the animals 
were sacrificed at the mid-dark phase compared to the mid-light phase of 
the light cycle (chapter 10). By Sephadex G-75 chromatography of the cyto­
solic proteins it was established that this binding can almost entirely be 
attributed to the presence of FABP. Evidence was also obtained that FABP 
possesses only one fatty acid-binding site per protein molecule. From the 
maximal palmitate binding by the cytosolic proteins we calculated that both 
rat heart and liver contain about 35-40 and 70-80 pg FABP/mg cytosolic pro­
tein at the mid-light and mid-dark phase, respectively. The affinity of the 
protein for palmitate is similar to that of albumin (к = 0.5-1 μΜ)· The 
palmitate oxidation capacity and citrate synthase activity also exhibited 
a concomitant diurnal periodicity in rat liver and, to a lesser extent, in 
rat heart. 
FABP was purified to homogeneity from both rat heart and liver by gel-
filtration on Sephadex G-75 and ion-exchange chromatography on DEAE-Sephacel 
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at pH 8.0 (chapter 11). The FABPs from both tissues have an almost identi-
cal molecular weight (M 12,000), but the liver FABP appears to be more 
basic (pi approximately 8.0) than the heart FABP (pJ approximately 7.0). 
Previous estimations of the FABP content of rat heart cytosol have 
been too low, due to the use of a less suitable binding assay or antibodies 
raised against liver FABP. The latter do likely not show complete cross-
reactivity with heart FABP, since both proteins have different molecular 
properties. Because of its high cytosolic concentration and its remarkable 
diurnal variation we suggest that FABP may play an important role in cel-
lular lipid metabolism by modulating the availability of fatty acids and 
their derived acyl esters. In this way the protein may indirectly be invol-
ved in many processes of cellular metabolism. 
A major part of this thesis is concerned with methodological aspects 
of the measurement of fatty acid oxidation in various muscle preparations 
and the detection and purification of FABP. On the basis of these studies, 
further investigations are feasible, in which the role of FABP in muscular 
fatty acid metabolism will be examined more directly. 
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SAMENVATTING 
VEIZUUROXIDATŒ IN SKELET- EN HARTSPIER 
Vetzuren leveren de belangrijkste bijdrage aan de energie voorziening 
in skelet- en hartspier van mens en dier, met name tijdens rust, bij lang-
durige inspanning en na vasten. Onze kennis omtrent het verloop en de regu-
latie van de vetzuuroxidatie in de spier is beperkt, met name bij de mens. 
Uitbreiding van deze kennis zal leiden tot een beter inzicht in het func-
tioneren van de normale en pathologische spier en tevens mogelijkheden ge-
ven tot diagnostiek en eventueel therapie van metabole spierziekten. Het 
biochemisch onderzoek dat in dit proefschrift wordt beschreven betreft twee 
aspecten van de vetzuuroxidatie in de spier: (a) een vergelijking van het 
gebruik van celvrije en cellulaire systemen voor oxidatiemetingen (hoofd-
stukken 3-7), en (b) de bestudering van de bepaling en de rol van vetzuur-
bindende eiwitten in het vetzuurmetabolisme (hoofdstukken 8-11). 
In hoofdstuk 1 wordt de morfologie van de skelet- en hartspier verge-
leken en wordt een overzicht gegeven van de huidige kennis omtrent het ge-
bruik van energie-leverende substraten door de dwarsgestreepte spier, en 
omtrent de fysisch-chemische eigenschappen en functionele aspecten van in-
tracellulaire vetzuurbindende eiwitten. In hoofdstuk 2 worden de materialen 
en enkele methodes beschreven, die bij het verdere onderzoek veelvuldig 
werden gebruikt. Deze methodes omvatten de preparatie van de verschillende 
cellulaire en celvrije systemen, de bepaling van de activiteit van enkele 
enzymen en de meting van glycerol en vrije vetzuren. 
Polarografische meting van het zuurstof verbruik is niet geschikt 
voor vetzuuroxidatie metingen aan homogenaten of cellulaire systemen, mede 
omdat deze meting gestoord wordt door de verbranding van endogene substra-
ten en door de aanwezigheid van het zuurstofbindend eiwit myoglobine. Daar-
om wordt de vetzuuroxidatie hierin meestal radiochemisch bepaald uit de 
vorming van '"'СОг uit ['''C]vetzuren. Uit eerdere studies van dit laborato­
rium, waarin de polarografische en radiochemische methodes werden vergele-
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ken, bleek echter dat de ^СОг productie geen goede maat is voor de vet-
zuuroxidatiesnelheid van geïsoleerde mitochondriën. Wanneer de oxidatie-
snelheid wordt berekend uit de som van 1ЦС02 en '''C-gelabelde zuur-oplosba-
re producten, werd een betere overeenstemming gevonden met metingen van het 
zuurstof verbruik. Deze radiochemische methode bleek nu ook bruikbaar voor 
de bepaling van de vetzuuroxidatiesnelheid in homogenaten en cellulaire 
spiersystemen (hoofdstukken 3 en 7). De bijdrage van de '''СОг productie aan 
de totale vetzuuroxidatiesnelheid was met celvrdje systemen minder dan 20%, 
maar met cellulaire systemen 30-70%. 
Toediening van het bloed-lipide gehalte verlagende geneesmiddel clo-
fibraat aan ratten bleek hoofdzakelijk het oxidatief metabolisme in de le­
ver te beïnvloeden, en nauwelijks dat in de skeletspier (hoofdstuk 6). Deze 
bevindingen weerleggen die uit de literatuur, welke gebaseerd werden op be-
paling van uitsluitend '''СОг productie. 
De radiochemische methode is ook toegepast voor de bestudering van de 
postnatale ontwikkeling van de palmitaat oxidatie (hoofdstuk 4). De oxida­
tiecapaciteit van diafragma, m.quadriceps en vooral van hartspier nemen in 
de rat na de geboorte aanzienlijk toe. Deze toename gaat gepaard met een 
toename van de activiteiten van de mitochondriële enzymen cytochroom с oxi­
dase en citraat synthase. De toename van de oxidatiecapaciteit із in hart 
het gevolg van een toename van zowel het mitochondrieel gehalte als de mi­
tochondriële activiteit, maar in de twee skeletspieren te danken aan uit-
sluitend een toename van de mitochondriële activiteit. 
In celvrije systemen is de hoeveelheid radioactiviteit, die gevonden 
wordt in СОг en zuur-oplosbare producten bij oxidatie van [1ЦС]palmitaat, 
afhankelijk van de positie van het label in het palmitaatmolecuul (hoofd­
stuk 5). Deze hoeveelheid is groter met [1-II,C]- dan met [ 16-ll,C]palmitaat, 
hetgeen duidt op accumulatie van B-oxidatie intermediairen. Deze intermedi-
airen bleken hoofdzakelijk dodecaan- en tetradecaanzuur en hun esters te 
zijn. Met intacte spierpreparaten trad geen accumulatie op. Uit studies, 
waarbij gekeken is naar de invloed van verschillende parameters op deze ac­
cumulatie en het feit dat peroxisomale vetzuuroxidatie kon worden aange­
toond in de spier, is geconcludeerd dat de onvolledige palmitaatoxidatie in 
celvrije systemen voornamelijk wordt veroorzaakt door een onvoldoende mito­
chondriële oxidatie van peroxisomale oxidatieproducten. 
De oxidatie capaciteiten gemeten aan homogenaten van humaan en ratte-
hart en van verschillende skeletspieren van de rat zijn aanzienlijk hoger 
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dan de oxidatiesnelheden gemeten met coupes of intacte spieren (hoofdstuk­
ken 3 en 7). Gemeten bij een constante albumine concentratie is de schijn­
bare К voor palmitaat oxidatie over het algemeen lager in homogenaten dan 
in cellulaire systemen, als gevolg van verschillen in labelverdunning van 
het toegevoegde palmitaat met vetzuren van endogene oorsprong. De palmitaat 
oxidatiesnelheid in hemidiafragma is sterk afhankelijk van de vetzuurcon­
centratie in het medium en van de vetzuur:albumine verhouding (hoofdstuk 
3). Een dergelijke afhankelijkheid is ook waargenomen met coupes van humaan 
en rattehart, maar niet met geïsoleerde hartcellen van de rat (hoofdstuk 
7). De vetzuuroxidatie gemeten met intacte spiersystemen wordt gehinderd 
door de langzame diffusie van het vetzuur in het spierweefsel. In geïso-
leerde hartcellen bleek de palmitaatoxidatiesnelheid hoger dan in hartcou-
pes van de rat, wanneer de oxidatiesnelheden werden gerelateerd aan de ci-
traatsynthase activiteit (hoofdstuk 7). 
In hoofdstuk 8 wordt een geschikte radiochemische methode beschreven 
voor de bepaling van de vetzuurbinding aan eiwitten. Bij deze methode wor-
den eiwitgebonden en vrije vetzuren gescheiden door binding van de laatste 
aan een hydrofoob kolomraateriaal, Lipidex 1000, bij 0 C. Van de eigenschap 
dat bij een hogere temperatuur de eiwitgebonden vetzuren ook worden ont-
trokken kan gebruik gemaakt worden voor het effectief delipideren van ei-
witfracties (hoofdstuk 8) en voor het ontvetten van commerciële albumine 
preparaten (hoofdstuk 9)· De met deze methode bepaalde vetzuurbinding aan 
albumine gaf resultaten, die vergelijkbaar zijn met literatuurgegevens 
(hoofdstuk 8). De palmitaatbinding aan cytosolische eiwitten van hart en 
lever van de rat is alleen evenredig met de hoeveelheid eiwit, wanneer ge-
delipideerde eiwitmonsters worden gebruikt (hoofdstuk 10). 
De vetzuurbindende capaciteit van de cytosolische eiwitten van hart 
en lever is twee keer zo hoog wanneer de ratten worden gedood in het midden 
van de donkerfase in vergelijking met de lichtfase (hoofdstuk 10). Deze 
vetzuurbinding kon grotendeels toegeschreven worden aan de aanwezigheid in 
het cytosol van het vetzuurbindend eiwit van M 12,000. Aangezien dit eiwit 
slechts één bindingsplaats voor vetzuren heeft (hoofdstuk 11), kon worden 
berekend dat zowel in hart als in lever het vetzuurbindend eiwit in de 
lichtfase ongeveer 4 en in de donkerfase ongeveer 8% van de cytosolische 
eiwitten uitmaakt. 
In hoofdstuk 11 is de zuivering van vetzuurbindende eiwitten uit rat-
tehart en lever beschreven. De eiwitten uit beide weefsels hebben een 
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zelfde molecuulgewicht (M 12,000), maar het lever eiwit is basischer (pJ 
ongeveer 8.0) dan het eiwit uit de hartspier (pi ongeveer 7.0). 
Het hoge vetzuurbindend eiwit gehalte van hart en lever cytosol en de 
opmerkelijke dagelijkse schommelingen daarin doen vermoeden dat dit type 
eiwit een belangrijke rol speelt in het lipide metabolisme van de cel door 
regulering van de beschikbaarheid van vetzuren en hun acyl esters. 
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CURRICULUM ГГАЕ 
De auteur van dit proefschrift werd op 20 januari 1955 te Oss gebo­
ren. Na het behalen van het diploma HBS-B aan het St. Сапізіиз College te 
Nijmegen in 1972 begon hij in datzelfde jaar de studie scheikunde aan de 
Katholieke Universiteit te Nijmegen. Op 30 juni 1975 werd het kandidaats­
examen (S 2) afgelegd. Voor de doctoraalstudie werden twee hoofdvakstages 
gevolgd: biofysische chemie (Prof. Dr. C.W. Hilbers en Dr. P.J.M. Salemink) 
en biochemie, gedeeltelijk uitgevoerd in Nijmegen (Prof. Dr. J.H. Veerkamp 
en Dr. V.W.M. Van Hinsbergh) en aan de Rijksuniversiteit te Utrecht (Prof. 
Dr. K.W.A. Wirtz en Dr. B.J.H.M. Poorthuis). Daarnaast behaalde hij op 21 
januari 1976 het diploma deskundigheid stralingshygiëne voor een C-labo-
ratorium. Tijdens de doctoraalstudie verleende hij assistentie bij het op-
zetten en begeleiden van een radionuclidencursus voor chemici. Op 25 juni 
1979 werd het doctoraalexamen afgelegd. 
Van 1 augustus 1979 tot 1 augustus 1983 was hij als wetenschappelijk 
medewerker in dienst van de afdeling Biochemie, Medische Faculteit van de 
Katholieke Universiteit te Nijmegen. In deze functie verrichtte hij onder 
leiding van Prof. Dr. J.H. Veerkamp een onderzoek waarin diverse aspecten 
van het vetzuurmetabolisme in skelet- en hartspier werden bestudeerd, zo-
als in dit proefschrift is beschreven. Gedurende deze tijd leverde hij te-
vens een bijdrage aan het onderwijs aan medische en tandheelkundige studen-
ten. 
In februari 1983 werd hij door financiële steun van de Medische Fa-
culteit in de gelegenheid gesteld werkbezoeken te brengen aan vijf labo-
ratoria in de U.S.A. 
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TOELICHTING 
ΥΕΙΖυυΚΟΧΙΟΑΉΕ IN SKELET- EN HARTSPIER 
De зріег speelt naast het skelet een belangrijke rol bij de hou­
ding en beweging van mens en dier. De voor het verrichten van spierar-
beid benodigde energie wordt voornamelijk verkregen door verbranding 
van koolhydraten en vetten, waarbij de laatste de belangrijkste bijdrage 
leveren. Grote verschillen in spieractiviteit zijn mogelijk door de aan­
wezigheid van een uiterst flexibel mechanisme, dat op elk moment zorg 
draagt voor de juiste energievoorziening. Het spierweefsel omvat АО tot 
50% van het lichaamsgewicht en is daardoor ook zeer belangrijk voor de 
energiehuishouding van het lichaam. Onze kennis omtrent het verloop van 
de energievoorziening in de spier en de regulatie daarvan is beperkt, 
met name bij de mens. Bij het in dit proefschrift beschreven biochemisch 
onderzoek is gekeken naar de betekenis van vetzuren (uit vetten ge­
splitste voedingsstoffen) voor de energieproductie in skelet- en hart­
spier. 
De verbranding van vetzuren tot koolstofdioxide (CO2) en water 
vindt plaats in bepaalde organellen van de cel, de mitochondriën, die 
energielevering als belangrijkste functie hebben. Bij de bestudering van 
de vetzuurverbranding (vetzuuroxidatie) is het gebruik van intacte mi-
tochondriën een vereiste. We kunnen gebruik maken van verschillende 
spierpreparaten, zoals zgn. cellulaire systemen (hele spieren en geïso-
leerde spiercellen) en celvrije systemen (spierhomogenaten en geïso-
leerde mitochondriën). Voor meting van de vetzuurverbranding wordt ge-
bruik gemaakt van radioactief gemerkte vetzuren, waarbij de verbran-
dingssnelheid wordt berekend uit de vorming van radioactief gemerkte 
oxidatieproducten. Met deze methode zijn onder andere de eigenschappen 
vergeleken van de celvrije en de meer complexe cellulaire systemen, en 
ook de verschillen bestudeerd tussen skelet- en hartspierpreparaten 
afkomstig van mens en rat. De hartspier heeft een hogere capaciteit 
voor vetzuurverbranding dan de onderzochte skeletspieren, die op hun 
beurt ook weer onderling verschillen in verbrandingscapaciteit. De be-
palingsmethode kan gebruikt worden voor diagnostiek van spierziekten 
die het gevolg zijn van storingen in de vetstofwisseling. 
De in de spier benodigde vetzuren worden door het bloed aange-
voerd gebonden aan het eiwit albumine, aangezien ze slecht oplosbaar 
zijn in water. Door de spier wordt alleen het vetzuur opgenomen; het 
albumine blijft in het bloed achter. Hoe de vetzuren vervolgens in de 
spiercel naar de mitochondriën worden getransporteerd is nog niet dui-
delijk. Men neemt aan dat ook hierbij een eiwit is betrokken. Inderdaad 
heeft men in verschillende weefsels, waaronder de spier, een klein ei-
wit aangetoond dat vetzuren kan binden. Van dit vetzuurbindend eiwit 
is echter nog weinig bekend, met name in de spier. In dit proefschrift 
wordt een gevoelige methode beschreven voor de bepaling hiervan. Ge-
bruikmakend van deze bepalingsmethode bleek dat zowel de hartspier als 
de lever van de rat een hoog vetzuurbindend eiwitgehalte hebben en te-
vens dat dit gehalte 's nachts tweemaal zo hoog is als overdag. Deze 
opmerkelijke resultaten doen vermoeden dat het vetzuurbindend eiwit een 
belangrijke rol vervult bij de stofwisseling van vetzuren door regulatie 
van de beschikbaarheid van vetzuren. Het is bekend dat in de hartspier 
hoge concentraties aan vetzuren, zoals die bijvoorbeeld voorkomen bij 
zuurstofgebrek, een schadelijke werking hebben. De aanwezigheid van 
vetzuurbindende eiwitten is mogelijk van belang bij het tegengaan van 
dit effect. 
De ontwikkelde methoden voor de meting van de vetzuurverbranding 
in verschillende spierpreparaten en voor de bepaling van vetzuurbin-
dende eiwitten kunnen goed gebruikt worden bij de verdere bestudering 
van de regulatie van de vetzuur-stofwisseling in de spier. 
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